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Summary 
This thesis describes the research and development of a decision support tool for 
determining a medical patient's suitability for surgical anaesthesia. At present, 
there is a change in the way that patients are clinically assessed prior to surgery. 
The pre-operative assessment, usually conducted by a qualified anaesthetist, is 
being more frequently performed by nursing grade staff. The pre-operative 
assessment exists to minimise the risk of surgical complications for the patient. 
Nursing grade staff are often not as experienced as qualified anaesthetists, and 
thus are not as well suited to the role of performing the pre-operative assessment. 
This research project used data collected during pre-operative assessments to 
develop a decision support tool that would assist the nurse (or anaesthetist) in 
determining whether a patient is suitable for surgical anaesthesia. The three 
main objectives are: firstly, to research and develop an automated intelligent 
systems technique for classifying heart and lung sounds and hence identifying 
cardio-respiratory pathology. Secondly, to research and develop an automated 
intelligent systems technique for assessing the patient's blood oxygen level and 
pulse waveform. Finally, to develop a decision support tool that would combine 
the assessments above in forming a decision as to whether the patient is suitable 
for surgical anaesthesia. 
Clinical data were collected from hospital outpatient departments and recorded 
alongside the diagnoses made by a qualified anaesthetist. Heart and lung sounds 
were collected using an electronic stethoscope. Using this data two ensembles of 
artificial neural networks were trained to classify the different heart and lung 
sounds into different pathology groups. Classification accuracies up to 99.77% 
for the heart sounds, and 100% for the lung sounds has been obtained. Oxygen 
saturation and pulse waveform measurements were recorded using a pulse 
xvii 
oximeter. Using this data an artificial neural network was trained to discriminate 
between normal and abnormal pulse waveforms. A discrimination accuracy of 
98% has been obtained from the system. A fuzzy inference system was 
generated to classify the patient's blood oxygen level as being either an 
inhibiting or non-inhibiting factor in their suitability for surgical anaesthesia. 
When tested the system successfully classified 100% of the test dataset. A 
decision support tool, applying the genetic programming evolutionary technique 
to a fuzzy classification system was created. The decision support tool combined 
the results from the heart sound, lung sound and pulse oximetry classifiers in 
determining whether a patient was suitable for surgical anaesthesia. The evolved 
fuzzy system attained a classification accuracy of 91.79%. 
The principal conclusion from this thesis is that intelligent systems, such as 
artificial neural networks, genetic programming, and fuzzy inference systems, 
can be successfully applied to the creation of medical decision support tools. 
xviii 
Chapter 1: Introduction 
CHAPTER 1 
Introduction 
This thesis presents the problem of providing a decision support tool for the 
anaesthetist, and ergo to model the knowledge of the anaesthetist in evaluating 
patients for pre-operative assessment. This chapter introduces the problem, and 
offers the motivation for this work. The structure of this thesis is outlined, and 
the proposed contribution of this work is stated. 
1.1 Introduction 
In 1798 a Clifton doctor by the name of Thomas Beddoes appointed a new 
superintendent of experiments at his Medical Pneumatics Institution in Bristol, 
England. The appointee was a Cornish chemist named Humphry Davy who set 
to work to investigate newly-discovered gases and their properties in curing and 
preventing disease [1,2]. Davy experimented with nitrous oxide (laughing gas) 
which lead him to describe the effects of breathing the compound as "a sensation 
I 
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Figure 1.1. Gillray's 1802 caricature of Davy's lecture on nitrous oxide at the 
Royal Institution. Davy is pictured holding the bellows [4]. 
analogous to gentle pressure on all the muscles, attended by a highly pleasurable 
thrilling, particularly in the chest and extremities" [3]. Davy became famous for 
these observations and in 1799 was appointed to the Royal Institution in London 
by its founder Count Rumford (Benjamin Thompson)'. Following these 
experiments Davy later went on to describe the effects of nitrous oxide on the 
clinical manifestations of pain and noted that: 
"In cutting one of the unlucky teeth called dentes sapientiae, I 
experienced an extensive inflammation of the gum, accompanied with 
great pain, which equally destroyed the power of repose, and of 
consistent action. On the day when the inflammation was most 
troublesome, 1 breathed three large doses of nitrous oxide. The pain 
always diminished after the first four or five inspirations; the thrilling 
' It may be of interest to note that Davy later went on to offer a young Michael Faraday his first 
scientific appointment at the Royal Institution in 1813. 
2 
z Sl'" _., 
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came on as usual, and uneasiness was for a few minutes, swallowed up 
in pleasure. As the former state of mind however returned, the state of 
organ returned with it; and I once imagined that the pain was more 
severe after the experiment than before. " [3] 
It was with this observation that nitrous oxide became the first anaesthetic of 
modern medicine. 
1.2 The role of the anaesthetist 
The science of anaesthesia has progressed considerably since Davy's first 
experiments to the point where the administration of such drugs requires 
specialist training. The anaesthetist is responsible for deciding whether a patient 
is fit for anaesthesia [5]. The modern anaesthetist plays a critical and varied role 
in healthcare delivery. 
Assessment of patient 
medication 
Assessment of patient 
patnologies 
Monitoring of patient 
respiration 
Monitoring of patient 
pre blood pressure 
Assessment of patient 
respiration 
I Post-operative pain ge management 
1 
Phase #1: 
Pre-operative assessment 
T Assessment of patient 
clinical notes / history 
Assessment o1 patient 
earoio-respiratory function 
Phase #2: 
Surgical process 
T Monoring of patient 
cardiac output 
Monaonng of patient 
anenal oxygenation 
Peri-operative process 
Phase #3: 
Post-operative recovery 
T Assessment of patient cardiac output 
Assessment of patient 
arterial oxygenation 
Figure 1.2. The main stages of the peri-operative process, including the role of 
the anaesthetist during each stage. 
3 
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The anaesthetist `follows' the patient through the entire peri-operative process: 
that is attending the patient when they first enter hospital; through the surgical 
process; and during post-operative recovery. This, however, was not always the 
case and the role of the anaesthetist has evolved over recent years. As Notcutt 
[6] observed, the traditional function of the anaesthetist was once clear: it was 
their job to render the patient insensible for the surgeon to operate. With the 
complexity of surgery increasing and the average patient becoming older due to 
increasing life expectancies [7], the traditional function of the anaesthetist is 
becoming displaced in favour of a more varied responsibility [6]. Figure 1.2 
illustrates the peri-operative process and the typical involvement of the 
anaesthetist. 
1.2.1 The pre-operative process 
In the pre-operative process (i. e., prior to the operation) the anaesthetist is 
responsible for assessing the patient's suitability for anaesthesia [5,8]. The 
anaesthetist decides whether the general physical state of the patient is robust 
enough for the stresses, etc., which are a natural part of surgery, by applying a 
series of tests and clinical scoring tools. Such tools include blood pressure 
measurements, pulse oximetry measurements, lung function tests, body weight 
measurements, etc., (these tests, and more, are discussed in Section 4.1.2). 
Frequently the anaesthetist may have to refer the patient for further investigative 
procedures before a decision can be made. A complete assessment of the 
patient's cardiovascular, respiratory and circulatory systems must be made as it is 
these systems in which the anaesthetist will be intervening during surgery. 
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1.2.2 The surgical process 
It is during the surgical process that the anaesthetist fulfils their more traditional 
role. The anaesthetist renders the patient insensible by placing them in a 
reversible coma using an appropriate mixture of drugs. The drugs and tools have 
changed substantially over recent years [6] and our understanding of human 
physiology has advanced at a steady pace thereby increasing dependency on the 
anaesthetist to care for the patient during surgery. Vohra comments that "its not 
just one big syringe and one small syringe followed by a cup of coffee and 
The Times crossword, " [9]. They liken the anaesthetist to the patient's 
`replacement brain' in that they regulate and control various critical bodily 
functions of the patient that the patient's brain would normally be responsible 
for. The anaesthetist's surgical role can basically be summarised in the context 
of the following main points [9]: 
" Assessing airway and respiration competence: determining the best type 
of airway (e. g., laryngeal mask, tracheal, bronchial tube, etc. ) for the 
patient; determining the best mode of breathing (e. g., spontaneous, 
assisted, etc. ); and determining blood gas composition. 
" Continuous appraisal of circulatory and cardiac competence: determining 
the appropriate blood pressure and heart rate parameters; and deciding on 
the adequacy of blood volume, haematocrit, acid base balance, clotting 
function, ionic composition, etc. 
The anaesthetist must be furnished with an adequate understanding of the 
patient's physiological condition prior to surgical intervention, in order to realise 
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optimal systemic control during surgery. It is this requirement that makes the 
pre-operative assessment a paramount consideration for the anaesthetist. In this 
context it should be noted that The Association of Anaesthetists of Great Britain 
and Ireland states: "The aim in assessing patients before anaesthesia and surgery 
is to improve outcome" [5]. Given the role of the anaesthetist throughout the 
peri-operative process, attention is now given to the pre-operative assessment. 
1.2.3 The importance of pre-operative assessment 
The UK National Confidential Enquiry into Patient Outcome and Deaths 
(NCEPOD)2 scoring system categorises patients into four groups based on the 
type of surgery they require. 
Category Description Surgery timing 
NCEPOD 1: Immediate life saving operation, resuscitation 
Emergency simultaneous with surgical treatment (e. g., trauma, 
ruptured aortic aneurysm). 
NCEPOD 2: Operation as soon as possible after resuscitation (e. g., 
Urgent irreducible hernia, intussusception, oesophageal 
atresia, intestinal obstruction, major fractures). 
NCEPOD 3: An early operation, but not immediately life-saving 
Scheduled (e. g., malignancy). 
NCEPOD 4: Operation at a time to suit both patient and surgeon 
Elective (e. g., cholecystectomy, joint replacement). 
Within one hour. 
Within 24 hours. 
Within 3 weeks. 
At time to suit 
patient & surgeon. 
Table 1.1. NCEPOD grades and their accepted definitions [8,10). 
Table 1.1 illustrates these grades and includes the accepted definitions of each 
classification [8,10]. Each NCEPOD group given in Table 1.1 requires different 
pre-operative investigative procedures to be ordered by the anaesthetist. These 
2 Prior to April 2002, this was called the National Confidential Enquiry into Peri-Operative 
Deaths. 
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classifications serve to ensure that the patient is thoroughly assessed during the 
pre-operative assessment phase, as any oversight can have serious repercussions 
during surgery. For example, failure to pre-operatively identify aortic stenosis in 
the patient, who is usually asymptomatic, can incur potentially fatal 
consequences. For example this can result in the anaesthetist monitoring the 
patient by non-invasive means during surgery thereby overlooking potentially 
severe cardiac incompetence. NCEPOD has published several case studies in 
which patients have died post-operatively due to the failure to adequately assess 
cardiac competence at the start of the peri-operative process [11]. Given this, it 
becomes imperative to the safety of the patient that the anaesthetist is sufficiently 
well trained and unburdened such that rigorous pre-operative assessments can be 
realised. 
1.3 Introduction to the problem 
In UK National Health Service (NHS) hospitals in 2003 the total number of 
operations in which a consultant anaesthetist was present was 53% [12]. This is 
a decrease from 2001 in which 77% of cases had a consultant anaesthetist present 
[11]. In addition to this the 2003 NCEPOD annual report expressed concern at 
the "low level of consultant supervision of trainee anaesthetists" [12]. 
The operating theatre is not the only place which has seen a shift in the delivery 
and management of anaesthesia. In 2001 the US Health Care Financing 
Administration announced its intention to remove the requirement that nurse 
anaesthetists be supervised by a qualified physician during the administration of 
anaesthetics to a patient [13]. The announcement generated debate about the 
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ability of nurses to perform this function which is normally discharged by the 
anaesthetist. The main concern is whether nursing grade staff possess the 
experience and clinical knowledge to adequately perform in this role. 
With the expanding role of the anaesthetist bringing with it new pressures and 
the trend towards assigning additional roles to nursing staff, a pertinent question 
is whether nursing grade staff are appropriate for making decisions which were 
once the responsibility of the anaesthetist. Anaesthetists are perceived to be 
overburdened, and in an attempt to reduce their workload healthcare providers 
are seeking ways of reallocating some of their responsibilities. Given the 
concerns expressed by NCEPOD over the level of supervision provided for 
existing anaesthetists, the risks associated with employing less experienced staff 
to discharge the anaesthetist's duty can only logically by implication be 
transferred to the patient. 
1.4 Research objectives 
The primary objective of this work is to investigate the potential application of 
intelligent systems to support the anaesthetist in pre-operative assessments. 
Additional sub-objectives will be outlined later in this section. 
Let us begin by considering the term `intelligent systems'. Kasabov describes 
intelligent systems as comprising "methods, tools, and systems for solving 
problems that normally require the intelligence of humans" [14]. A more 
detailed exposition of intelligent systems is provided in Chapter 3. For the 
purposes of this section it is sufficient to describe intelligent systems as being 
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systems which can learn; can emulate human inductive reasoning; and which can 
perform pattern recognition and classification tasks. 
Given the overarching objective here; to investigate the potential of intelligent 
systems for assisting the anaesthetist in making pre-operative assessment 
decisions, let us now refine this into several sub-objectives in a modular sense. 
The key ones are: 
1. to research and develop new techniques for assessing the competence of 
the cardiac and respiratory systems of the patient by listening to heart and 
lung sounds; 
2. to research and develop new techniques for assessing the patient's arterial 
oxygen saturation which can account for artefacts in the observed data; 
and 
3. to research and develop new techniques for determining the patient's 
suitability for surgical anaesthesia which accords with the anaesthetist's 
decisions. 
Upon first inspection the three points above may appear to be divorced from the 
primary objective. In clarifying these points we must firstly consider the 
anaesthetist's decision-making strategy. When presented with a range of 
information concerning the physiological state of a patient (e. g., blood pressure, 
blood oxygenation, etc. ) the anaesthetist assesses each of these metrics 
individually prior to forming a decision. It is these intermediate decisions - and 
how they are made - to which the aforementioned objectives pertain. 
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Objective 1, which pertains to the heart and lung sounds, is a complex diagnostic 
manoeuvre for the anaesthetist. For example, Wipf et al., [15] identified that 
experienced physicians were capable of identifying respiratory pathology from 
the lung sounds with a sensitivity of 60-70%. The objective of this work is 
therefore to develop tools to help improve this performance in terms of 
sensitivity of cardio-respiratory pathology classification. Objective 2 pertains to 
adequate continuous pulse oximetry assessment (i. e., blood oxygenation). A 
detailed account of the motivation towards the research into this objective is 
given in Section 6.2. Suffice it to say at this juncture that assessing arterial 
oxygen saturation is integral to the accurate appraisal of a patient's suitability for 
surgical anaesthesia [5]. Objective 3 pertains to the research and development of 
novel classification techniques to assist the anaesthetist. The system is referred 
to as a Decision Support Aid (DSA). The purpose of the DSA is to classify 
patients into one of the following three categories depending upon their clinical 
circumstances [5]: 
i. Suitable for surgical anaesthesia. Although suitability for anaesthesia 
partially depends upon factors such as the type of anaesthetic (local, 
general, sedative, etc. ), type and duration of surgery; whether a patient is 
suitable primarily depends upon whether their biometric parameters are 
within an `acceptable range' [5]. Acceptable ranges are discussed in 
Section 7.3. 
ii. Possibly suitable for surgical anaesthesia conditional on further 
investigative tests. This category stipulates that a patient is deemed 
provisionally suitable for surgical anaesthesia. It is usually applied if one 
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or more tests reveal abnormalities (e. g., aortic stenosis) which require 
further investigation but may not preclude surgery. The anaesthetist's 
`tests' will be discussed in Section 4.1.2. 
iii. Unsuitable for surgical anaesthesia. Patients in this category typically fail 
one or more of the anaesthetist's tests, and whereby the risk of surgical 
mortality outweighs the benefits of the operation for which they are 
scheduled. While this does not necessarily preclude them from undergoing 
their operation, they may require prior surgical intervention or treatment for 
the identified abnormality, This will be discussed further in Chapters 5 and 
6. Examples of such abnormalities would include excessively obese 
patients with respiratory disorder, or those with malignant hypertension 
(i. e., dangerously high blood pressure). 
Given the above three classifications, the requirement is that the DSA must make 
determinations as to the patient's suitability for surgical anaesthesia when 
furnished with input data pertaining to their physiological condition. Linked to 
this is the requirement that the DSA must be able to linguistically express to the 
anaesthetist its classifications and how it arrived at them. As we will show in 
Chapters 5,6 and 7, certain standard intelligent system techniques do not have 
this ability and so new techniques must be researched and developed. 
Having presented an overview of the key objectives of this research work, 
Section 1.6 later presents an overview of the subsequent chapters and how they 
pertain to the realisation of the objectives. 
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1.5 Contributions to knowledge 
In the context of the objectives outlined in Section 1.4, this thesis aims to provide 
a contribution to scientific knowledge via the demonstration of intelligent 
systems in the provision of healthcare. In particular, it will show that the 
complex task of cardio-respiratory pathology detection can be effectively 
performed using intelligent system techniques, and that these techniques can 
afford superior levels of accuracy and sensitivity than the average physician. It is 
however not the objective of this work to replace the physician, but rather to 
provide the physician with high-quality information to help in the decision- 
making process. Furthermore it will be demonstrated that the information 
pertaining to the anaesthetist's domain can be encapsulated using intelligent 
systems. It is the opinion of the author that the work reported here is a 
`significant and original contribution to knowledge'. 
1.6 Thesis outline 
In brief, this thesis contains a review of selected clinical applications of 
intelligent systems. This is supplemented with an overview of the theory 
underpinning intelligent systems which is intended to clarify their operation. 
Methods of data acquisition and analysis are discussed, alongside the application 
of intelligent systems in disseminating information and knowledge interpretation. 
New applications of intelligent systems are presented, as are novel techniques for 
the analysis of arterial oxygenation. The thesis finishes with the creation of a 
new, hybridised classification mechanism to perform as the DSA. In conclusion 
the problems facing decision support are discussed and further areas of 
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investigation are recommended. The contents of each chapter is summarised 
below. 
In Chapter 2a review of intelligent systems in healthcare is provided. This is 
foremost intended to assess the capabilities of various intelligent system 
paradigms in a medical context. Methods of delivering improved healthcare 
using these techniques are discussed, as are the potential pit-falls associated with 
each technique. 
Chapter 3 gives a more detailed description of each intelligent system paradigm 
selected for consideration in this research. This includes a technical description 
of each paradigm. The chapter illuminates the merits and limitations of each 
approach and is intended to provide the background for the work presented in 
subsequent chapters. 
Given detailed reviews of the theory of intelligent systems and their applications 
in healthcare in previous chapters, Chapter 4 begins by describing the purpose of 
our data collection, followed by the selected data acquisition methods. Each 
biometric collected is discussed and its relevance to the research is expounded. 
The equipment utilised throughout the experiments is presented as is any 
additional development work undertaken to acquire relevant information from 
the equipment. 
Chapter 5 presents the work undertaken to develop a novel means of detecting 
cardio-respiratory disease processes using intelligent systems with heart and lung 
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sounds. Here strategies for audio data processing are discussed as well as 
methods for extracting sufficient, appropriate information from the data on which 
to base classifications as to the patient's cardio-respiratory state. Various 
classification techniques are applied and a combined classification approach is 
finally implemented. 
Chapter 6 addresses issues regarding the acquisition of reliable pulse oximetry 
data. Motivation is presented for the application of intelligent systems to 
identifying erroneous pulse waveforms. The chapter presents two novel 
techniques for extracting artefact-corrupted pulse waveforms thus improving 
confidence in pulse oximetry measurements. 
Given that the two previous chapters addressed pertinent issues concerned with 
the acquisition and reliable processing of cardio-respiratory sounds and pulse 
oximetry measurements, Chapter 7 discusses the principal means by which these 
data could be fused with other biometric values to form a DSA. The main 
aspects of fuzzy intelligent systems are discussed and an application of these 
systems is presented in the context of clinical data classification. The DSA is 
subsequently evaluated against other techniques. The chapter concludes by 
considering the applicability of this technique to the classification of clinical data 
in order to support the anaesthetist. 
Chapter 8 summarises the results of the research presented in Chapters 5,6 and 
7. The relative merits and limitations of the approaches are discussed and 
suggestions for improvement are provided. The chapter provides the principal 
14 
Chapter 1: Introduction 
conclusions of the research and suggests how the system may be expanded to 
take on more varied roles in the delivery of healthcare. 
1.7 Summary 
To summarise this chapter, the clinical function of the anaesthetist has been 
introduced to be a varied and complex one, usually requiring the specialist to 
perform critical tasks across the peri-operative process. The literature suggests 
that as healthcare develops, pre-operative assessment may be adversely affected 
by the substitution of anaesthetists with potentially less experienced staff. So an 
implicit part of this work is to ameliorate the possible consequences this may 
have for the good of the patient and to the healthcare system as a whole. In order 
to do this, the work presented here researches and develops various intelligent 
system solutions. The thesis outline has been discussed and new contributions of 
this research presented herein identified. 
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CHAPTER 2 
Intelligent Systems in Healthcare 
This chapter presents an overview of some of the more common types of 
intelligent systems which have been applied in healthcare. In each case, a review 
of how these techniques have been applied to healthcare to solve particular 
problems is outlined. 
2.1 Introduction 
Whilst there is no formal definition, it can be said that an intelligent system is a 
system which can be considered to be able to learn from and adapt to input 
stimuli [1]. In particular they can solve problems by applying knowledge gained 
from past experiences. Intelligent systems are varied and encompass Artificial 
Neural Networks (ANNs), Fuzzy Logic (FL), Genetic Algorithms (GAs) and 
hybrid approaches such as Neural Fuzzy Systems (NFS), some of which are 
discussed here. A detailed account of ANNs can be found in Chapter 3; FL in 
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Chapters 6 and 7; and GAs in Chapter 7. Figure 2.1 presents the three main 
intelligent system paradigms and shows possible areas of hybridisation. 
Evolutionary Neural 
Networks 
Neuro-fuzzy 
Systems 
Evolutionary Fuzzy 
Evolutionary 
Fuzzy Systems 
Figure 2.1. The neural, evolutionary, and fuzzy paradigms with areas of possible 
hybridisation. 
The following sections focus on clinical applications of ANNs. In particular, in 
Section 2.2, we discuss applications of Multi-Layer Perceptrons (MLPs); Radial 
Basis Function Networks (RBFNs) in Section 2.3; and Probabilistic Neural 
Networks (PNNs) in Section 2.4. Some clinical applications of NFS are given in 
Section 2.6. 
2.2 Clinical applications of the Multi-Layer Perceptron 
MLPs are a particular type of ANN favoured in classification problems as they 
are relatively simple to use, and have been shown to operate well on linear and 
non-linear problems [1]. An in-depth discussion of MLPs and linear separability 
is presented in Section 3.2. 
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There are numerous publications which report on the application of MLPs to 
medical problems; for example see reviews by Baxt [2], Itchhaporia et al., [3] 
and Lisboa [4]. These largely concentrate on prognosis and prediction, Coronary 
Heart Disease (CHD) and general disease process classification. We will discuss 
some of these application areas in turn in the following sections. 
2.2.1 MLPs in medical prognosis 
A major area of application is prognosis and in particular, surgical risk analysis: 
Lisboa et al., [5] utilised the MLP to determine prognostic risk groups of patients 
undergoing breast cancer surgery in order to best target post-operative resources. 
They found that the MLP was more specific in allocating patients to prognostic 
risk groups than their clinically-accepted benchmark proportional hazards model 
[5]. Santos-Garcia et al., [6] applied an ensemble of MLPs to the prediction of 
post-operative morbidity after pulmonary resection for lung cancer bronchogenic 
carcinoma. The ensemble consisted of 100 different MLPs trained on patient 
data (i. e., age, gender, body mass index, etc. ) and operative information, 
(i. e., extent of resection, peri-operative blood transfusion, etc. ). They found that 
the ensemble gave 98% accuracy for the prediction of cardio-respiratory 
morbidity. The authors concluded that patient criteria as well as operative 
criteria have a direct impact on the predicted post-operative morbidity and 
mortality, a point which is supported by Bernard et al., [7,8]. 
Prognostic applications range from surgical risk analysis to diabetes prediction 
and CHD prediction [9,10,11]. CHD prediction using MLPs has generated 
considerable interest; in particular examination of the prognostic survival curve 
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based on patient lifestyle variables [11] and risk prediction based on biomedical 
indicators [12]. Ohno-Machado et al., [11] applied MLPs to predict the 
probability of CHD development over a period of time. They applied MLPs 
sequentially such that the prediction of CHD development at one instant in time 
was used to bias a subsequent MLP to the probability of CHD development at a 
later instant. They incorporated patient criteria (i. e., age, gender, etc. ) as well as 
patient lifestyle variables, such as tobacco use, into their prediction model and 
concluded that the MLP ensemble constituted a good alternative to existing 
survival analysis models. 
In a different study Azuaje et al., [12] explored the prediction of CHD by 
assessing Heart Rate Variability (HRV) with an MLP. HRV dynamics were 
assessed from the R-R interval of the cardiac QRS wave [12]. They approached 
the prediction of CHD development from the biosignal direction, as opposed to 
the patient criterion basis adopted by Ohno-Machado et al., [11]. Azuaje et al., 
[12] found that an MLP could predict the onset of CHD from small HRV datasets 
with a sensitivity of 90%. 
2.2.2 MLPs in disease management 
As well as detection and prediction of CHD, MLPs have also been applied to 
disease management, such as determining the suitability of medical procedures 
and treatments. For example, Mobley et al., [13] employed the MLP to try to 
determine the suitability of coronary angiography - which is an invasive 
diagnostic manoeuvre. They found that when tested with 100 historical cases the 
MLP identified 81 patients who had stenosis and required coronary angiography. 
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Of the remaining 19 patients asymptomatic of stenosis, the MLP identified 9 who 
did not require the procedure. Mobley et al., concluded that "The results 
demonstrated that, given a multiplicity of input data or risk factors for coronary 
artery disease, artificial neural networks could nonetheless become valuable 
tools in identifying patients who do not need coronary angiography" [13]. 
2.2.3 MLPs in general disease process classification 
There is quite a large number of publications that report on the success of MLPs 
in prognosis and prediction. This is rivalled by the number of publications 
reporting similar successes in disease process classification. Topical subjects 
such as cardio-respiratory analysis and cancer detection have attracted the 
majority of research in recent years and this is reflected in the available literature 
[2,3,4]. For example, cardiac disease process detection has been considered by 
authors such as Cathers [14] and Turkoglu et al., [15] who have applied MLPs to 
the analysis of auscultated heart sounds. Cathers [14] applied the MLP to the 
analysis of time-domain heart sounds. Cathers found that by increasing the size 
of the MLP, the classification rate was improved to the extent that 95% of the 
training dataset was successfully separated. Cathers proposed that time- 
frequency analysis in the form of wavelet transforms may afford a more 
comprehensive approach to heart sound analysis. Turkoglu et al., [15] utilised 
wavelet decomposition of auscultated heart sounds as a processing technique 
prior to MLP analysis in order to develop a sensitive classification system. They 
trained their MLP on wavelet decompositions of Doppler heart sounds. Their 
study was motivated by the effectiveness with which they perceived that wavelet 
analysis could capture heart sound information. The authors attained a 
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classification accuracy of 94.5% with abnormal subjects, and 94% accuracy with 
normal subjects. 
Whilst Cathers [14] and Turkoglu et al., [15] attained classification accuracies in 
excess of 90%, Ölmez et al., [16] commented that the MLP suffered from 
problems concerning local minima in the available datasets (we will discuss this 
in more detail in Section 3.2.1), is slow at learning the `data features' and suffers 
from the requirement that the MLP architecture be predefined at the outset. 
These observed problems, whilst they are technically true, can be overcome, or at 
least ameliorated, by for example: (i) the appropriate selection of MLP 
parameters; (ii) increasing the computational power of the processing platform; 
and (iii) the appropriate selection of the architecture prior to training using 
techniques such as Cascade Correlation [17] (this is discussed in more detail in 
Section 5.4.2). 
2.2.4 MLPs in cardio-respiratory disease process classification 
Consideration has also been given to the analysis of respiratory abnormalities 
and disease processes. This has resulted in MLP-based classifiers that are trained 
to operate by analysing auscultated lung sounds, for example. Both 
Rietveld et al., [18] and Leonhardt et al., [19] applied the MLP to discriminate 
between respiratory disease processes. The authors assessed different biosignals, 
namely respiratory auscultation and Tidal Breathing Flow Volume (TBFV), 
respectively. Both applied the MLP in the same configuration with the same 
training algorithm, and although tackling the problem of classification using 
different signals, they found that the MLP could significantly outperform human 
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experts. Rietveld et al., found that using the Fourier power spectrum of lung 
sounds to identify airway obstruction resulted in 43% of their test data being 
correctly classified by the MLP. Leonhardt et al., found that TBFV analysis 
resulted in the MLP correctly classifying 70% of the test data. Both of these 
findings suggest that respiratory disease processes can be identified in a variety 
of ways and that the appropriate selection of the `indicating biosignals' is 
imperative for accurate diagnosis. 
MLP-based analysis of the respiratory system is not confined to disease process 
detection but is also applicable to other abnormalities. Wilks et al., [20] 
approached the subject of Sudden Infant Death Syndrome (SIDS) by identifying 
a correlation between changes in the pattern of respiration with the onset of 
hypoxaemic episodes. Such correlations were achieved by simultaneous MLP 
analysis of the respiration pressure and breathing pattern of the patient. In a 
similar way, Oud [21] showed that it was possible to establish a relationship 
between the obstruction of the airways (through FEV1 measurements) and the 
sounds produced by the lungs. In their study the airway obstruction was allergen 
provoked and they observed that the MLP could successfully identify the 
obstruction characteristics through assessment of the consequent lung sounds. 
Wilks et al., concluded that it is possible to predict changes in oxygen saturation 
earlier with an MLP than with existing techniques [20]. 
2.2.5 MLPs in disease identification 
Whilst cardio-respiratory abnormalities and disease processes account for a 
considerable amount of interest in the application of MLPs to medical 
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classification and prognostic determination, other applications are also presented 
in the available literature. Two other areas are cancer detection and 
classification, and ECG analysis which have both been of significant interest 
over recent years. Two publications representative of this are by Antal et al., 
[22] and Papaloukas et al., [23]. In the former, Antal et al., discriminated 
between benign and malignant tumours by incorporating prior beliefs into the 
MLP to form an informative MLP model. Their prior beliefs were probability 
statements concerning the differences between benign and malignant tumours. 
The authors concurred with the general notion that selection and coding of the 
relevant training data features is of central importance when developing an MLP 
for medical analysis in order to attain not only highly accurate but also highly 
sensitive systems. This notion was also expounded by Papaloukas et al., who 
applied MLPs to the detection of myocardial ischemia (defined by insufficient 
blood supply to the heart muscle [23]) in long-duration ECGs. Their results 
showed a 90% sensitivity of the system towards ischemic episodes and they 
attribute this achievement to numerous factors, including for example the 
reduction in size of the dataset whilst retaining its informative features 
(i. e., components that contain the most information). 
2.2.6 Discussion 
A recurring theme throughout the presentation of the above literature is that of 
appropriate data coding, i. e., an appropriate data representation scheme. Whilst 
it is true of most ANN architectures, the MLP will not perform well with 
seemingly homogeneous datasets. These types of problems usually require 
different ANN solutions. When considering highly non-linear separable datasets 
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a popular ANN architecture used is the RBFN. Many medical imaging problems 
tend to be non-linear in ways which are better suited to the use of RBFNs. 
Whilst the RBFN architecture is discussed in Section 3.3 some of its reported 
applications are presented in the following section. 
2.3 Clinical applications of the Radial Basis Function Network 
It can be seen from the previous sections that the MLP has found numerous 
applications within the field of clinical data prediction, prognosis and 
classification. An alternative approach is discussed presently. As we will 
discuss in Chapter 3, the neuronal activation functions of the hidden layer of a 
RBFN are locally active, or locally tuned. This term is used to describe the 
behaviour of a Gaussian function in response to an input datum which is similar 
to the function's local maximum. Input data which are substantially different 
from the function's centre will prompt a low (Le., near zero) response and it is 
this property that makes the RBFN an attractive neural network for some medical 
applications. 
2.3.1 RBFNs in medical imaging 
One particular area in which RBFNs have been found to be applicable is that of 
medical imaging. In particular, frequent applications of the RBFN involve 
medical images such as Magnetic Resonance Imaging (MRI) scans or X-ray 
images of tumours and other `growths'. For example, Fornefett et al., [24] 
extended the Gaussian function to incorporate compact support (i. e., spatial 
limitation) and found that networks of these radial basis functions can perform 
well with local changes (e. g., scanner-induced deformations, differences in 
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patient anatomy, etc. ) in medical images. The authors of the work noted that 
these localised differences in medical images were particularly difficult for 
conventional image recognition paradigms to solve. They applied RBFNs to the 
localisation and identification of brain tumour images and attained higher 
degrees of accuracy than with existing automated systems. 
Not only are RBFNs used in classification of images, but technical issues arising 
from medical equipment have also been addressed using these ANN 
implementations. For example, Lai et al., [25] applied RBFNs to determine the 
re-mapping of MRI images for display on a computer screen. The objective was 
to reduce the colour depth of the image whilst retaining the features by 
appropriate adjustment of the colours and contrast. The RBFNs were used in an 
ensemble and the authors concluded that the processed images could be 
successfully re-mapped and analysed by clinicians. 
Identification and classification has also been of substantial interest and RBFNs 
have been applied to a range of areas from the detection of cancers to the 
isolation of particular image features. For example Behloul et al., [26] applied 
RBFNs to the identification of the myocardium in noisy Positron Emission 
Tomography (PET) images. The authors trained the RBFN to generate fuzziness 
measures of the image and to minimise this fuzziness such that a high contrast 
image for the myocardium could be obtained with respect to the noisy 
background. They concluded that the RBFN could segment the image of the 
myocardium to a degree of sensitivity comparable to an expert human examiner, 
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thereby allowing further computerised methods of image analysis to be 
performed. 
2.3.2 RBFNs in medical prediction 
Non-linear modelling of biological processes is also ideally suited to the RBFN 
due to the nature of Gaussian functions. One particular area of interest has been 
in the assessment and prediction of Heart Rate Variability (HRV). HRV is an 
important factor in assessing cardiac activity yet it remains difficult to predict 
due to the complexity of the controlling mechanisms such as the Autonomic 
Nervous System (ANS). Investigation into the non-linearity of heart rate 
dynamics and the prediction of HRV from these dynamics has resulted in mixed 
reports, in which authors identify partial success. In a study by Bezerianos et al., 
[27] normal heart rate dynamics were modelled by RBFNs and compared to the 
same subjects after ANS blockade. The authors found that normal ANS control 
over HRV dynamics resulted in the RBFN attaining high prediction accuracies 
(0.009 mean square prediction error). Dysfunctional ANS yielded poorer results 
(0.08 mean square prediction error) [27]. Total ANS blockade resulted in the 
inability of the RBFN to predict the heart rate. The authors concluded that the 
results obtained could support the hypothesis that HRV dynamics are non-linear 
and chaotic in nature. These claims are partially supported by Haque et al., [28] 
in that the authors determined the HRV controlling characteristics to be non- 
linear. The authors used the RBFN to predict HRV under ANS control and 
compared their system with a non-linear autoregressive model. They found that 
the RBFN outperformed the autoregressive model in 2 out of 5 cases of heart rate 
prediction. 
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2.3.3 Discussion 
It can be concluded from the presented literature that the RBFN is ideally suited 
to situations requiring locally receptive functions such as medical image analysis; 
and scenarios such as non-linear predictions of complex biological processes. 
The advantages of the RBFN over the MLP in these areas seem to arise from the 
Euclidean distance manner in which the network responds to new data. The 
Gaussian functions used by the RBFN respond to data based on its similarity to 
the function's centroid. RBFNs are also naturally disposed towards probability 
density estimation which makes them ideal in classification scenarios [1]. A 
natural extension to this is an ANN paradigm that is firmly rooted in probability 
density estimation; one such example is the Probabilistic Neural Network (PNN). 
At this juncture it is important to note that the PNN, (which will be discussed in 
more detail in Section 3.4), can only be employed as a classifier and it cannot 
function as a prediction mechanism [29]. 
2.4 Clinical applications of the Probabilistic Neural Network 
The PNN was introduced in 1990 [29] and is a relatively new neural network 
architecture compared to the MLP and RBFN and as such few authors have yet 
reported on the clinical applicability of this architecture. The PNN operates by 
constructing a plurality of Gaussian functions describing the distribution of the 
training data features. This principle is similar to that for the RBFN, but whereas 
the RBFN attempts to learn the partitions between classes, the PNN forms class 
probability densities. 
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In the paper by Shan et al., [30] the PNN was applied directly in the role of a 
classifier to detect cancers in patients based on nucleosides in their urine 
samples. In comparison with methods such as Linear Discriminant Analysis 
(LDA) [1] the authors found that the PNN could differentiate between healthy 
patients and those with cancer with an accuracy of 85% (LDA achieved 80%). 
The PNN was presented with a binary (i. e., 2-class) partially homogenous dataset 
representing patients with and without cancer. Shan et al., further concluded that 
the PNN demonstrated high sensitivity and specificity (80% and 90% 
respectively) towards the classification of cancers [30]. 
The range of classification problems that the PNN could be applied to is large 
and varied. A study by Piliouras et al., [31 ] concluded that the PNN could be a 
good patient management tool for the assessment of stroke risk resulting from 
atherosclerotic carotid plaque. The PNN was trained to classify patients into 
prognostic risk groups based on ultrasound images. The trained PNN 
successfully identified 23 of the 24 high-risk cases and 29 of the 32 low-risk 
cases. Whilst Piliouras et al., advocated the necessity for extensive and thorough 
testing of their approach, they concluded that it had the potential to be a valuable 
second opinion in the classification of risk groups [31]. 
Given that the PNN alongside other ANNs such as the MLP and RBFN can be 
reformulated in the Bayesian framework [1], the classifications or predictions 
resulting from these systems can be argued to be probabilistic assertions. It is 
possible to assess the ANN responses in terms of basic belief assignments, i. e., 
the level of belief that is attributed to classifying some quantity x as class k. By 
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considering the responses of multiple neural network implementations to a given 
input, it is possible to improve the classification (or predictive) accuracy, of the 
ensemble by combining these responses at the decision-theoretic level. 
Piliouras et al., [31] considered this in their work as a means for increasing the 
accuracy of their classification system. Methods of evidence combination are 
considered later in more detail in Section 3.5. The PNN and RBFN are generally 
more efficient than the MLP at handling homogeneity within datasets due to their 
ability to mix Gaussian functions of all classes to obtain optimal discrimination. 
Hybridised intelligent systems have also found applications in biomedical 
engineering, in particular evolutionary systems such as GAs, Genetic Programs 
(GPs) and Neural Fuzzy Systems (NFS). The following sections present an 
overview of a few of these pertinent applications; in the context of this work. 
2.5 Clinical applications of Evolutionary Systems 
This section discusses clinical applications of GAs and GPs in the context of 
healthcare delivery. The theory underpinning these techniques is given in 
Section 7.5.2 and Section 7.5.3. The available literature is replete with reports on 
the application of GAs to medical classification scenarios; primarily concerning 
the evolution of ANN-based classifiers to diagnosis [32,33]. In a paper of 
particular relevance, Vinterbo et. al., [34] discussed the problem of multi- 
disorder diagnosis i. e., that expert systems frequently assume that multiple- 
disorders do not co-occur in a single patient. The focus of the paper was on a 
means of evolving a classifier that did not attempt to explain all of the symptoms 
pertaining to a disorder but to a plurality of input-output ANN mappings that 
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could account for multiple disorders. The authors concluded that the GA 
approach afforded a good framework for managing the ANN in performing these 
multi-diagnoses. For an in-depth discourse on the subject of evolutionary 
techniques in medicine the reader is referred to [35]. 
In their paper Tsakonas et. al., [36] applied the GP technique to the evolution of 
fuzzy classifiers. They examined two classification problems: diagnosis of the 
subtype of aphasia (impairment of the power to use or pronounce words); and 
pap-smear examinations. In the former case the authors applied GP to the 
evolution of a fuzzy rule-base and concluded that the GP-evolved fuzzy system 
could attain classification accuracies of 88.5% on the training dataset, and 79.1% 
on the test dataset. When applied to pap-smear examinations, the GP-evolved 
fuzzy system that attained an average classification accuracy of 90.3% on the test 
dataset. The authors concluded that the GP approach to fuzzy system evolution 
offered a more comprehensible rule-base than competitive expert systems like 
C4.5 [36]. Other methods of rule-base construction and fuzzy systems learning, 
in the medical context, is given in the following section. 
2.6 Clinical applications of Neural Fuzzy Systems 
This section focuses on clinical applications of NFS. The fuzziness in NFS is 
derived from the fact that real-world classes and concepts are fuzzy rather than 
crisp, thus potentially resulting in imprecision and ambiguity in the classification 
process. A complete account of Fuzzy Set Theory (FST) and ensuing NFS can 
be found in texts such as [37,38]. In their review, Mahfouf et al., [39] noted that 
fuzzy systems provide an excellent approach to defining inexact medical entities 
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and affords the user a means for approximate reasoning with medical data. It is 
these qualities that have drawn researchers to the field of NFS in medicine, and 
some of the results of these endeavours are presented here. 
Fuzzy logic [37], and more recently NFS, has found numerous applications in the 
field of medicine and biomedical engineering due to the inherent fuzziness in 
medical data; uncertainty in the co-occurrence of medical events; and 
incompleteness of medical theories [40]. ANNs can be used to attempt to resolve 
these issues, but when combined with fuzzy representations of medical variables 
and data, these hybridised approaches can offer potentially superior levels of 
performance in certain scenarios. In one such approach, Allen et al., [41] trained 
an MLP to attempt to identify latency in delivering anaesthesia and the response 
from the patient. The MLP was trained to generate fuzzy outputs that a fuzzy 
controller could use in administering the anaesthetic. The authors concluded that 
the MLP and fuzzy controller could adequately maintain the depth of anaesthesia 
of a patient. 
Control systems based on real-time biosignals is an area in which NFS have 
found considerable applications. One type of NFS which is popular in this area 
is the Adaptive Neuro-Fuzzy Inference System (ANFIS) [38,42]. Kwok et al., 
[43] applied ANFIS to the control of intensive care ventilators. The authors 
examined 71 clinical scenarios in which patients undergoing ventilator assisted 
respiration experience changes in respiration pattern. This was achieved by 
examining the relationships between the inspired fraction of oxygen (Fi02), the 
arterial oxygen tension (Pa02) and the positive end-expiratory pressure. For each 
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of the scenarios, the responses of eight clinical experts were recorded and used to 
train both ANFIS and MLPs. They found that the performance of the systems in 
controlling the ventilator was comparable to the expert clinicians and concluded 
that adaptive neuro-fuzzy systems can facilitate the modelling of clinicians' 
knowledge. ANFIS is discussed in more detail in Chapter 7. 
Aside from control systems, NFS have also been applied to signal identification. 
For example the diagnosis of Gastro-Oesophageal Reflux (GOR) is of great 
interest to paediatric gastroenterologists as it is considered to be one possible 
reason for sudden infant death syndrome [44]. In their paper Trachtema et al., 
[45] used intraluminal electrical impedance measurements to allow long-term, 
detailed, pH-independent registration of GOR in 50 paediatric patients. They 
trained an ANFIS to recognise GOR and compared this method with existing 
intraluminal measurement techniques. They found that the ANFIS reduced the 
time taken to register GOR by 96% and did not suffer any loss in precision. The 
authors concluded that ANFIS offers a robust and suitable method for the 
detection of GOR in infants. 
2.7 Summary 
Intelligent systems have found wide and varied application in healthcare. 
Different types of intelligent systems confer different advantages and as such 
have been found applicable in scenarios ranging from prognosis to hardware 
control of medical imaging. This chapter has sought to present an overview of 
the medical applications of ANNs and NFS, whilst the following chapters discuss 
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the technical aspects of these intelligent systems. Fuzzy Logic and evolutionary 
techniques are discussed in Chapters 6 and 7. 
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CHAPTER 3 
Introduction to Artificial Neural Networks 
This chapter presents some of the main theory underpinning the principles of 
ANNs. In particular the MLP, RBFN and PNN architectures are discussed. The 
purpose of this chapter is to furnish the reader with an understanding of how 
these ANNs function. The chapter concludes with an overview of Dempster- 
Shafer Theory (DST). 
3.1 Introduction 
This section introduces ANNs and begins with an overview of Bayesian 
Probability Theory. Section 3.1.2 introduces the artificial neurone - the most 
basic component of an ANN. The subsequent sections present an overview of 
the MLP, RBFN, PNN and Constructive PNN (CPNN). 
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ANNs are biologically-inspired statistical methods i. e., they `learn' probability 
distributions. An ANN is a collection of neurones that are inter-connected with 
synapses. The biological inspiration is derived from the fact that the ANN 
exhibits what is seen to be a crude resemblance to the mammalian brain. The 
statistical nature of ANNs is derived from their ability to classify or predict data 
based upon past experience. ANNs can be examined in the context of Bayesian 
Probability Theory (BPT) which affords a mathematical description of how an 
ANN operates. The following subsection provides an overview of BPT whilst a 
more in-depth account can be found in texts such as [1,2]. 
3.1.1 Bayesian Probability Theory 
The Bayesian approach to probability theory offers a robust method to model the 
statistical distribution of data; to construct prior probabilities about the 
occurrence of data within the distribution; and to estimate posterior probabilities 
of occurrence based on previous knowledge [1]. As will be demonstrated in this 
chapter, ANNs estimate these probabilities during learning. 
Let us consider some value x drawn at random from a statistical distribution. We 
may possess knowledge of the mechanism that generates the distribution. 
Furthermore, this knowledge may enable us to form statements about the 
probability of x being some value; for example P(x > 6) = 0.7 i. e., there is a 
probability of 70% that the value of x will be greater than 6. The equality x>6 
can be considered a class of values Ck and therefore the probability statement can 
be written as P (Ck) = 0.7. These statements are referred to as the prior 
probabilities as they encapsulate our knowledge of the distribution prior to any 
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observation being made. Let us now consider a scenario in which a classification 
is made based on the observation x. The objective is to correctly classify some 
event indicated by x and to minimise the probability of misclassification. The 
conditional probability P (x I Ck) is the probability that the observation x 
indicates the event given that the event belongs to class Ck. Bayes Theorem 
expresses the posterior probability P (C, k I x) as: 
P(Ck Ix)= 
P(X1k)P(Ck) 
P(x) 
(3.1) 
which is defined as the probability of the event belonging to class Ck given the 
observation x. In (3.1) P (x) represents the probability of occurrence of datum x 
irrespective of class assignment. It serves as a normalisation factor ensuring that 
the posterior probabilities sum to unity. Posterior probabilities are of central 
importance in classification systems insofar that given K posterior probabilities 
resulting from the measurement of x, a classifier can assign the event to class Ck 
entailing the highest posterior probability [2]. 
It will be shown in Section 3.2.2 that ANNs estimate Bayesian posterior 
probabilities during their learning process [2]. These estimations are determined 
from the available data in an iterative manner i. e., the posterior probabilities are 
updated in response to the observed data. These estimations arise through the 
iterative adjustments made to the ANN neurones during the learning process. 
The following section introduces the artificial neurone model employed in 
ANNs. 
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3.1.2 The artificial neurone model 
An ANN is a collection of inter-connected artificial neurones. Generally, input 
data is presented to these neurones which as a collective perform a mathematical 
transform, generating output data as a result of these calculations. The artificial 
neurone was first proposed by McCulloch and Pitts in 1943 [3]. It comprises of 
three components: the m inputs xm which are weighted with some arbitrary factor 
wu (1 <_ j <_ m, for neurone i); the processing element in which the weighted 
inputs are summed and translated through some function a (f); and the output 
response y; of the function. 
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Figure 3.1. Representations of (a) the biological neurone; and (b) the artificial 
neurone. 
An illustration is given in Figure 3.1. The function a (f) determines the 
behaviour of the McCulloch and Pitts neurone. The sigmoid function is the most 
popular due to it being continuously differentiable - an important factor during 
the learning process (discussed in Section 3.2.1). The two sigmoid functions are 
the unipolar (3.2) and bipolar (3.3) functions: 
a(f) 
i1-ii' (3.2) 
a(f) 
1+e , ýi -L 
(3.3) 
45 
Chapter 3: Introduction to Artificial Neural Networks 
where .Z defines the slope of the function. The output of the neurone is the 
transform of the weighted sum of inputs such that: 
m 
yi=a 
EWijxj-Bi 
j-1 
(3.4) 
where 0, is an arbitrary offset. As can be seen from (3.2), (3.3) and (3.4) the 
neurone has a number of adjustable parameters such as the weights wÜ, offset 8; 
and function slope % which affect how the neurone responds to input data. 
When neurones are inter-connected with synapses the output of an individual 
neurone is passed to the inputs of its neighbours. These collections of neurones 
are typically structured such that they exist in layers, with the output of one 
neuronal layer connecting to the input of the subsequent layer. In this 
configuration, the collection is referred to as a Multi-Layer Perceptron (MLP). 
The following section introduces the MLP and discusses how it employs the 
neuron parameters of (3.2), (3.3) and (3.4) in its learning process. 
3.2 The Multi-Layer Perceptron architecture 
The MLP architecture is comprised of layers of neurones inter-connected in such 
a way that the outputs of one layer are propagated to the subsequent layer. 
Figure 3.2 shows the architecture of the MLP and illustrates the relationships 
between neurones, layers and inter-connections. The illustration is of a three 
layer MLP. In Figure 3.2 some data vector x, is presented to the input layer. At 
this layer, the values of xn are not weighted and are transformed through the 
neurones (depicted by circles in Figure 3.2). The values are propagated to the 
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hidden layer neurones through the inter-connecting synapses (denoted in 
Figure 3.2 by the unbroken and dashed lines). Here they are weighted and 
transformed by the neurones as given by (3.4). This process is replicated as the 
transformed outputs are propagated to the subsequent layer(s). It can be seen 
from Figure 3.2 that the output vector of the MLP is some transform of the input 
vector xn. It follows that the MLP's response to an input vector xn, is governed 
by the parameters of the individual neurones. Rumelhart et al., [4] elegantly said 
of the MLP, "In this case the information coming into the input units [neurones] 
is recoded into an internal representation and the outputs are generated by the 
internal representation rather than the original pattern" [4]. 
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Figure 3.2. Architecture of the MLP. 
In classification scenarios the MLP adjusts the neuronal parameters to 
discriminate between input patterns. Presented with an input pattern x linked to 
some class Ck (i. e., xe Ck) the neurone parameters will be adjusted such that the 
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MLP output signifying Ck is amplified and that all other-class output patterns are 
attenuated. A process referred to as a training algorithm is responsible for this. 
We will discuss this in the following section. 
3.2.1 Training the Multi-Layer Perceptron 
Many different training algorithms exist that can be applied to the MLP, by far 
the most common being the error Back-Propagation (BP) algorithm [4,5]. The 
purpose of the error BP algorithm is to minimise the difference between the 
generated network output and the desired output, termed the error. As was 
shown by Rumelhart et al., [4,5] this minimisation cannot be solved analytically 
but is an iterative process employing the derivatives of the error, neuronal 
activation functions and weights. The error between the j-dimensional generated 
network output o and the desired output t for pattern p is expressed in the form of 
the Sum-Squared Error (SSE) Ep as: 
Ep =2 
Z(tpj 
_oPI)2ý 
J 
(3.5) 
Many implementations of the MLP with error BP algorithm use the Mean 
Squared Error (MSE) which is merely the SSE averaged over the number of 
output neurones j. The error BP algorithm follows a method known as gradient 
descent [4,5]. That is the algorithm follows the largest negative error gradient in 
minimising the error. This is shown in the derivation of the error BP algorithm 
formalised in Appendix I. Suffice to say that the change in synapse weight 
Apwf, between neurones j and i in response to pattern p is: 
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&PwJ! 17spiopi, 
(3.6) 
where 6, j is the total neuronal error and op, is the network response to pattern p. 
q is the learning rate [4] and is used to modify the weight change. The MLP 
when trained with the error BP algorithm attempts to minimise the SSE Ep 
through iterative adjustments to the network weights (henceforth referred to as 
the weight matrix) but the success of this approach cannot be guaranteed. 
Considering that a q-dimensional error surface can be constructed representing 
the problem at hand (where q is the number of neuronal weights in the ANN), the 
objective becomes that of finding the global minimum on this surface. The 
global minimum represents the lowest error for a given weight matrix. It is 
possible for the error surface to present a number of local minima and as a 
consequence of the algorithm's gradient descent method, it becomes possible for 
the process to terminate prematurely upon finding one of these minima. 
Rumelhart et al., [4] introduced the concept of momentum (denoted by a) to 
ensure that the change in weight matrix during an iteration is influenced by the 
change made during the previous iteration. They give the modified learning rule 
as being: 
Opw,, (n+1) =; 7 
(8, 
pop, 
)+a0pw, 
t 
(n), (3.7) 
where n is the iteration number. This modified algorithm is popularly termed 
error Back Propagation with Gradient Descent and Momentum (BPGDM). By 
iteratively updating the weight matrix, the MLP begins to discriminate between 
different classes of patterns based on their indicative features. As is evident from 
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(3.7) and Appendix I, in order for the BPGDM algorithm to be successfully 
applied, a set of training input patterns accompanied by their associated target 
outputs need to be provided. Target outputs are required in order to calculate 42;. 
The process of providing target outputs alongside input patterns is referred to as 
supervised learning. For methods of unsupervised learning the reader is referred 
to [6] for a non-exhaustive description of some of the more popular algorithms. 
Supervised learning requires a dataset of input patterns with associated target 
patterns. This dataset is referred to as the training dataset. The MLP is trained 
to recognise indicative features from this dataset with the BPGDM algorithm. 
There are no formalised rules governing the size of the training dataset in terms 
of the patterns it contains. The number of patterns required for successful 
training (i. e., the number of patterns that will allow the error to be reduced to its 
lowest possible value) largely depends upon the type of data used e. g., the 
number of features present in the patterns (typically corresponding to the number 
of input neurones in the MLP). Methods for estimating the number of required 
training patterns for a given problem exist in the form of qualitative guidelines 
and these are discussed in Section 5.4.1. 
3.2.2 Bayesian formulation of the Multi-Layer Perceptron 
The MLP can be reformulated in the Bayesian framework. The network attempts 
to determine the posterior probabilities P(Ck I x) for each class I. e., the 
probabilities of some input pattern x belonging to class Ck. Estimation of the 
posterior probabilities occurs as the error BP algorithm minimises the error 
between network output and the desired target output during the learning phase. 
Let us consider an MLP in some dichotomous classification scenario with binary 
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targets. Given an MLP F(x, W) of weight matrix W, the response of the 
network to an m-dimensional pattern x in Euclidean space (i. e., xe 1R ) can be 
expressed as: 
EMSE (w) = (F(X, w)-1)2 +Z F(x, W)Z, 
IEC, YECZ 
(3.8) 
where C, is class i (1= 1,2) [7]. Assuming that there are an infinite number of 
learning samples in the training dataset, the MSE generalises to: 
EE(W)=P(CI) J(F(xW)_1)2r(xjCi)dx 
(3.9) 
xP(C2) JF(x, W)2P(x1 C2)dx, 
where the P probability distributions have their usual meanings. Using (3.1) 
Ruck et al., [8] obtained the following expression: 
EMSE(W)=e2(W)+ JP(C1IX)(1-P(C1IX))P(X)dx, (3.10) 
RM 
where: 
e2(W)= j[F(x, W)-P(C1, x)]2 P(x)dx. (3.11) 
As is evident from (3.10) and (3.11) the MSE is proportional to e2 (W). As the 
MSE decreases during MLP learning the difference between the MSE and 
posterior probability densities decreases i. e., the MLP tends towards the posterior 
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probability densities P (Ck I x) [7]. Further treatment of this subject can be 
found in [2,9]. 
Chapter 5 demonstrates the abilities of the MLP as a classification mechanism by 
showing that it can differentiate between different cardio-respiratory disease 
processes based on the associated heart and lung sounds. Furthermore, it is 
demonstrated in Chapter 6 that the MLP can be applied to predict arterial 
pulsatile waveforms in forming classification systems. 
The standard MLP is only one type of ANN. It is a fully inter-connected 
network insofar that the neurones in one layer are fully inter-connected with 
neurones in the subsequent layer. This level of connectivity affords the MLP a 
large set of parameters which can be adjusted during the training process and it 
follows that learning can be a computationally intensive task. Some other ANN 
architectures are computationally less intensive, such as the RBFN, which we 
discuss in the next section. 
3.3 The Radial Basis Function Network 
Similar to the MLP, the RBFN is an ANN consisting of artificial neurones. 
Recalling Figure 3.2, the RBFN has a similar architecture to the standard MLP, 
exhibiting fully interconnected layers. Whilst the output layer neurones follow 
the McCulloch and Pitts model, the hidden layer employs a different type of 
neurone - the Radial Basis (RB) neurone, 
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The RBFN, suggested by Moody et a!., [10] employs RB neurones which have 
activation functions based on dissimilarity measures. An RB neurone's 
activation function has an m-dimensional Gaussian kernel cp centred around some 
prototype vector p. Considering an m-dimensional input pattern x, the response 
of the activation function is a measure of the similarity of the input pattern and 
prototype vector. The activation function So (x) is expressed as: 
2 
ip, (x)=exp 
IIx-µ21ý 
2, xERm, n=1,..., 
N, 
0 
(3.12) 
where the variance of the nth Gaussian function is Q,,. The Gaussian functions 
are typically normalised such that: 
ön 
(X) 
_ 
9n 
(x) 
(3.13) 
It is evident from (3.12) that the response of a Gaussian activation function is 
partially governed by the Euclidean distance between the input pattern and the 
prototype vector. The smoothness of the function is defined by a,,. 
The output layer of the RBFN consists of M-P neurones with linear activation 
functions. Linear activation functions perform linear transforms of the input 
pattern as opposed to the non-linear transforms performed by (3.2) and (3.3). 
The output neurones sum the weighted outputs of the hidden-layer RB neurones 
and transform the result through the activation function so the output o, becomes: 
o, =a, 
(2: 
k-1WikSk(X) `01), i=1,..., L, (3.14) 
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where o; is the it' final-layer neurone output, L is the number of neurones in the 
output layer, N is the number of neurones in the hidden layer and O is the ith 
neurone offset (i. e., bias). 
3.3.1 Training the Radial Basis Function Network 
Training an RBFN is a two-stage process. Similar to the MLP, the RBFN is 
trained in a supervised manner, being presented with the input patterns and 
associated target patterns simultaneously. During the first stage of the training 
process, the RBFN establishes RB neurones for each pattern in the training 
dataset. Each RB neurone prototype vector is set to a training pattern from the 
dataset. The second stage performs the weight Wk adaptations required by the 
output layer. It is evident from (3.14) that normalisation of the Gaussian 
functions as given in (3.13) is not strictly required as the normalisation effect can 
be incorporated into the w; k weights [2]. The weights in the output layer are 
updated using the expression: 
'äw; k =17 
(ti -oi ) gk (X) 9 (3.15) 
where tf is the desired target value for the it' output neurone. It is axiomatic from 
the above expressions that the RBFN can be trained with relatively lower 
computational overheads than would be required by the MLP with the error BP 
algorithm. Firstly, the establishment of the RB neurones (D is a relatively trivial 
exercise as the prototype vectors µ are the training dataset patterns. Secondly 
the output neurones' weights are updated without the lengthy iterations required 
by the error BP algorithm. 
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From the above account it follows that as the size of the training dataset increases 
so does the computational overheads required by the RBFN. A technique for 
estimating the number of RB neurone Gaussian functions (or [radial] basis 
functions) that is optimally required for the training dataset is the K -means 
algorithm [6,11,12]. This algorithm is discussed in the following section. 
3.3.2 RBFN optimisation methods 
Establishing one RB neurone per pattern is not an optimal method of 
constructing an RBFN. For the method to be optimal, it demands that each 
training pattern presents unique information about the problem - which is often 
not the case [2,13]. Optimisation becomes the process of selecting only the 
training patterns that are useful for solving the problem. Hartman et al., [14] 
considered an artificial (i. e., non real world) dataset containing patterns of 20 
dimensions (i. e., elements). 19 of the dimensions consisted of noise and 
contained no useful information whilst the remaining element contained 
information about the classification scenario. The RBFN when trained with the 
dataset exhibited poor performance in discriminating against the irrelevant 
features and found that the error could only be minimised by increasing the 
number of RB neurones in the hidden layer [14]. This non-optimal method 
motivates the need for a prior selection of the number of RB neurones and their 
prototype vectors. 
Optimisation through selection falls into two distinct categories: non-informative 
and informative. Non-informative methods typically involve randomly selecting 
subsets of training patterns to be utilised as prototype vectors [2]. These methods 
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often result in sub-optimal RBFNs as the chosen patterns can be non- 
representative of the overall statistical distribution. Informative methods often 
work by sequentially adding RB neurones to the network and assessing the 
impact these additions have on the error. Let us now consider two key methods. 
" One particular method which follows this strategy is the orthogonal least 
squares algorithm proposed by Chen et al., [15]. The method involves 
sequentially adding those RB neurones to the RBFN which prompt the 
largest decrease in error. Without termination criteria, the algorithm will 
create as many RB neurones as there are training patterns thereby 
undoing any optimisation that may have occurred. The algorithm offers 
an account of how the error changes with the addition of each prototype 
vector and leaves it to the user to determine how many prototypes to add. 
" Another method for analysing the training data to determine the optimal 
number of RB neurones is the K-means clustering algorithm (also 
referred to as hard C-means clustering). 
The K-means clustering algorithm operates by partitioning the training dataset 
into c clusters C1 (i =1,..,, c). The clusters are chosen such that the dissimilarity 
(or distance) between each datum in the cluster and the cluster centre is 
minimised. This dissimilarity measure is sometimes referred to as a cost function 
or objective function. Typically a Euclidean distance measure is used such that 
the total cost J, incurred for cluster i can be expressed as: 
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J1= Y llXk -ei ll2, (3.16) *, Ik ECG 
where Xk is the kt' pattern vector in the cluster and c1 is the i`h cluster centre 
vector. The expression in (3.16) can be rewritten to give the total cumulative 
cost J for all clusters: 
Y lkXk -eif' J=1 k, IkeC, (3.17) 
The partitioned training dataset (comprising of n vectors) is represented by the 
binary matrix U= {uv I, i=1,..., c and j=1,..., n. The element uy is 1 if the jth 
vector belongs to cluster i, and is 0 otherwise. Once all cluster centres are 
established, U can be populated as follows: 
uI 
if jjxi -ei112 5IlXj -ek112'`dk *i 
U 
0 otherwise 
(3.18) 
Therefore xj is assigned to cluster i if c1 is the closest cluster centre to xx. Given a 
populated partition matrix U the cluster centre ci that will minimise (3.17) can be 
computed from the mean vector of all pattern vectors in cluster i such that: 
c, ý, 
Z xk, (3.19) 
where IC, I is the number of patterns assigned to cluster C,, i. e.: 
n IC1I = u,. (3.20) 
i=1 
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As can be seen from (3.16) and (3.20) optimisation of the membership matrix U 
is an iterative problem requiring the successive recalculation of cluster centres 
and their impact upon the total cumulative cost. The algorithm terminates when 
the change in cluster centres between two successive iterations falls below some 
predefined threshold. The algorithm - formalised in [11,16] - does not provide a 
means to ascertain the optimal number of RB neurones. The user selects the 
number of clusters, executes the algorithm, and then examines the suitability of 
the clusters based on the incurred cumulative error. The process of determining 
the number of clusters is best performed via an inspection of the available 
training data. From inspection of the dataset it could be argued that there should 
be more clusters than there are classes in some scenarios. Such a requirement is 
plausible and indeed advisable with heterogeneous datasets. The final cluster 
centres obtained using the algorithm can be directly employed in the RBFN 
architecture by setting one hidden RB neurone prototype vector µ to a cluster 
centre vector c,. Using this technique it proves possible to reduce the size of the 
RBFN architecture without compromising its classification ability. 
These methods of RBFN optimisation provide a means to reduce the complexity 
of the architecture. Random selection of training data subsets can frequently 
result in sub-optimal solutions whilst the orthogonal least squares method 
provides a more informative account of how the network error is related to the 
training patterns. The orthogonal least squares method is limited insofar that it 
exclusively uses the training patterns and cannot deviate from these prescribed 
vectors. The K-means algorithm however is free to adjust its cluster centres 
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away from the initial training vectors if this provides a general decrease in error. 
The K-means algorithm is therefore an attractive heuristic in RBFN optimisation. 
RBFNs are attractive architectures when attempting to solve certain types of non- 
linear problems. Classification and prediction tasks are frequently solvable using 
these ANNs but they can suffer from problems. In particular the work of 
Hartman et al., [14] demonstrated that the RBFN cannot easily discriminate 
between relevant and irrelevant dataset features. The authors found that the MLP 
can outperform the RBFN in this respect. Chapter 5 of this thesis shows an 
example of the abilities of the RBFN in classifying cardio-respiratory disease 
processes by analysis of the associated heart and lung sounds. The RBFN is 
compared to the MLP in order to assess its generalisation capabilities. Due to the 
nature of the hidden layer RB neurones the RBFN is particularly adept at 
probability density estimation. Each RB neurone can represent the probability of 
occurrence of its prototype vector. Given that the final layer aggregates the 
responses of the RB neurones into the final output, the RBFN can be considered 
to be a form of Gaussian Mixture Model (GMM) [2]. An ANN which follows 
the GMM and is firmly rooted in probability density estimation is the PNN. This 
architecture is discussed further in the next section. 
3.4 The Probabilistic Neural Network 
The PNN -- introduced by Specht in 1990 [17] and later refined in 1992 [18] - is 
architecturally similar to the MLP and RBFN discussed in Sections 3.2 and 3.3 
respectively. Recalling Figure 3.2, the PNN is similar to the 3-layer MLP in that 
it is comprised of an input layer, hidden layer and output layer. The PNN 
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possesses a fully inter-connected input and hidden layer, ensuring that all pattern 
vectors presented to the network are available to all hidden neurones. The 
hidden neurones utilise an exponential activation function in their neuronal 
model and there exist as many neurones as there are patterns presented to the 
network - similar to an un-optimised RBFN. The second synaptic layer of inter- 
connections exists to aggregate the responses of the hidden neurones into class 
neurones and is only partially connected (Figure 3.2). The existence of these 
partial inter-connects indicate that the true class assignments of the training data 
are known during the training phase i. e., that the PNN employs a supervised 
training mechanism. The final layer represents the probability of class 
assignment for each class [19]. As discussed in Section 3.1.1 the function of any 
classifier is to estimate the statistical distribution of the training data and use this 
estimation to define posterior probability densities P (x I Ck) for classification of 
unlabelled data. One of the most straightforward approaches to this statistical 
density estimation is to represent the probability density P (x) in a functional 
form. The PNN represents these densities as multivariate normal distributions 
which can be expressed as: 
T 
`2 (X -µf Y--1 (x - µ) (3.21) (2n)m/2 IEI1/2 exp 
1 P(X) ^1 
where m is the dimensionality of x and µ, E is an mxm covariance matrix, and 
IEI is the determinant of E. The factor on the left hand side of the exponent in 
(3.21) ensures that the integral of P (x) is unity. Furthermore the quantity 
(x - µ)T E-' (x - p) is the distance measure between the pattern vector x and the 
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mean vector µ, and is termed the Mahalnobis distance. Given (3.21) it can be 
seen that the expressed probability contours of the distribution are 
hyperellipsoidal with the principal axes being given as the eigenvectors ui 
(i =1,..., m) of E such that: 
Eu; = Au; (3.22) 
where A. i is the variance along the i` axis. As is evident from the description of 
the hidden neurone's activation functions, the PNN behaves in a manner not 
dissimilar to a GMM [2]. Considered in the GMM framework the individual 
hidden neurones can be argued to be independent probability distributions of the 
training data. The PNN models the class densities (pi of the input data by 
aggregating the probability densities weighted by the prior probabilities of 
occurrence: 
M 
co(x) =Zp(j) Pi 
j: 1 
(3.23) 
where M is the number of prototype vectors (i. e., number of patterns in the 
training dataset) belonging to class i, P(j) is the prior probability of occurrence 
of the response from the p component and PP (x) is the probability density given 
in (3.21). The PNN architecture can be extended to incorporate a fourth layer 
that serves to attribute decision risks to classes. If an erroneous classification 
results in xe Ck instead of xeC, then a penalty vk can be imposed. The risk 
function pk (x) of class k can then be expressed as: 
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Pk (x) _ ZvkP (C, ) q!, (X), 
(3.24) 
, =i 
where c is the number of classes and P(C, ) is the prior probability of class i. 
Used in a risk-based framework, the PNN would simply classify input patterns 
based on minimum risk, selecting the class that incurs the lowest cost i. e.: 
Ck =argmin( pk(x)}. 
lese 
(3.25) 
The fourth layer can be omitted if there are no cost functions utilised in the 
classification scheme, reverting the architecture to a three-layer network that 
directly employs GMM. The PNN suffers from the same drawback as the RBFN 
insofar that a hidden-layer neurone is created for each pattern in the training 
dataset. Numerous training algorithms have been proposed that can optimise the 
neuronal parameters of the PNN. These parameters include the covariance 
matrix 2 and mean vector µ in (3.21) which respectively affect the 
multidimensional smoothness and centre point of the activation function. Specht 
[17] proposed the method of generating one hidden neurone per training pattern 
and further proposed restricting E to a scalar quantity a in (3.21). Substitution of 
E for a results in homoscedastic activation functions under which even small 
changes can affect the density function along all principal axes. Berthold et al., 
[19] commented that minimal adjustments of o can impact heavily on network 
performance. It is axiomatic that large datasets will yield large PNN 
architectures which can detrimentally increase computational complexity. 
Another proposal by Specht [18] involved replacing o- with a diagonal matrix E 
and iteratively adjusting the diagonal entries in E depending upon the network 
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error. This method of adjustment mimics the error BP algorithm in Section 3.2.1 
which is computationally intensive and does not address the issues surrounding 
large datasets. Streit et al., [20] proposed fixing the number of hidden neurones 
in each class followed by an iterative adjustment of the parameters in (3.21) 
using a maximum likelihood training method [1,2]. This approach becomes 
attractive when training a PNN with large datasets as it minimises the size of the 
PNN and hence computational complexity. These methods of training or 
optimising the PNN either require homoscedastic activation functions (which 
limits the network's adaptability) or fixed-size architectures. A more attractive 
method is one in which the PNN architecture is constructed by sequentially 
adding neurones in a similar manner to the orthogonal least squares algorithm 
discussed in Section 3.3.2. Such networks are referred to as Constructive 
Probabilistic Neural Networks (CPNNs). CPNNs ameliorate the problems 
encountered by PNNs by dynamically `growing' the architecture whilst retaining 
heteroscedastic activation functions. 
3.4.1 The Constructive Probabilistic Neural Network 
The CPNN is essentially a PNN that is grown by the sequential addition of 
neurones in the hidden and output layers. The neurones are added in response to 
patterns presented in the training dataset. Prior to adding a neurone, an 
assessment is firstly made as to whether existing neurones can perform the same 
function. If they can, then they are adjusted to encompass the new training 
pattern, otherwise a new neurone is added. This method of constructing the 
CPNN often results in highly compact and efficient architectures requiring low 
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computational overheads. The algorithm responsible for constructing the PNN is 
now discussed. 
The Dynamic Decay Adjustment (DDA) algorithm [19] is an extension to the 
Restricted Coulomb Energy (RCE) [21] and Probabilistic Restricted Coulomb 
Energy (P-RCE) [221 algorithms. The DDA algorithm, introduced by 
Berthold et al., [ 19] is a constructive algorithm in that it iteratively adds neurones 
to the network and adjusts the parameters of the neuronal activation functions in 
(3.21). Parameters are adjusted by the algorithm to prevent conflict between 
neurones i. e., when two or more neurones linked to different classes respond to 
an input pattern hence resulting in an ambiguous classification. Adjustment to 
the parameters include modification of the amplitude of the function and the 
covariance matrix E. Berthold et al., [19] define two terms: 
" 0' the minimum correct-class probability. Given an input pattern x 
linked to class k presented to the network, at least one neurone linked to 
the same class must respond with an activation greater than 0+ . 
90 the maximum incorrect-class probability. Given an input pattern x 
linked to class k presented to the network, any neurones linked to any 
other class are permitted to respond provided that their activations are no 
greater than 0- . 
Presented now is an annotated formal description of the algorithm as given by 
Berthold et al., [19] followed by a qualitative description. For clarity Vpk (x) is 
the activation function for neurone i linked to class k as given in (3.21). 
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Step 1. Present a training pattern - target class pair (x, k) to the network. 
Step 2. If 3 rpk (x) : rpk (x) > B+ then increase the amplitude Ak of 
function (pk (x) by 1 and proceed to step 4. 
Step 3. Introduce a new neurone with activation function qp+, (x), 
amplitude A +1 =1 and mean vector p +, =x. Calculate the 
standard deviation using: 
_ 
II tk 
Qrk 
II z 
(3.26) 
+1 = min q, In B+ 
where I# k, 1 <_ j<_ q, is equivalent to all neurones connected to 
all classes other than class k (the correct class), and q, is the 
number of neurones in class 1. 
Step 4. Adjust the standard deviation of all conflicting neurones using: 
Vl #k, 1<_J ýqr: a; =min Qý, (3.27) 
=X 
and then proceed to step 1. 
In qualitative terms, when a pattern-class pair (x, k) is presented to the network 
during training, if any neurone i linked to class k responds with an activation 
z B" then the neurone's activation function amplitude is increased by 1. All 
neurones linked to classes 1#k have their standard deviations a reduced using 
(3.27). The reduction is such that their activation responses to pattern x will be 
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less than B- F. If no neurone of class k responds to the pattern x then a new 
neurone is added to the architecture, linked to class k and centred around x 
i. e., µ +, = x. The new neurone is added to the architecture to account for future 
occurrences of the pattern. 
Once all training patterns have been presented to the network and the algorithm 
has created the activation functions, it can be noted that the activation functions 
may have differing amplitudes; as a consequence of step 2 of the algorithm. 
These amplitudes relate to the prevalence of the training patterns that these 
neurones respond to and hence can be seen to represent the prior probabilities 
P(j). The prior probabilities can be computed by normalising the activation 
function's amplitudes against their same-class counterparts such that: 
Ak 
Pk W_', F 9=14 (3,28) 
where hidden neurone j is linked to class k and qk is the number of hidden 
neurones linked to class k. As can be seen from the aforementioned steps the 
purpose of the DDA algorithm is to iteratively determine an appropriate mixture 
of Gaussian density functions to represent the training dataset drawn from 
m-dimensional input space R'. Berthold et al., [19] found that this algorithm 
can offer substantial advantages in terms of the final PNN network size and 
generalisation capabilities. Indeed it can be argued that the CPNN affords the 
user a less computationally complex architecture and can remain a network 
capable of generalising well with unseen data because the algorithm creates only 
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the number of elements (Le., neurones) required to represent the underlying 
statistical distribution. 
As can be seen from the above PNN and CPNN descriptions, these ANN 
architectures can only be used in classification scenarios. Function or time series 
prediction is beyond the capabilities of these architectures whereas it has been 
shown in Chapter 2 that the MLP and RBFN have both found numerous 
applications in this field. These mainstream ANN architectures can all be used 
as classifiers, being capable of effectively resolving some linear and non-linear 
problems. Whilst the PNN and CPNN are inherently computationally 
lightweight ANNs, the RBFN requires an optimisation heuristic to impart the 
same level of flexibility. In comparison, whilst the MLP demands higher 
computational overheads than the PNN and CPNN, the ability of the BPGDM 
training algorithm allows the MLP to reject aspects of the training data that are 
not pertinent to the classification problem. From this it can be seen that selection 
of the appropriate ANN architecture for solving a problem can heavily impact on 
the solution. An inappropriate ANN selection may yield an ineffective solution, 
or a solution prone to erroneous classifications. 
Given that the main purpose of statistical pattern recognition is to formulate 
decision rules whereby data can be assigned to classes, application of a singular 
ANN may be insufficient in solving the problem [23]. One practical problem is 
the scarcity of training data which can introduce uncertainty into the estimation 
of posterior probability densities. Binaghi et al., [24] noted that "Classification 
problems may present different kinds of uncertainty that render classification 
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statements vague and doubtful, membership in classes a matter of grades, and 
probability theory requirements either too restrictive or all together inadequate" 
[24]. A plurality of different ANN architectures (or topologies) may be required 
to render the problem solvable - or at least improve on single-classifier 
approaches. Uncertainty, the requirement of multiple ANN topologies, and near- 
homogeneous data all conspire to produce a scenario which Bayesian theory 
cannot effectively solve [23]. A robust method of combining the results of 
multiple classifiers whilst providing a framework for evaluating uncertainty is 
Dempster-Shafer Theory (DST) which falls under the umbrella of Evidence 
Combination Theory (ECT). These concepts are discussed in the next section. 
3.5 The Dempster-Shafer Theory of evidence combination 
The Dempster-Shafer Theory of evidence offers a framework for reasoning 
between imprecise, ambiguous and conflicting hypotheses (i. e., classifications or 
probabilistic assertions). This section presents an overview of DST whilst a 
complete account can be found in [25]. DST extends traditional Bayesian 
classification to incorporate belief and plausibility terms. In order to define these 
concepts and examine how they can assist in combined classification, we 
consider the following. Let us consider each possible classification xE Ck as 
being one of a number of mutually exclusive propositions Ai where i =1,..., k. 
These propositions form the frame of discernment 0= {A1,..., Ak 1. The 
classification from an ANN in an ensemble can be considered to be a basic belief 
assignment m. The value m (A) can be considered to be the mass of belief that is 
committed to xe Ak (and to none of its subsets) [23,25]. Consequently for all 
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subsets (i. e., classifications) BcA the belief measure Bet (A) can be expressed 
as: 
Bel(A)= 1: m(B). 
BCA 
(3.29) 
The quantity Bel (A) is the extent to which one believes in A either directly 
attributable to m (A) or indirectly attributable to m (B) for all BcA [23]. In 
extension to this, plausibility is defined as the body of evidence committed to A 
or its subsets i. e., the extent of doubt of xe Ak . Plausibility is therefore 
expressed as: 
PI (A) =m (B) =1- Be1(A ). 
Ana*a 
(3.30) 
Belief and plausibility measures afford the user with a framework for assessing 
the strength of classifications from ANNs. An important aspect of DST is its 
ability to combine classifications (i. e., evidence) provided by multiple sources 
(e. g., ANNs in an ensemble). Given two basic belief assignments ml and m2 
from two independent sources, Dempster's rule of evidence combination follows 
the form: 
n (B) m2 (C) 
ME , VA ý 0, 1 m, (B) m2 (C) 
arts=0 
(3,31) 
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where ml (B) >0 and m2 (C) >0 for some non-disjoint subsets B and C of e 
and mE(A) is the orthogonal sum of mi and m2. As can be seen from (3.31), 
Dempster's rule of evidence combination permits the aggregation of independent 
ANN classifications at the output-neurone level. It facilitates the creation of a 
combined ANN classifier that accounts for conflicting and ambiguous 
classifications. The following sections summarises the discussions presented in 
this chapter. 
3.6 Summary 
This chapter has introduced some of the most prevalent ANN architectures in the 
field of biomedical engineering. It has introduced the field of Bayesian 
Probability Theory and demonstrated how these ANNs perform classifications 
based on these probabilities. It has considered the relative merits of each type of 
ANN and has highlighted their shortcomings, emphasising the necessity for 
appropriate selection of architectures based on the problem at hand. This chapter 
has further examined situations where single ANN approaches cannot effectively 
solve classification problems, and has introduced an effective means by which to 
aggregate ANNs by way of DST. The following chapters discuss how ANNs 
were applied to the development of biosignal classification systems as part of 
this work. 
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CHAPTER 4 
Experimental Method and Data Collection 
This chapter discusses the manner in which the data for this research was 
acquired. It describes the hardware used and the rationale behind the 
experimental methods. The chapter concludes by discussing the construction of 
the final datasets that are used for the subsequent analyses. 
4.1 Rationale behind data collection 
In order to develop intelligent systems which can clinically assess patients, the 
systems must firstly have been `trained' with appropriate medical data. As was 
discussed in Chapter 3, the BPGDM training algorithm, RBFN, and CPNN 
require datasets from which to learn. Motivation for our data collection is 
derived from this fact. In order to model clinical processes using these systems, 
`patient data' must be at hand. The type of data considered as part of this 
research, and motivation towards its collection, is presented in Section 4.1.2. 
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The following section discusses how the data collected as part of this research is 
used to generate information, and how this information is used elicit knowledge. 
4.1.1 From data-mining to knowledge extraction 
Section 4.1 gave a brief account of the motivation for data collection. In 
Chapter 1 we introduced one of our objectives which was to attempt to model the 
anaesthetist's knowledge in order to provide an automated means of decision 
support. One of the most important questions therefore, is how one progresses 
from data (e. g., raw, unprocessed numbers relating to biomedical parameters) to 
knowledge, i. e., an understanding of the underlying relationships between 
biological processes and how these can be affected by medical intervention. The 
process one typically follows is illustrated in Figure 4.1, in which information is 
elicited from data, and in turn, knowledge is extracted from the information. As 
one follows the process it is usually the case that the 'data' becomes more and 
more useful in the context within which it is being utilised. 
Data processing ANN learning 
Data acquisition --*( -f Information elicitation 
Data mining 
Figure 4.1. Process flow, from data to knowledge. 
In its raw, unprocessed form, data imparts little information concerning the 
process or event that it describes. Typically it is correlated, noisy, incomplete, 
etc., so a method of refining the data must be applied to elicit useful information. 
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Throughout the remainder of this thesis - and in particular Chapters 5,6 and 7- 
we will observe that the first process to be performed on the acquired dataset is 
to process the data to elicit information. In the context of cardio-respiratory 
auscultation, information could mean that: a certain range of coefficient values is 
indicative of a certain pathology; or in the context of arterial pulse waveforms, 
that an aperiodic (and hence) abnormal waveform has a low cross-correlation 
with a periodic version. In the context of this work we define information to be 
some quantity, refined - or mined - from raw data. Figure 4.2 illustrates the 
relationships between data and information in the context of this work. 
Data Information Anaesthetist-lead 
training 
Biometrics Data Knowledge 
Cardiac Assessment (Classifier) 
Decision Support 
Figure 4.2. Relationships between data, information, and knowledge. 
Figure 4.2 gives an illustration of the components of the proposed decision 
support tool, discussed in Section 4.1.2. Importantly it shows how information 
can be elicited from data, and how this information can be used to form 
knowledge. In this work we define knowledge to be the application of 
information in fulfilling a mandated task, e. g., the classification of patients for 
surgical anaesthesia; and to be an understanding of the relationships between the 
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`tokens' of information. The decision support system extracts knowledge from 
the information provided by the previous components in conjunction with 
information provided by the anaesthetist during `learning'. In essence a trained 
system will encapsulate the knowledge of the anaesthetist to this particular 
problem. By extracting knowledge and encapsulating it within the decision 
support system, the objective of an expert medical assessment system can be 
realised. One of the first rule-based expert medical assessment systems is 
MYCIN [1] which provides a framework for constructing tree-based decision 
systems. MYCIN-style systems are rule-based knowledge systems with 
weighted rules of the form E H(w) (i. e., if the premise E holds, then the 
consequent H holds with weight w) [2]. Given a user-defined set of symptoms 
S= {S,,..., Sn } and diagnoses D= {D,,..., D, } and user-specified weights, the 
objective is to accurately map symptoms to diagnoses through the application of 
combinatorial logic: AND, OR, NOT, etc. The primary drawback to these 
approaches is that output diagnoses cannot be considered to be probabilistic 
assertions [3]. Systems which express the output diagnoses and reasoning as 
belief measures are preferable in the context of clinical, and hence this, research. 
For examples of some expert rule-base systems and their application in clinical 
diagnosis the reader is referred to [4,5]. 
Throughout subsequent chapters we will refer back to this section in detailing 
how the presented research and development adheres to this objective. 
Discussed now are the information sources considered as part of this research. 
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4.1.2 Data types and information sources 
This section briefly outlines the different types of data collected as part of this 
research. Motivation for its inclusion is presented, alongside the information that 
each data type provides. The data types are defined as: 
" Cardio-respiratory auscultation. Since the advent of Laennec's 
stethoscope in 1816 [6] the process of auscultating (i. e., listening to) the chest 
has been of central importance in the assessment of patients. Auscultation 
provides the anaesthetist with useful data from which they derive information 
as to the presence of cardio-respiratory disease processes. Anaesthetists 
consider that it is important to perform this assessment. This is because 
knowledge about the presence or absence of cardio-respiratory disease 
processes can ultimately help them prescribe the appropriate type and 
duration of surgical anaesthesia; or this may prevent the patient from 
undergoing surgery altogether [7]. 
41 Blood pressure sphygmomanometry. The sphygmomanometer (or blood 
pressure (BP) monitor) provides data about the state of the patient's 
cardiovascular system. In particular cardiac output, arterial distension, and 
the volume and viscosity of the blood. The sphygmomanometer measures 
systolic BP and diastolic BP in millimetres of mercury (mmHg), and also 
heart rate (HR) in beats per minute (bpm). These values inform the 
anaesthetist as to whether the patient is suffering from e. g., hypertension, 
hypotension, cardiac fibrillation, etc. This assessment affords the anaesthetist 
a view as to how the cardiovascular system will respond to surgical 
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anaesthesia and is considered to be an important factor as to whether the 
patient can undergo surgery or not [8]. 
" Pulse plethysmography. Pulse oximetry data provides a means by which to 
quantify the extent of arterial haemoglobin oxygen saturation (Sp02) i. e., the 
amount of oxygen being transported by the blood. This is typically measured 
by a pulse oximeter. Data pertaining to the patient's level of 
oxyhaemoglobin may provide important clues about cardio-respiratory 
competence and of blood chemistry. The anaesthetist must assess this metric 
in order to safely prescribe the type and duration of surgical anaesthesia [8]. 
" Lung spirometry. Respiratory competence can be assessed using data 
relating to the amount of air exhaled by the patient during respiration. 
Respiratory function is typically measured as Peak Expiratory Flow Rate 
(PEFR), measured in L/min, and Forced Expiratory Volume in 1 second 
(FEVI), measured in L. Respiratory competence may be diminished by 
existing disease processes, which may also result in complications during 
surgery. In Section 1.2.2 it was shown that the anaesthetist is responsible for 
the patient's respiration during surgery [8,9]. It is therefore important to the 
patient, and to the anaesthetist, that the respiratory system can convey 
sufficient oxygen during respiration and that the process is not impeded by an 
abnormality, e. g., asthma, etc. 
" Clinical history. Data pertaining to the clinical history of a patient can be 
shown to possibly be an indispensable source of information, regarding the 
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patient's state of health [10]. For example, anaesthetists rely upon the 
clinical history to provide indications about the patient's current state of 
disease processes and pathologies, e. g., asthma, blood pressure, diabetes 
(affecting blood chemistry), etc. Used in conjunction with cardio-respiratory 
auscultation, blood pressure, pulse oximetry and lung function 
measurements, the clinical history can provide an informative account of the 
state of health of a patient. It can assist the anaesthetist in prescribing the 
most appropriate types of anaesthesia and any appropriate monitoring 
required during surgery. An exhaustive list of the clinical history indicators 
used throughout this research is presented in Section 4.4, 
The types of data described above are essential to the accurate appraisal of a 
patient undergoing surgical anaesthesia [8]. As will be demonstrated through 
subsequent chapters, these metrics can be `processed' using intelligent systems to 
produce accurate patient pre-operative assessments. 
4.1.3 Dataset sources 
Data was acquired from 194 patients between June 2003 and August 2004. The 
patients were scheduled for outpatient appointments at the Ear, Nose & Throat 
(ENT) clinics at Good Hope Hospital (Sutton Coldfield, U. K. ), Birmingham 
Heartlands Hospital (Birmingham, U. K. ) and Solihull Hospital (Solihull, U. K. ). 
These hospitals are operated by NHS Trusts. These patients are henceforth 
referred to as the sample group. 
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In Section 4.2, an account of the cardio-respiratory data acquisition process is 
presented. This is followed in Section 4.3 by a description of how BP, HR, 
PEFR, FEVI and SpO2 measurements were made. Section 4.4 presents the 
indicators that were taken from the patient's anonymous clinical notes. Section 
4.5 gives a brief introduction to the ways in which this data is used in subsequent 
chapters. 
4.2 Cardio-respiratory data acquisition 
Cardio-respiratory sounds were collected from patients at the aforementioned 
hospitals. The author developed appropriate data collection protocols and 
worked with qualified physicians in order to collect `sound data'. The purpose of 
these experiments was to acquire auscultated cardiac and respiratory sounds 
indicative of different disease processes and pathologies. 
4.2.1 Experimental procedure for cardiac auscultation 
Cardiac auscultation was performed on four areas of the precordium: the aortic 
area, pulmonic area, ventricular area and tricuspid area; in accordance with 
existing clinical practice. Certain cardiac pathologies manifest themselves at 
different locations in the heart. For example, aortic stenosis will manifest itself 
in the aortic region whilst ventricular impairment will be best heard when 
auscultating the ventricular region. It is this disparity between the audible 
location of disease processes and pathologies that motives the necessity for 
auscultating the various regions of the heart. 
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Aortic Area 
Ventricular Ar 
Pulmonic Area 
icuspid Area 
Figure 4.3. Cross section of the heart with the regions of auscultation [10]. 
Figure 4.3 shows the areas of auscultation in relation to the heart. Each patient in 
the sample group was assessed by a qualified physician and the presence of any 
cardiovascular disease process or pathology was recorded. 
4.2.2 Data collection protocol for cardiac auscultation 
Each heart sound and associated diagnosis was noted against their unique patient 
ID (PID) number and digitally recorded using the methods described in the 
following section. The PID was used as an anonymous identifier such that in the 
event of uncertainty an echocardiogram could be performed to ascertain the 
disease process. The echocardiogram is the standard and accepted tool for non- 
invasive cardiac valvular assessment [11]. When used in conjunction with the 
auscultated diagnostic assessment, the echocardiogram can present a sufficiently 
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informative record from which to make an accurate diagnosis. A further factor 
that was noted was whether the patient was fitted with prosthetic heart valves. 
Start 
Auscultate aortic 
area of heart 
Auscultate 
ventricular area of 
Auscultate 
tricuspid area of 
heart 
Auscultate 
pulmonic area 
heart 
Perform 
alongside the 4 
heart sounds 
Save data on PC 
End 
Yes 
Figure 4.4. Flow diagram of the experimental procedure defined for 
cardiovascular auscultation. 
Prosthetic valves can present audible clicks during the cardiac cycle which could 
affect subsequent audio signal processing. The experimental procedure is 
summarised in Figure 4.4. The data collection sheet is presented in Appendix II. 
4.2.3 Equipment configuration for cardiac auscultation 
The electronic stethoscope used throughout these experiments was the i-Stethos 
(Andromed Inc., Quebec, Canada), given in Figure 4.5. The electronic 
stethoscope is ergonomically similar to its acoustic counterpart and possesses an 
electret microphone and basic signal `conditioning' electronics. For example, the 
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stethoscope employs a band-pass filter that attenuates extraneous noise from the 
signal during auscultation. 
Figure 4.5. The i-Stethos electronic stethoscope used in these experiments. 
When configured to auscultate the heart, the stethoscope exhibits a pass-band 
frequency range of 20Hz - 200Hz. This is in agreement with the audible 
frequencies of normal heart sounds and cardiac murmurs. By filtering out 
extraneous non-cardiac sounds the electronic stethoscope affords the physician a 
less obstructed account of cardiac competence'. The electronic stethoscope was 
connected to a Personal Computer (PC) via a 3.5mm jack plug and audio cable. 
The electronic stethoscope signal was sampled by the PC at a frequency of 
44kHz using 16-bit data resolution. The duration for each auscultated sound was 
approximately 30 seconds. The cardiac sounds recorded by the electronic 
stethoscope were subsequently stored by the PC in an uncompressed form for 
The physicians who used the electronic stethoscope commented favourably on the clarity with 
which cardiac auscultated sounds could be heard. 
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subsequent analysis. A list of the cardiac abnormalities considered in this 
research is presented in Section 5.2. 
4.2.4 Experimental procedure for respiratory auscultation 
Respiratory auscultation was conducted in a similar manner to that described in 
Section 4.2.2. Auscultation was performed on two areas of the chest: the tracheal 
region and the bronchial region. 
Tracheal Region 
Bronchial Region 
Figure 4.6. Cross section of the lungs showing the regions of auscultation [101. 
Most of the breath sounds extrinsic to regular lung function manifest themselves 
in these two regions, particularly in the bronchial region [101. Figure 4.6 shows 
a diagram of the lungs overlaid with the regions of auscultation. Respiratory 
auscultation was performed by a qualified physician with the i-Stethos electronic 
stethoscope (Figure 4.5). The filtering mechanism was configured for lung 
assessment, in which the frequency response band is 100Hz - 500Hz. Patients 
were auscultated in both bronchial and tracheal regions for approximately 30 
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seconds during which time a representative account of respiratory competence 
could be established. The physician identified whether the patient was 
presenting crackles, wheezes, etc., which were possibly indicative of a disease 
process. These indicators are presented in Section 5.2. 
Start 
Auscultate 
bronchial region 
the lungs 
Auscultate 
tracheal region of 
the lungs 
Perform CXR 
we data on PC 
Record diagnosis \ 
alongside the 2 
lung sounds 
End 
Figure 4.7. Flow diagram of the experimental procedure defined for 
respiratory auscultation. 
The PID was again used as an anonymous identifier such that in the event of 
uncertainty a chest x-ray (CXR) could be performed to ascertain the abnormality. 
The experimental procedure for respiratory auscultation is summarised in the 
flow diagram presented in Figure 4.7. Section 5.2 gives the respiratory 
abnormalities considered as part of this research. 
4.3 Biometric data acquisition 
Biometric data comprising BP, HR, PEFR, FEV, and Sp02 was collected from 
the sample group during their visit to the ENT outpatient clinics. Data was 
collected by the author under the partial supervision of a clinical nurse. 
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Start 
Check patient for 
ALND history, and 
for asthma 
Yes Nurse's No measurement 
No I Nurse takes 
BP and 
Record 4- 
measurements 
Patient Yesi Nurse's No 
asthma? decision 
No I Nurse takes 
Reword 
Conduct and 
R nts --- 
1 record Sp02 
measurement 
End 
Figure 4.8. Biometric acquisition process accounting for patient risk. 
Under certain circumstances it was required that BP, HR, PEFR and FEV, 
measurements be acquired by a qualified nurse. For example, in the instance of 
the patient having had axillary lymph node dissection (ALND), i. e., removal of 
the axillary lymph nodes for cancer staging (detection), it is inadvisable to 
measure blood pressure on the side of the resection. Furthermore, if the patient is 
asthmatic then PEFR and FEV, measurements can aggravate the patient's 
condition. As such, the supervising nurse was required to decide whether it was 
appropriate to measure BP, HR, PEFR and FEV1. The data acquisition process is 
formalised in Figure 4.8. 
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4.3.1 Hardware connectivity and data storage 
Lung (unction spirometer 
The three items of hardware used during these experiments were the digital BP 
monitor (Boso Medicus: Bosch & Sohn, Germany), pulse oximeter (Nonin 
OEM2 monitor: Nonin Medical Inc., Minneapolis, USA), and lung function 
spirometer (KoKo Peak Flow: Ferraris CardioRespiratory, Colorado, USA). The 
digital BP monitor and spirometer were previously used by the supervising 
physicians and were recommended to the author. The Nonin OEM2 monitor was 
chosen as it was designed for rapid prototyping as well as clinical accuracy. 
Pulse oximeter 
BP & HR monitor 4 way DB9 switch Data acquisition PC 
Figure 4.9. Diagram of the experimental setup, including the pulse oximeter, BP 
monitor and lung function spirometer. 
These devices were connected to a PC via an RS232 serial port which enabled 
the devices to transmit their recorded values directly to the computer. Custom 
software to pre-process and store the data is discussed in Section 4.3.2, whilst 
data communication protocols are discussed in Section 4.3.3. A diagram 
showing the hardware setup is given in Figure 4.9. 
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Technically it was permissible to run the three tests in any order. The tests were 
not all run concurrently for the reason that they could interfere with one another. 
For example, the lung function test is a physically demanding exercise for the 
patient, requiring them to perform a forced respiratory expiration. The pulse 
oximeter is sensitive to physical movement and hence could collect a corrupted 
pulse waveform, i. e., a waveform with motion artefacts. Motion artefacts are 
discussed at length in Section 6.2.2. However, BP, HR and Sp02 data could be 
collected simultaneously if - and only if - measurements were taken from 
opposing sides of the patient, i. e., left and right side. This is because, when in 
use, the BP monitor cuff exerts a pressure on the patient's arm and can restrict 
arterial blood flow, ergo potentially affecting the Sp02 measurement. In the 
interests of expediency BP, HR and Sp02 measurements were acquired 
simultaneously. 
Start 
PC 
data 
acquisition f 
pulse oxime 
switch box to 
Begin lung 
º function 
measurement 
Conduct lung 
spirometry test 
1 
Conclude lung 
Function 
measurement 
Save data to PC 
End 
Figure 4.10. Flow diagram of the adopted experimental process. 
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The BP monitor was attached to the patient's (usually) right arm and the cuff was 
allowed to inflate in preparation for the BP measurement. During this time the 
oximeter sensor was attached to the index finger on the left hand and the 
instantaneous Sp02 and pulse waveform measurements were transmitted to the 
PC via the switch box (Figure 4.9). After the BP monitor had completed its 
measurement the switch box was reset allowing the BP monitor to transmit its 
measurements to the PC. Subsequently the PEFR and FEV1 measurements were 
taken. The process is summarised in Figure 4.10. 
4.3.2 Data acquisition software 
A computer program was written by the author to expedite the process of data 
collection and enable recording of the biometric measurements on the PC. An 
example of the user interface is presented in Figure 4.11. The data acquisition 
software was written in the Java programming language (Sun Microsystems, 
USA). This programming language was used to write further programs 
discussed in Chapter 7 and motivation for this choice is given in Chapter 8. 
Suffice to say at this juncture, the main benefit to using Java is derived from its 
object-oriented nature. Java programs are typically constructed out of objects 
(i. e., programmatic code blocks that have attributes and behaviours rather than 
variables and subroutines). It allows the user to expedite the process of writing 
programs that - due to their object-oriented nature - can easily integrate into 
other object-based programs. Other object-oriented languages such as C++ offer 
similar benefits, but Java has potential benefits such as platform independence, 
improved networking (and worldwide web) capabilities, etc. We believe that 
Java will provide substantial benefits as the results of the work presented here are 
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integrated, and to what we might call the universal diagnostic machine 
(discussed in Section 8.3). 
4. B&ohazaids ',. P4 tient Dein 6. PatwM Surgery 
1. Patient Ido. ý 2. Paben* Condition I 
ýF 
Piliert Dara 
Pulse Measu; emeni Sys, Dra (HR) MeasuremefMs 
Systole: --- rtmp 
Diastole: --- nwmq 
HR --- bpm 
Collect 
PEFRIFEV1Measwemenls 
PFFR 0. Mrn): 
FEVI (L): 
Edler 
Sa02MR Mea urement Settmgs 
oxw ry -- x" RS232 source 
C -81M Blaetodh source 
Click to start collecting pulse mimetry data 
Figure 4.11. Graphical user interface for the data acquisition software. 
The data acquisition program was structured into 6 tabbed panels: 
" `Patient Info. ' panel. This panel allowed for the entry of basic patient 
information such as PID, age, gender, etc. 
" 'Patient Condition' panel. This panel allowed for the entry of clinical history 
indicators (discussed in Section 4.4). 
" `Patient Drugs' panel. This panel recorded the medication the patient was 
taking that was relevant to the anaesthetist (discussed in Section 4.4). 
" 'Biohazards' panel. This panel allowed for the entry of biohazard indicators 
such as MRSA infection, active Tuberculosis (TB), etc. These biohazard 
indicators are discussed in Section 4.4. 
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0 'Patient Data' panel. This panel (given in Figure 4.11) allows the user to 
start and stop acquiring data from the PC-connected equipment such as pulse 
oximeter, BP monitor, etc. 
" `Patient surgery'. This panel allows the user to enter additional information 
concerning the patient's proposed operation. Information entered into this 
panel is stored directly alongside the patient information. 
Figure 4.12. Structure of the data acquisition program and the information each 
panel requests. 
4.3.3 Data transmission protocols 
The data transmission protocol is defined as the way in which the PC 
communicates with the acquisition hardware and the manner in which the data is 
transferred from the device to the computer. This section gives a brief overview 
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of the data transmission protocols for the BP monitor, pulse oximeter and lung 
spirometer. The protocols are given as follows. 
" The BP monitor was interfaced to the PC via an RS232 interface with a 
DB-9 terminated cable. The BP monitor used serial data transmission with 
the communication speed set at 4800 bits per second (bps), 8 data bits per 
frame, I start bit, 2 stop bits and no parity bits. The connection was opened 
to the device using the above parameters and the ASCII bytecode (denary 
equivalent) `240' was transmitted to the BP monitor. The BP monitor then 
polled back to the PC the data stored in its Erasable Programmable Read- 
Only Memory (EPROM). In Table 4.1 the values polled from the BP 
monitor are encoded in hexadecimal, save for the header which is transmitted 
in ASCII plain text. 
Sequence No. Parameter Length Example 
I Header 10 bytes UB0401_ 
_20 
(ASCII) 
2 Systolic - Diastolic BP 2 bytes 
38H (= 56DEN) 
3 Diastolic BP 2 bytes SOHL (= 80DEN) 
4 Pulse rate 2 bytes 59HEx (= 89DEN) 
5 Error code 2 bytes O1HEx (= IDEN) 
6 Event code 2 bytes 01 HEX (= I DEN) 
7 Year 2 bytes iX (= 99DEN) 8 Month 2 bytes 09HEX (= 9DEN) 
9 Day 2 bytes 02HEX 2DEN) 
10 Hour 2 bytes OEHEx & 14DEN) 
11 Minute 2 bytes 2DHEx (= 45DEN) 
12 Checksum 2 bytes 8CHEx (= MODEN) 
Table 4.1. Data transmission values for the BP monitor. 
Datum sequence 2 in Table 4.1 is defined as the difference between systolic 
and diastolic BP in mmHg. Diastolic BP (sequence 3) is expressed in mmHg 
and pulse rate (sequence 4) in bpm. The error codes and event codes 
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(sequences 5 and 6 respectively) were inconsequential with regards to these 
experiments. Measurements were only accepted by the software if these 
codes were zero (i. e., no error). The error and event codes did not relate to 
issues with patient physiology, rather to mechanical failings of the BP 
monitor which impeded the collection of reliable measurements. The year 
(sequence 7) represented the last two digits of the year whilst the checksum 
(sequence 12) was the last two digits of the hexadecimal sum of sequence 2- 
11. Upon transferring the string of values, the BP monitor closed the 
connection and awaited another connection attempt. 
" The pulse oximeter was interfaced to the PC via an RS232 interface with a 
DB-9 terminated cable. When turned on, the oximeter attempted to make a 
connection to the attached fingerclip sensor and when connected it began 
calculating the Sp02 values. The PC established a serial data connection at a 
speed of 9600 bps with 8 data bits per frame, 1 stop bit and no parity bits, 
The oximeter began polling the measurements at a rate of 75 times per 
second. 5 bytes were transmitted on every poll, which are detailed in 
Table 4.2. In Table 4.2, the first byte is the synchronisation character and 
was always `01'. The second byte is the status byte and was 128 during 
normal operation. In the event of errors (sensor misalignment, etc. ), the 
status byte takes any value between 129 and 255. During this time the PC 
ignored all data from the oximeter until the error has been resolved and the 
status byte returned to the value 128. 
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liz 
1175 1 2 
Byte 
3 4 5 
Ilz 
1/75 1 2 
Byte 
3 4 5 
Ilz 
1/75 1 2 
Byte 
3 4 5 
1 01 ST PLE HR1 CS 26 01 ST PLE HR1 CS 51 01 ST PLE HRI CS 
2 01 ST PLE HR2 CS 27 01 ST PLE HR2 CS 52 01 ST PLE HR2 CS 
3 01 ST PLE Sp02 CS 28 01 ST PLE Sp02 CS 53 01 ST PLE Sp02 CS 
4 01 ST PLE REV CS 29 01 ST PLE REV CS 54 01 ST PLE REV CS 
5 01 ST PLE * CS 30 01 ST PLE CS 55 01 ST PLE * CS 
6 01 ST PLE * CS 31 01 ST PLE * CS 56 01 ST PLE * CS 
7 01 ST PLE * CS 32 01 ST PLE * CS 57 01 ST PLE * CS 
8 01 ST PLE * CS 33 01 ST PLE * CS 58 01 ST PLE * CS 
9 01 ST PLE * CS 34 01 ST PLE * CS 59 01 ST PLE * CS 
10 01 ST PLE * CS 35 01 ST PLE * CS 60 01 ST PLE CS 
11 01 ST PLE * CS 36 01 ST PLE CS 61 01 ST PLE * CS 
12 01 ST PLE * CS 37 01 ST PLE * CS 62 01 ST PLE * cs 
13 01 ST PLE * CS 38 01 ST PLE * CS 63 01 ST PLE * CS 
14 01 ST PLE * CS 39 01 ST PLE * CS 64 01 ST PLE * CS 
15 01 ST PLE * CS 40 01 ST PLE * CS 65 01 ST PLE * CS 
16 01 ST PLE * CS 41 01 ST PLE * CS 66 01 ST PLE * CS 
17 01 ST PLE * CS 42 01 ST PLE * CS 67 01 ST PLE * CS 
18 01 ST PLE * CS 43 01 ST PLE * CS 68 01 ST PLE * CS 
19 01 ST PLE * CS 44 01 ST PLE * CS 69 01 ST PLE CS 
20 01 ST PLE * CS 45 01 ST PLE * CS 70 01 ST PLE * cs 
21 01 ST PLE * CS 46 01 ST PLE * CS 71 01 ST PLE * CS 
22 01 ST PLE * CS 47 01 ST PLE * CS 72 01 ST PLE * CS 
23 01 ST PLE * CS 48 01 ST PLE * CS 73 01 ST PLE * CS 
24 01 ST PLE * CS 49 01 ST PLE * CS 74 01 ST PLE * CS 
25 01 ST PLE * CS 50 01 ST PLE * CS 75 01 ST PLE * cs 
unaennea 
Table 4.2. Data transmission values for the pulse oximeter [12]. 
The third byte is the instantaneous arterial pulse waveform value. The fourth 
byte changed on every poll and was used to transmit HRI and HR2 (heart 
rate most significant and least significant bits respectively), the Sp02 
measurement and hardware version number. The fourth byte is a checksum 
value calculated by summing the preceding 4 bytes. The undefined values 
given in Table 4.2 were typically zero. This transmission process continued 
until the device was switched off. 
" The lung function spirometer was interfaced to the PC via an RS232 
interface with a DB-9 terminated cable. When a measurement was taken by 
the spirometer, the device attempted to instantiate a serial data connection at 
a speed of 9600 bps with 8 data bits per frame, 1 stop bit and no parity bits. 
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The PEFR and FEV1 measurements were transmitted as ASCII plain text 
which the data acquisition program parsed into numeric values. 
This section has presented a summary of the biometric data that was acquired as 
part of this research. It has presented the methods by which the data was 
acquired and stored on the PC. The following section details the data acquired 
from the patient's anonymous clinical notes. 
4.4 Clinical history indicators 
As was discussed in Chapter 1, and further in Section 4.1.2, the patient's clinical 
history provides indications as to their physiological state. These indicators are 
grouped here into 5 categories determined by the author, i. e., the categorisation is 
merely performed for clarification and does not affect the information content of 
the data. 
" Medication indicators. These indicators relate to the medication that the 
patient is currently taking. These drugs may affect hormone production 
or other chemicals that are present in the patient. The drugs considered as 
part of the relevant medication indicators are given in Table 4.3. Patients 
taking any of these medicines may require further investigative tests prior 
to being deemed suitable for surgical anaesthesia. 
" Biohazard indicators. These indicators relate to potentially dangerous 
infections that the patient may have. Common biohazard indicators are 
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given in Table 4.3. Testing positive for any of these indicators may 
require the patient to be referred for further investigative tests. 
" Haemodynamic indicators. Haemodynamic abnormalities can affect 
blood chemistry which may have a detrimental effect during anaesthesia. 
For example, patients of an Afro-Caribbean origin are particularly 
susceptible to certain blood disorders such as sickle cell disease which 
can affect blood circulation and hence arterial oxygen transportation. The 
haemodynamic indicators (given in Table 4.3) must be carefully studied 
by the anaesthetist when determining the circulatory competence of the 
patient. 
" Cardiovascular indicators. These indicators pertain to any patient 
activity or physiological abnormality that may impede normal 
cardiovascular function. For example, whether the patient is a `heavy 
smoker' (i. e., smokes more than 40 cigarettes (or equivalent) per day) is 
an important indicator. 
" Respiratory indicators. These indicators can affect respiratory 
competence which can detrimentally affect the patient's risk of mortality 
during surgical anaesthesia. As discussed in Section 1.2.2 and 
Section 4.1.2, adequate respiratory competence is essential for 
minimising patient risk during surgical anaesthesia. Testing positive for 
any of the respiratory indicators could motivate the anaesthetist to refer 
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the patient for further investigative tests prior to deeming them suitable 
for surgical anaesthesia. 
The clinical history indicators were taken from the patient's notes during the 
consultation period by the physician, using protocols devised by the author. 
Table 4.3 presents each category with the associated indicators. 
Medication Biohazard Haemodynamic Cardiovascular Respiratory 
indicators indicators indicators indicators indicators 
Warfarin Hepatitis B Afro-Caribbean Smoker (>40 per day) Smoker (>40 per day) 
Inhalers Hepatitis C Excessive alcohol intake Cardiovascular disease Pneumonia 
HRT MRSA Infection Varicose veins Chronic bronchitis 
Steroids Active TB Blood disorders Diabetes Asthma: controlled 
Aspirin HIV Anaemia Asthma: hospitalisation 
Diuretics Diabetes Shortness of breath at rest 
Contraceptive pill kidney problems Respiratory disease history 
Urinary problems Productive cough 
Bleeding disorders 
Thyroid disease 
Malignancy 
Open wound 
Table 4.3. Clinical history indicators considered as part of this research. 
The indicators in Table 4.3 were recorded alongside PID on the information 
sheet prior to the biometric data acquisition presented in Section 4.3. Following 
the consultation, the data on the information sheet was recorded alongside the 
biometric measurements. A blank information sheet is included in Appendix II, 
whilst the final format of the acquired patient data is discussed in the following 
section. 
Card io-resp i ratory Clinical history Biometric data 
assessment with --ºi recorded acquisition e-stethoscope 
Figure 4.13. Sequence of data acquisition events. 
98 
Chapter 4: Experimental Method and Data Collection 
For clarity, the processes of data acquisition given in Section 4.2 through Section 
4.4 are summarised in the diagram presented in Figure 4.13. 
4.5 Dataset construction 
The result of the process given in Figure 4.13 was a database of 194 anonymous 
patients. The database contained BP, HR, Sp02, PEFR and FEV1 measurements; 
digital audio recordings of the heart and lung sounds; and categorised clinical 
history indicators. It was proposed by the author that the dataset contained 
sufficient information on which to base a decision as to whether a patient was 
suitable for surgical anaesthesia or not. This proposition is validated in 
Chapter 7 with the results obtained from the decision support system. 
Chapters 5,6 and 7 discuss the various means by which intelligent systems were 
trained to recognise physiological abnormalities from this dataset, and hence 
identify patients who are unsuitable for surgical anaesthesia. 
As was discussed in Section 1.4, the problem of identifying whether a patient is 
suitable for surgical anaesthesia, based on their physiological assessment, is 
broken down into a series of manageable sub-problems, e. g., listening to the 
heart sounds; then listening to the lung sounds; then checking BP; and so forth. 
Individual intelligent systems are required to `learn solutions' to these sub- 
problems. As such the patient dataset was separated into three components: 
cardio-respiratory sounds (used in Chapter 5); pulse oximetry and arterial pulse 
waveforms (used in Chapter 6); and biometrics and clinical indicators (used in 
Chapter 7). In each instance, individual intelligent systems were applied to the 
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analysis of these components. Chapters 5,6 and 7 respectively address the three 
problems that need to be solved in order to derive a DSA: 
1. diagnosing cardio-respiratory abnormalities via auscultation; 
2. identifying valid arterial pulse waveforms, and hence the SpO2 
measurement; and 
3. forming a generalised classifier for the accurate appraisal of patients for 
surgical anaesthesia. 
4.6 Summary 
This chapter has described the types of data considered as part of this research, 
and outlines the motivation for their analysis. The types of hardware employed 
in the data collection process have also been discussed alongside the 
experimental procedure used. The data transmission protocols - which give an 
appreciation of how the hardware reports these biometric measurements - are 
also described. The chapter finishes by identifying that a compartmentalised 
approach to creating a DSA presents two requirements. These requirements are: 
that there exists a pre-DSA classifier that can diagnose cardio-respiratory 
abnormalities; and that there exists a pre-DSA mechanism that can remove 
corrupt arterial pulse waveforms and hence accurately measure Sp02. These two 
requirements are respectively addressed in Chapter 5 and Chapter 6. Referring to 
Figure 4.2, this chapter has discussed the protocols used in acquiring the medical 
datasets. In Chapters 5,6 and (partially) 7, this data is processed to elicit 
information regarding the biological processes such as cardio-respiratory 
pathologies, indicative features of motion-corrupted arterial pulse waveforms, 
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etc. The information extracted from this data is subsequently used in Chapter 7 
to form the DSA, and hence model, and extract the knowledge of the anaesthetist 
for performing the task of assessing patient suitability for surgical anaesthesia. 
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CHAPTER 5 
Cardio-respiratory Data Analysis 
The aim of this chapter is to provide an account of how an ANN ensemble was 
developed to determine cardio-respiratory abnormalities based on auscultated 
sounds. An account of the data pre-processing methods and subsequent ANN 
analysis is presented. The chapter concludes with a statement of how the final 
ANN ensemble can be applied to patient diagnosis. 
5.1 Introduction 
In Chapter 1 we discussed the importance of cardio-respiratory examination in 
the assessment of a patient's suitability for surgical anaesthesia. We also 
discussed the requirement that an intelligent systems-based technique is 
developed to identify cardio-respiratory abnormalities. In this chapter we discuss 
a novel means for the automated classification of abnormal heart and lung sounds 
using ANNs and demonstrate that these methods can be used to successfully 
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diagnose cardio-respiratory pathologies and other abnormalities. The chapter 
begins with a description of the cardio-respiratory abnormalities under 
consideration, followed in Section 5.3 by an account of how these sounds were 
investigated. Section 5.4 details ANN classification of these sounds whilst 
Section 5.6 describes a method which can potentially improve classification 
performance. 
Figure 4.2 presented the relationships between data, information and knowledge. 
This chapter is concerned with the processing of cardio-respiratory 'sound data' 
and the subsequent elicitation of information. The information derived from this 
work exists in the form of probability statements relating heart and lung sounds 
to their respective pathologies. These probability statements are learned by the 
ANN implementations as part of their learning processes. We now extend Figure 
4.2 and show the sequence of data processing events, presented in Figure 5.1. 
Uainmg 
Biometrics Data 1-- 
LJPpoil Cy ; ierh --ý 
Data 
nfr)rm: dinn 
Data 
Processing 
Data 
Processing 
Information 
Extraction 
Figure 5.1. Data processing and information extraction. 
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Figure 5.1 shows the sequence of data processing events as part of this chapter, 
and how they relate to the overall decision support system. The following 
section discusses the cardiac and respiratory pathologies that are considered as 
part of this work. 
5.2 Cardiac and respiratory pathologies 
The audible sounds heard during auscultation are the consequence of either 
normal or abnormal cardio-respiratory function. Abnormal sounds are frequently 
the result of some pathology or defect. The different cardiac and respiratory 
sounds that the ANNs were trained to recognise are presented in Table 5.1 and 
Table 5.2 respectively. The regions of auscultation are also indicated in both 
cases. 
Cardiac abnormality Region of auscultation 
Normal heart sound Mitral region 
Hypertrophic obstructive cardiomyopathy Aortic region 
Non-rheumatic mitral regurgitation Mitral region 
Mitral valve prolapse Mitral region 
Bicuspid aortic valve Aortic region 
Aortic stenosis Aortic region 
Severe calciphic aortic stenosis Aortic region 
Aortic regurgitation Aortic region 
Mixed aortic valve disease Aortic region 
Mitral stenosis Mitral region 
Mixed rheumatic mitral valve disease Mitral region 
Atrial septal defect Aortic region 
Ventricular septal defect Ventricular region 
Dilated cardiomyopothy Ventricular region 
Aortic incompetence Aortic region 
Papillary muscle dysfunction Ventricular region 
Left ventricular impairment Ventricular region 
Table 5.1. Cardiac abnormalities the ANNs were trained to recognise. 
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Respiratory abnormality Region of auscultation 
Normal tracheal-bronchial sounds Tracheal region 
Normal broncho-vesicular sounds Bronchial region 
Normal vesicular sounds Bronchial region 
Diminished sounds Bronchial region 
Tubular breath sounds Bronchial region 
Fine inspiratory crackles Bronchial region 
Medium, coarse inspiratory and Bronchial region expiratory crackles 
Fine, late inspiratory crackles Bronchial region 
Mild expiratory wheeze Bronchial region 
Medium inspiratory crackles with Bronchial region 
moderate and severe expiratory wheeze 
Pleural friction rub Bronchial region 
Inspiratory and expiratory stridor Tracheal region 
Bone crepitus Bronchial region 
Subcutaneous emphysema Bronchial region 
Table 5.2. Respiratory abnormalities the ANNs were trained to recognise. 
These sounds are the most commonly occurring and are deemed important by 
anaesthetists as to whether the patient is suitable for surgical anaesthesia [1]. 
Two separate ANN ensembles were trained: one which classified cardiac 
auscultated sounds into the classes given in Table 5.1; and one which classified 
respiratory auscultated sounds into the classes given in Table 5.2. Prior to ANN 
training, the acquired samples were pre-processed using methods which are 
discussed in the next section. 
5.3 Cardio-respiratory data pre-processing 
Data pre-processing is defined as the processes that are undertaken prior to data 
analysis (e. g., ANN classification). These processes are used primarily to 
address several key issues when analysing data, the most pertinent being 
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dimensionality reduction and feature extraction. Real-world data is frequently 
unsuitable for direct analysis because the information it contains is inefficiently 
represented [2]. For example, given a dataset pertaining to some process we 
wish to model, each datum within the set is N dimensional (i. e., N variables that 
describe the data). It is often the case that a subset of these dimensions is 
irrelevant as it contains no apparently useful information (e. g., the dimensions 
are correlated with each other). Dimensionality reduction is the process by 
which one identifies and removes redundant dimensions from the dataset. By 
removing apparently unimportant dimensions we retain the informative features 
of the dataset which may be used in a subsequent analysis. The importance of 
feature extraction is exemplified by Hartman et al., [3] and was discussed in 
Chapter 3. Figure 5.2 summarises the data processing stages performed in this 
chapter. The methods employed for pre-processing the cardiac and respiratory 
sounds are presented in the following sections alongside the rationale behind 
their use. 
1Frequency spectra Parametric signal Dataset ANN training & 
computation estimation normalisation testing 
Figure 5.2. Data processing stages used for information extraction. 
5.3.1 Fourier analysis 
The Fourier Transform J is based on the principle that periodic, symmetric, 
real-world signals can be decomposed into a series of N sinusoidal waves of 
frequency co, and phase 0 (1 <_ n _< 
N). 
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Recalling the methods of data acquisition in Section 4.2, the auscultated sounds 
were stored on a PC in uncompressed form. The sounds were sampled at a rate 
of 44kHz and were approximately 30 seconds in duration. The following 
processes were performed separately for the cardiac and respiratory sounds. 
1. Each sound was imported into MATLAB 6.5 (Mathworks Inc., USA) which 
represented the sample as a column vector of approximately 1.32x 106 
elements (i. e., -30 seconds x 44 kHz). Unless otherwise stated all 
computations were performed in MATLAB 6.5. 
2. A matrix was created by importing the auscultated sounds and transposing 
the vectors (so they became row vectors). Considering that each vector was 
of a different length they were cropped to the size of the smallest vector. The 
resultant matrix was X= {x, } where x. was the jth element of sample i. 
0.6 
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Figure 5.3. Example of (a) 2 normal cardiac sound cycles; and (b) the associated 
frequency spectrum. 
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3. The frequency spectra of the acquired sounds were computed using the Fast 
Fourier Transform (FFT) [4] which afforded a frequency domain 
representation of the sounds. The frequency domain representation was 
chosen over the temporal domain for two reasons; 1) that it is resilient to 
variations in the cardio-respiratory cycle i. e., heart-rate or respiratory-rate 
variations; and 2) it readily contains information that is difficult to detect in 
the temporal domain [5]. 
We recall that the observed frequencies for cardiac auscultation cut off at 200Hz, 
and 500Hz for respiratory auscultation. Figure 5.3 shows (a) a normal heart 
sound over 2 seconds auscultated in the aortic area, and (b) the associated 
normalised frequency spectrum. Matrices were constructed containing the 
absolute values of the Discrete Fourier Transforms (DFTs). The available 
dataset contained samples from 194 patients (given in Section 4.5). Given that 
some cardio-respiratory pathologies are more prevalent than others, the dataset 
was unbalanced. Additional cardio-respiratory sounds were acquired on 
compact-disc (Medicdirect. co. uk Ltd., UK) and used to augment the existing 
dataset. Each new `sound' was a new source of information regarding cardio- 
respiratory pathology. To further increase the size of the available dataset, 
individual samples were replicated with additive white noise. Without noise 
each replicate would be identical to its `parent' and hence provide no additional 
information. Although the noisy replicates would provide no new information, 
they would ensure that there was variation in the samples of each cardio- 
respiratory pathology class. The final size of the cardiac dataset was 1700 
samples, and the respiratory dataset was 1400 samples. 
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Given that the cardiac DFTs presented 200 dimensions (corresponding to the 
200Hz range) and the respiratory DFTs had 500 dimensions (corresponding to 
the 500Hz range), visual inspection of the dataset heterogeneity was not possible. 
Principal Component Analysis (PCA) affords a means by which to reduce the 
dimensionality of the dataset whilst retaining as much information as possible 
[2]. This method was applied in order to facilitate an appraisal of dataset 
heterogeneity. 
5.3.2 Principal Component Analysis 
Principal Component Analysis - otherwise knows as the Karhunen-Loeve 
Transform - affords a method with which to remap n-dimensional datasets to 
m-dimensional space where m<n (typically m« n) [2]. 
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Figure 5.4. Plot of the first 3 principal components of the cardiac DFTs. 
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This is achieved by firstly evaluating the eigenvalues and eigenvectors of the 
dataset's covariance matrix. The smallest n-m eigenvalues of the matrix afford 
the least information in the dataset and are consequently discarded. PCA was 
applied to the DFT datasets in an attempt to reduce their dimensionality. This 
was performed so that the datasets could be projected into 3-dimensional space to 
facilitate visual inspection of class heterogeneity. 
The plots presented in Figure 5.4 and Figure 5.5 demonstrate the class 
heterogeneity exhibited by the cardiac and respiratory DFT datasets respectively. 
Whilst certain classes from both datasets were non-separable in the first three 
dimensions, a degree of confidence in overall heterogeneity could be ascribed to 
both datasets. A statistical measure as to the degree of separability cannot easily 
be given as such a value is conditional on the number of dimensions considered 
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in the PCA. Given a visual inspection of Figures 5.4 and 5.5, analysis of the 
cardiac and respiratory sounds by ANNs could be undertaken with a degree of 
confidence that the ANNs could separate the different classes and hence classify 
future (i. e., novel) sounds. 
5.3.3 Spectral estimation with autoregression 
Direct analysis of these spectra by ANNs was not feasible due to the DFTs being 
highly-dimensional. A method of encoding the DFTs whilst reducing the 
dimensionality of the dataset was required. The method employed was the 
Levinson-Durbin autoregression algorithm for spectral estimation [6]. The 
method is a computationally light-weight approach to parametric signal 
estimation, constructing a P-order data model that describes the frequency 
spectra [6]. Pardey et al., [7] found the method to be attractive in spectral 
matching problems. Given a data model sx, (f) which is a P-order estimate of 
signal s, information from s can be encoded into the estimation model 
parameters. We consider each DFT to be a frequency spectral composition 
sx (f) of the discrete sound sample x(n) such that: 
00 
; (1) =R (m) e JZffmm, 
m=-oo (5.1 
where R(m) is the autocorrelation function of x(n) and the unit time At is 1. 
The normalised maximum entropy spectral estimation sx (f) is expressed as: 
sz( fý_ 1 
Pa 
e-j2"krI2 
" (5.2) 
1+ Yk=1 
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The set of values {ak Ik =1,..., P} in (5.2) are coefficients of the signal 
estimation model sx (f) . Appropriate selection of 
P and ak is required to form 
an adequate model such that sx (f) -* sx (f) . The coefficients must satisfy: 
1, m=0 Ia,, R(m-k)= 
kso 0, m =1,2,..., P 
which can be expanded in the form of the Yule-Walker matrix [6]: 
R(0) R(-1) """ R(-P) 
a1 
R(1) R(O) "". R(1-P) 
'0 
a2 = 
R(P) R(P-1) . "" R(0) 0 
ýap 
(5.3) 
(5.4) 
The Levinson-Durbin algorithm estimates the frequency spectrum by firstly 
estimating the P+1 autocorrelation values 
h (k) from the initial sample x (n) 
where {x(n)l n=1,..., N-1} with: 
R(k)=I V x*(n+k)x(n), k=0,1,..., P. 
n 
(5.5) 
The algorithm then constructs the Yule-Walker matrix given in (5.4) and 
calculates the estimated model parameters äk with (5.3) by substituting R (m) 
for h (m) and ak for äk . 
The Levinson-Durbin method of spectral estimation is not without problems. 
Luo et al., [6] noted that the computational complexity of the exercise prevents 
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real-time spectral estimation. In this case the datasets were intended to be 
analysed offline and hence real-time estimation was not a consideration. This 
also fulfils the requirement that this form of parametric signal estimation be only 
used in stationary processes [6,7]. Christini et al., [8] noted that sharp spikes in 
the original signal can also impede estimation accuracy; a consideration not 
required as the DFTs were smooth over their frequency ranges. A final 
consideration is from de Hoon et al., [9] who found that nearly-periodic signals 
can result in incorrect parameter estimations; again a consideration not required 
as the spectral signals were aperiodic. Given that the Levinson-Durbin algorithm 
was capable of computing the optimal values of the autoregressive model, the 
most important criterion was the appropriate selection of the number of 
parameters to use in the estimation. 
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Figure 5.6. Backwards prediction error (SSE) for normal cardiac sound spectral 
estimation vs. autoregressive model parameters. 
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From (5.2) and (5.5) it follows that the number of parameters P influences the 
error between s, (f) and 9,, (f) - called the residual error. The spectral 
estimation of a normal cardiac DFT was computed with models of order 
P=1,2,..., 100 which can be seen in Figure 5.6. From visual inspection of 
Figure 5.3b, models of order P <I 0 were insufficiently complex enough to 
capture the information content of the DFT and were therefore discounted. 
However, at P= 15 the SSE curve became asymptotic to the horizontal 
(Figure 5.6) indicating that further increases in the number of coefficients did not 
significantly change the error. Consequently a model order of 15 coefficients 
was selected. Given that each frequency spectrum was unique to a class of 
cardiac and respiratory abnormalities, the associated estimated spectral model 
would also be unique with this being reflected in the model coefficients. The 
Levinson-Durbin algorithm was applied to all of the frequency spectra for both 
the cardiac and respiratory sounds. This resulted in two matrices, one containing 
cardiac DFT estimation coefficients and the other containing respiratory DFT 
estimation coefficients, both containing 15 columns. The coefficients for each 
sample were linearly normalised such that {ak ik =1,2,..., 15} --ý [0,1] with: 
Qý = Ran, aK -- Clarmin 'k =1,2,..., 
15, (5.6) 
where: 
amax = arg max {a } and am;,, = arg min {an }. (5.7) 
1 5nS15 15nS15 
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ANNs were trained to discriminate between the different cardiac and respiratory 
sounds based on these model coefficients of their estimated frequency spectra. 
The following sections introduce the procedures underpinning the training and 
testing of the ANNs alongside the results obtained. Section 5.4 follows the 
processes undertaken to develop an ANN-based classification system in 
conjunction with the auscultated cardiac and respiratory sounds. 
5.4 Classification by Artificial Neural Network 
This section details the ANN approaches that were used in classifying the cardiac 
and respiratory sounds. We recall the result of the data pre-processing stages as 
being a matrix of spectral estimation model coefficients which were 
representative of the frequency spectra of the sounds. We recall the operation of 
an ANN from Chapter 3, in particular supervised learning methods. We now 
discuss the application of the three ANN architectures, notably the MLP, RBFN 
and CPNN. 
5.4.1 Analysis by Multi-Layer Perceptron 
The MLP was applied in the discrimination between the different classes of 
cardiac and respiratory sounds. The 3-layer topology (i. e., input layer, hidden 
layer, and output layer) MLP was employed. The size of the MLP topology was 
firstly estimated using the geometric mean approach suggested by Widrow et al., 
[10], and was later validated against Bayesian Regularisation after training 
(discussed later in this section). Firstly discussed is the development of an MLP 
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intended for the classification of the cardiac dataset. This is followed by a 
similar description concerning the respiratory dataset. 
5.4.2 MLP analysis of the cardiac dataset 
The cardiac dataset contained 1700 samples which were used in the training and 
subsequent testing of the MLP. Given that the dataset contained 15 dimensions 
(features), the input layer to the MLP contained 15 input neurones. Furthermore, 
the output layer contained one neurone per target class resulting in 17 output 
neurones. Provided with these two layers, a single hidden layer comprising 15 
neurones was added to the ANN (the geometric mean of inputs and outputs). 
The resulting topology is referred to a 15-15-17 MLP. There are alternative 
methods of estimating the number of hidden layer neurones. For example, one of 
these methods is the Cascade-Correlation architecture proposed by 
Fahlman et al., [11,12]. The method involves the continual addition of hidden 
layer neurones and the successive recalculation of the network weight matrix in 
growing the MLP. The method constitutes a significant departure from the error 
backpropagation algorithm discussed in Chapter 3 and is a time-consuming 
process. This coupled with the existing ability to assess MLP capacity utilisation 
with Bayesian Regularisation motivated the exclusion of this method from 
consideration. The MLP (consisting of 512 neuronal weights and biases) was 
trained with 1000 samples for 2500 epochs after which the network training SSE 
differential became negligible. Given that there were 1000 training samples, and 
512 network parameters, upon first inspection it would appear that there were too 
few parameters available for effective learning. However, we recall that 
approximately 40% of the available samples were noisy replicates, and hence 
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contributed no additional information. The MLP was tested with the remaining 
700 data samples, from which a results matrix was formed (of dimensions 
700 x 17). Given that each MLP response y took some value y --> [1,0] a 
threshold 0 was used to convert these results to a binary I -in-N equivalent such 
that: 
_ 
1: yzO Ybin 
0: y<O (5.8) 
With the threshold 0 initialised to zero and incremented by 0.01, the optimal 0 
was found to be 0.30, yielding an MLP classification accuracy of 99.20% with 
sensitivity of 88.24% and specificity of 99.88%. On the training dataset the MLP 
correctly classified 98.56% of the samples (84.10% sensitivity, 99.47% 
specificity, 0= 0.33). 
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Figure 5.7. MLP accuracy, sensitivity and specificity in classifying the cardiac 
auscultated test dataset. 
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The classification accuracy curve alongside sensitivity and specificity is 
presented in Figure 5.7. 
Prior to accepting these accuracy, sensitivity and specificity values as being true 
indicators of MLP performance, an assessment of MLP capacity utilisation was 
performed. The ability of an MLP to classify input data inherently depends on 
the ANN's neuronal weights and biases. Bayesian Regularisation [2] affords a 
means of estimating these parameters in a MLP through application of the Bayes 
Theorem (discussed in Section 3.1.1). Prior to training a MLP, the optimal 
network weights are unknown and can be represented as a broad prior probability 
distribution P(W) over weight space. When input and target data D is 
presented to the MLP, the posterior probability distribution P(W I D) (i. e., the 
probability of the weight matrix W given the data D) using (3.1) can be 
computed. Through successive calculations of P(W I D) the weight matrix can 
be estimated using the Bayesian technique. A more in depth account of this 
technique can be found in [2]. The method is called Bayesian Regularisation and 
gives the number of weights and biases being used by the MLP (called the 
effective parameters). If the number of effective parameters is smaller than the 
total number of parameters of the MLP then it can be concluded that the size of 
the architecture is not constraining its learning and classification abilities. 
The MLP was re-initialised and trained using the above technique with the aim 
of identifying the number of effective parameters used in the learning process 
and ergo whether the MLP was being constrained by its architecture. The 
number of effective parameters used by the MLP was 253 (out of a total of 512 
119 
Chapter S:: Cardio-respiratory Data Analysis 
weights and biases) and it was concluded that the size of the MLP topology did 
not constrain its learning abilities. The results from these experiments are 
discussed in more detail in Section 5.5, whilst attention is now given to the 
MLP's abilities in discriminating between different classes of respiratory sounds. 
5.4.3 MLP analysis of the respiratory dataset 
The processes used to train an MLP in identifying different classes of respiratory 
abnormalities were similar to those used in the previous cardiac sounds 
experiments. We recall that the respiratory dataset contained 1400 samples. 
Recalling Section 5.3.3 the respiratory dataset was a matrix consisting of 15 
columns (corresponding to 15 autoregressive coefficients). The resulting MLP 
topology was a 15-15-14 architecture. The MLP was trained for 2500 epochs on 
a dataset of size 1000 x 15 and was later tested against a dataset of size 400 x 15. 
When presented with the test dataset the MLP gave responses which were not 
binary and hence required thresholding with (5.8). The optimal threshold 0 was 
found to be 0.10 resulting in a classification accuracy of 67.11% (77.00% 
sensitivity, 66.35% specificity). Bayesian regularisation indicated that the MLP 
was using 448 of its parameters (out of 464 weights and biases). Discussion of 
these results and their statistical significance in relation to other cases is 
presented in Section 5.5. 
5.4.4 Analysis by Radial Basis Function Network 
A Radial Basis Function Network was trained to classify the cardiac and 
respiratory datasets in an attempt to compare with - and improve upon - the 
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MLP-based classifier. The RBFN's architectural considerations - discussed in 
Section 3.3 - are such that an appropriate number of hidden radial basis neurones 
should be selected prior to training. K-means clustering analysis was performed 
on the cardiac dataset in order to determine the optimal number of clusters that 
could partition the data and hence the optimal number of neurones in the RBFN 
hidden layer. Figure 5.8 shows the relationship between the number of clusters 
utilised by the K-means algorithm and the resulting sum of distances between 
data points and cluster centroids. 
4500 
4000 
3500 
3000 
12500 
2000 
1500 
1000 
X 
k 
X 
X 
XX 
500 
04 0 10 20 30 40 50 60 70 80 90 100 
Number of elusion 
Figure 5.8. The number of clusters used by the K-means algorithm vs. the 
within-cluster sums. 
As can be seen from Figure 5.8, the optimal number of clusters was 27 and 
further clusters did little to optimise data partitioning. 
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5.4.5 RBFN analysis of the cardiac dataset 
A 15-27-17 RBFN was created and trained on the 1000-sample training dataset 
with the resultant SSE being 92.30. Given the 700-sample novel test dataset, the 
RBFN attained a classification accuracy of 99.88% (sensitivity 99.06%, 
specificity 99.93%). The optimal threshold cut-off 0 yielding these results was 
found to be at 0.45. A discussion of these results and how they compare with 
other ANNs' is given in Section 5.5. Attention is now given to the application of 
the RBFN in discriminating between the different respiratory sounds. 
5.4.6 RBFN analysis of the respiratory dataset 
Training and subsequent testing of the RBFN to discriminate between the 
different respiratory sounds followed a similar procedure to that discussed in 
Section 5.4.5. The K-means clustering technique identified that 24 clusters 
provided the optimal coverage of feature space and hence the optimal number of 
RBFN hidden layer neurones. A 15-24-14 RBFN was created and trained on 
1000 samples of the available respiratory dataset. The ANN was then tested on 
the remaining 400 samples and attained a classification accuracy of 95.79% 
(100% sensitivity, 95.46% specificity). The optimal 0 was found to be 0.02. 
These results are discussed in Section 5.5, whilst the following section details the 
application of the CPNN to the discrimination between different cardio- 
respiratory abnormalities. 
5.4.7 Analysis by Constructive Probabilistic Neural Network 
Prior to creating, training and testing a CPNN with the cardiac data the threshold 
levels 8+ and 0- were defined (Section 3.4.1). These two values fundamentally 
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govern the resulting sensitivity and specificity of the CPNN [13]. Berthold et al., 
[13] stated that the respective values of 0.4 and 0.2 provided excellent results in 
practical situations. 
5.4.8 CPNN analysis of the cardiac dataset 
The CPNN was trained using 1000 of the cardiac data samples, with a fixed input 
layer size of 15 neurones, and fixed output layer size of 17 neurones. The 
number of training epochs was set to 5 and the algorithm grew the architecture 
entirely within the first training pass. Adjustments to the hidden neurones' 
density functions were made during each training epoch. After training the 
CPNN hidden layer contained 286 neurones and when tested with the remaining 
400 test patterns, attained a classification accuracy of 89.17% (89.17% 
sensitivity, 99.36% specificity). 
5.4.9 CPNN analysis of the respiratory dataset 
A CPNN was also created and trained to discriminate between the different 
abnormalities presented in the respiratory dataset. Similar to the previous CPNN 
implementation, the classifier was trained for 5 epochs on 1000 samples from the 
respiratory dataset. The CPNN added all 390 neurones in the first training pass. 
When tested with the remaining 400 samples the CPNN attained a classification 
accuracy of 97.80% (97.80% sensitivity, 89.60% specificity). 
5.5 Statistical Significances with McNemar's Test 
Given the results obtained from the MLP, RBFN and CPNN implementations, 
this section investigates their statistical significance. A direct comparison 
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between different ANNs is insufficient to determine whichever architecture is 
best in terms of classification accuracy and sensitivity. Whilst sensitivity and 
specificity measures afford the user with an account of the ability of the ANN to 
detect the presence or absence of events (e. g., cardio-respiratory abnormalities), 
it does so without reference to a benchmark case. Statistical significance testing 
offers a means by which to determine whether the two classification accuracies 
could occur by chance rather than by direct association [14]. 
McNemar's Test provides a means by which to assess the statistical significance 
in the difference between two different ANNs' responses to the same stimuli 
[14]. The following notation is applied: no is (in the context of this scenario) 
the number of samples misclassified by e. g., the RBFN but not by the MLP; and 
no, is the number of samples misclassified by the MLP but not by the RBFN 
[15]. McNemar's value x2 (based on the chi-squared test) can be expressed as: 
xz _ 
(Ino, 
-nlol-1)2 
not+n0 
/ (5.9) 
where the -1 term is Yates' continuity correction which is applied due to the data 
being discrete whilst the x2 is continuous. The Null Hypothesis was defined as 
being that the error rates between two ANNs were the same. With the level of 
significance being P=0.05 (or 5%), expressed as xý'1,0.95) or 3.84, for the Null 
Hypothesis to be true (i. e., the difference between the two ANNs' error not to be 
statistically significant), x2 would have to be below 3,84. Conversely for the 
difference to be considered statistically significant x2 would have to be above 
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this value. For example, when analysing the cardiac dataset the statistical 
significance x2 of the difference between the MLP's and RBFN's error rates 
was 316.87. This indicated that there was a significant difference between the 
ANN's abilities to classify the dataset. This was not readily apparent from the 
classification accuracies attained (99.20% from the MLP and 99.88% from the 
RBFN). In analysing the respiratory dataset the statistical significance between 
the error rates of the MLP and RBFN was 16.46 which suggested that there was a 
difference in the classification abilities. Such significance could arise from one 
ANN demonstrating a poor ability to classify one class of sounds which the other 
ANN could, and vice-versa. Tables 5.3 and 5.4 give the statistical significance 
of the error rates between the MLP, RBFN and CPNN classification mechanisms 
for both the cardiac and respiratory datasets respectively. 
Method M LP RBFN CPNN 
-(Accuracy) 
(99.20%) (99.88%) (89.17%) 
MLP - 316.87 207.66 
RBFN - - 113.41 
CPNN - -- 
Table 5.3. Statistical significance of the error rates between ANNs on the heart 
sounds dataset. 
Method MLP RBFN CPNN 
(Accuracy) (67.11%) (95.79%) (97.80%) 
MLP - 16.46 14.75 
RBFN - - 7.17 
CPNN - -- 
Table 5.4. Statistical significance of the error rates between ANNs on the lung 
sounds dataset. 
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Section 5.6 presents a method of combining the results of these different ANN 
implementations in forming a more accurate and sensitive classification 
mechanism. 
5.6 Combined Classification 
This section reports on the efforts to improve upon the MLP, RBFN and CPNN 
implementations in classifying cardiac and respiratory sounds. In both cases the 
ANNs occasionally gave conflicting or ambiguous classifications when analysing 
the test datasets. By combining classifiers to form a single system it becomes 
possible to improve classification accuracy and sensitivity. We recall from 
Section 3.5 the Dempster-Shafer Theory (DST) method of aggregating the 
outputs of multiple ANNs to facilitate this type of improvement. 
The results of the MLP, RBFN and CPNN classifiers for both the cardiac and 
respiratory experiments were linearly normalised such that for any given 1-in-N 
binary classification, all output neurones summed to unity. The results of the 
ANNs could then be directly considered to be probabilistic assertions to class 
assignment and could be employed in the DST framework. For clarity, given a 
class Ck the opposing assertion -'Ck was 
-'Ck = 'Cl. rYk 
(5.10) 
Using Dempster's rule of evidence combination presented in (3.31) the combined 
classifications for both datasets were established. Table 5.5 and Table 5.6 
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present the individual ANN classifications and their combined results for both 
the cardiac and respiratory datasets respectively. 
Classifier Accuracy Sensitivity Specificity 
MLP 99.20% 88.24% 99.88% 
RBFN 99.88% 99.06% 99.93% 
CPNN 89.17% 89.17% 99.36% 
Combined via DST 99.77% 98.14% 99.88% 
Table 5.5. Comparison of accuracy, sensitivity and specificity of the MLP, 
RBFN, CPNN and DST approaches to the cardiac sounds classification. 
Classifier Accuracy Sensitivity Specificity 
MLP 67.11% 77.00% 66.35% 
RBFN 95.79% 100.0% 95.46% 
CPNN 97.80% 97.80% 89.60% 
Combined via DST 100.0% 100.0% 100.0% 
Table 5.6. Comparison of accuracy, sensitivity and specificity of the MLP, 
RBFN, CPNN, and DST approaches to the respiratory sounds classification. 
Table 5.5 and Table 5.6 demonstrate that given a plurality of ANN classifiers, an 
aggregated approach can improve classification accuracy. Whilst the accuracy of 
the combined classification mechanism for analysing cardiac auscultated sounds 
appeared lower than the RBFN, the difference was negligible (0.11%). This 
coupled with the desire to increase generalisation capability of the cardiac 
classifiers motivated the ensemble's inclusion in the overall classification 
schema discussed in Chapter 7. Table 5.6 shows that the combined classification 
scheme attained 100% classification of the test dataset, with 100% sensitivity and 
specificity. This suggests that a DST approach can aggregate multiple 
classifications and improve upon general classification accuracy. In both cases 
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of cardiac and respiratory dataset classification, a threshold 0 of 0.11 was shown 
to be the optimal binary 1-in-N encoding parameter. 
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Figure 5.9. Variation in accuracy and sensitivity for the DST-based classifier on 
the respiratory dataset. 
Figure 5.9 gives the relationship between the cut-off threshold and the attained 
accuracy and sensitivity of the combined respiratory classifiers. 
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Figure 5.10. Classification accuracies of the RBFN, DST and MLP classifiers on 
the respiratory dataset. 
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Figure 5.10 gives the combined classifier's accuracy against those attained from 
the RBFN and MLP. It is interesting to note that for low (< 0.3) values of 0 the 
DST system behaves like the RBFN classifier in terms of its accuracy, whereas 
above this 0 value it tends towards the relatively poorer abilities of the MLP. At 
0>0.3 the MLP sensitivity approached 2% so a trade-off between classification 
accuracy and sensitivity was found at 0=0.10. Given the results in Table 5.5 
and Table 5.6, the combined classification mechanism does not inherit the 
relatively poor sensitivities attained by the weakest classifier in the ensemble. 
5.7 Conclusions 
This chapter was concerned with classifying different cardio-respiratory 
pathologies and abnormalities based on the audible sounds heard during chest 
auscultation. In terms of ANN architecture, Widrow's method of computing 
MLP topology enabled an efficient and compact architecture with over 50% of 
the available network parameters being effectively used in classification. The 
presented solution classifies the sounds using the associated frequency spectra 
which are unique to each class of sound. The two principal means of 
discriminating between the different classes of cardio-respiratory sound are the 
RBFN and CPNN which independently attained classification accuracies in 
excess of 90%. It has been identified that these methods of classification are 
sensitive to different classes of cardio-respiratory sound and a means of 
combining their results has been explored. Evidence combination via DST 
enabled a higher classification rate for respiratory sounds that would not 
otherwise have been possible. 
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In conclusion it can be observed that the problem of discriminating between 
different classes of cardiac and respiratory abnormalities by assessment of their 
associated frequency spectra is solvable. In particular, it is suggested that the 
problem can be solved to a degree of accuracy that would be clinically 
acceptable by individual ANNs or an ensemble of such techniques. The methods 
presented in this chapter are further used in Chapter 7 where a generalised 
classification schema is developed. Prior to this Chapter 6 discusses a further 
important clinical measurement and the effort taken to form a suitable 
classification mechanism. 
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CHAPTER 6 
Pulse Oximetry Data Analysis 
This chapter presents an analysis of the arterial pulse waveform and arterial 
oxygen saturation measurements. It describes the steps taken towards an 
automated means of identifying motion artefacts in the pulse waveform, and 
hence validating the associated Sp02 measurements. The chapter also presents 
the development of a system for classifying arterial oxygen saturation 
measurements into different patient suitability groups for surgical anaesthesia. It 
is shown that an MLP can successfully classify 98.9% of the example normal and 
abnormal arterial pulse waveforms. Furthermore, the final system successfully 
classified 100% of the example Sp02 measurements, in complete agreement with 
the expert anaesthetist. The chapter concludes with a statement of how the final 
system can be applied to patient diagnosis. 
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6.1 Introduction 
We recall from Section 4.1.2 the importance of oxygen saturation measurements 
in facilitating an accurate appraisal of cardio-respiratory function. Here we 
examine the arterial pulse waveform and its effects on pulse oximetry. Also 
discussed is the manner in which the arterial oxygen saturation measurements 
were analysed and the information they provide. We demonstrate that the 
arterial oxygen saturation measurement is too important a criterion to act upon 
without validating the accompanying pulse waveform. 
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Figure 6.1. Data processing and information extraction performed in this 
chapter. 
In this chapter we present three novel techniques. Firstly we demonstrate that the 
arterial pulse waveform can be predicted, and hence classified by a MLP. 
Secondly we apply a statistical method to extract information from normal and 
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abnormal arterial pulse waveforms in forming a gating mechanism which 
identifies bad (i. e., distorted, corrupt, etc. ) waveforms. Thirdly we apply a fuzzy 
systems technique to classify Sp02 measurements into the `anaesthesia suitability 
groups' presented in Section 1.4. In the following section we introduce the 
theory underpinning pulse oximetry and demonstrate why this technology is 
prone to errors which must be addressed. 
In Figure 6.1 we show the stages of data processing and subsequent information 
extraction that is performed in this chapter. We observe the two approaches of 
corrupt arterial waveform detection being MLP waveform prediction and 
stochastic resonance. These two approaches are discussed in Section 6.3. The 
final stage of processing concerns the classification of Sp02 data into the 
different categories introduced in Section 1.4. This stage serves to process the 
Sp02 and learn the relationships between patient age, gender, cardio-respiratory 
disease history and Sp02 in stating whether the arterial oxygenation is high or 
low in the context of decision support. We now discuss arterial pulse oximetry. 
6.2 Arterial pulse oximetry 
Pulse oximetry relies on two underlying principles: 1) that there exists a pulsatile 
signal generated by arterial blood flow which is largely independent of venous 
blood flow (i. e., blood flow in the veins); and 2) that oxyhaemoglobin 02Hb 
(oxygen-saturated red blood cells) and reduced haemoglobin Hb (desaturated red 
blood cells) have different light-absorption spectra [1]. We present a definition 
of the oxyhaemoglobin measurement and how it is calculated, followed by an 
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account of motion artefacts; how they are introduced into the pulsatile waveform; 
and how they impact upon the accuracy of oxygenation measurements. 
6.2.1 Oxyhaemoglobin measurements 
The oxygen-carrying red blood cells are comprised of haemoglobin (Hb) 
molecules which due to their iron content have an affinity to oxygen. When 
bound to oxygen, the haemoglobin molecule is referred to as oxyhaemoglobin. 
Conversely when devoid of oxygen molecules, the haemoglobin is referred to as 
being reduced. Oxygen saturation (SaO2, expressed as a percentage) is derived 
from the ratio of oxyhaemoglobin to total haemoglobin in the blood stream [1] 
using the expression: 
Sao OZHb X100. 2 Hb + O2Hb 
(6.1) 
Due to pulse oximetry being a non-invasive technique, Sa02 is indirectly 
estimated and the result is expressed as the SpO2 measurement. An alternative 
albeit invasive technique is blood gas analysis which affords a directly measured 
SaO2 value. This technique is not frequently employed as it is time consuming, 
invasive and inappropriate for certain patients, e. g., those with comorbidity from 
cardiovascular disease [2]. In order to estimate Sa02 an indirect measure of 
oxyhaemoglobin and reduced haemoglobin is made. This is achieved by 
transmitting light waves through the artery and measuring the level of absorption 
by the haemoglobin. Two wavelengths are used in the measurement: red light 
(wavelength A= 660nm) and near-infrared light (A = 940nm). The former is the 
peak absorption wavelength of reduced haemoglobin whilst the latter is that of 
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oxyhaemoglobin. A receiver (typically a photodiode) collects the transmitted 
light, and the received luminous intensity is directly proportional to the potential 
difference. The oximeter used in these experiments calculated Sp02 by 
monitoring light attenuation at the photodiode as a result of blood flow. This is 
based on the Beer-Lambert law: 
V= Ioe ad' (6.2) 
where V is the received luminous intensity (at the photodiode), Io is the 
transmitted luminous intensity and a is the extinction coefficient of the medium 
(i. e., tissue, arterial walls, blood, etc. ) of width d. Given that the artery expands 
and contracts by Ad during a cardiac cycle, maximal absorption (V.. ) and 
minimal absorption (Vmin) [3] can be derived from (6.2) and expressed as: 
VR-max =IROe-(ad+a4d)I VR-min ='Me-"d 1 (6.3) 
and: 
VIII-nm =1,, oe-(ad+aed)' 
V 
IR-min = 
IIROe ad, (6.4) 
where the subscript R denotes red light and subscript IR denotes near-infrared 
light. SpO2 can be estimated from the ratio of these values using: 
Sp02 _ 
(ýR-max /VR-min) 
X100. (6.5) 
l IR-max 
/VIR-min 
J 
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Given the estimated oxygenation measurement in (6.5), hypoxaemia is defined as 
being the condition when the SpO2 < 90% [4]. Considering the means by which 
the oximeter determines the level of oxyhaemoglobin it can be seen that the 
technology is prone to errors. For example, ambient light can affect the oximeter 
[5,6,7] as well as physical disturbances of the patient which introduces motion 
artefacts (MA) into the pulsatile waveform. It follows that Sp02 measurements 
cannot not be relied upon unless a valid pulse waveform trace accompanies the 
reading [8]. This critical fact provides the motivation for developing a means of 
automatically and reliably assessing the validity of the pulse waveform. In the 
following section we discuss the impact that MA has on the pulsatile waveform. 
6.2.2 The pulse waveform and motion artefacts 
A motion artefact is some disturbance of the pulsatile waveform which corrupts 
the observed signal, e. g., by suppressing or distorting the waveform. Whilst MA 
can in many circumstances be attributed exclusively to physical disturbances 
(e. g., patient movement) these artefacts can also be exaggerated by sensor 
misalignments. Hamber et al., [4] found in their study that the placement of the 
sensor impacts the time taken for the pulse oximeter to respond to changes in 
oxygen saturation. In their study of 13 healthy patients (aged 18 to 44 years old) 
they examined the responsiveness of a pulse oximeter (Nellcor N-200, 
Nellcor Inc., Pleasanton, CA, USA) to hypoxaemia when attached to the 
patient's toe, ear and finger. They found that there were statistically significant 
differences between the simultaneous ear and hand monitoring (6 seconds mean 
lag, i. e., 6 seconds between the onset of hypoxaemia and the oximeter reporting 
the episode), hand and foot monitoring (57 seconds mean lag), and ear and foot 
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monitoring (63 seconds mean lag). Whilst it may appear clear from the above 
account that optimal placement of the pulse oximeter sensor is on the patient's 
hand (finger) or ear to rapidly detect hypoxaemic episodes, these sites frequently 
generate false-positive alarms. In their observational study Tsien et al., [9] 
monitored a paediatric bedside pulse oximeter for 298 hours and found that the 
device generated 2,942 alarms during this period. They found that 86% of these 
alarms were false-positive and that 18% were the result of patient intervention, 
e. g., motion artefacts and sensor misalignments. Furthermore Poets et al., [10] 
reported a case of the oximeter sensor becoming completely detached from an 
infant patient without triggering an alarm. These instances highlight the 
necessity for continual appraisal of the arterial pulse waveform as a means for 
identifying clinical and non-clinical events. 
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Figure 6.2. (a) A normal pulse waveform for one cardiac cycle; and (b) a MA- 
corrupted waveform. 
Considered now is the structure of the arterial pulse waveform given a normal 
cardiac cycle. Figure 6.2(a) shows a normal cycle whilst Figure 6.2(b) gives an 
example of a waveform corrupted due to some motion artefact. The waveform in 
Figure 6.2(a) comprises the P (percussion) wave, D (dichotic) wave, U (up 
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stroke) point, and V notch. In particular, the region between U and U' 
represents one cardiac cycle, whilst the segment between U and P represents the 
systolic ejection. The segment between V and D represents the diastolic shut 
whilst the region between P and V represents the ejection slow time [11]. These 
waveform characteristics correspond to the mechanical operation of the heart. 
Cardiac pathologies can on occasion alter these characteristics. We now present 
a means of automatically identifying and flagging MA in the arterial pulse 
waveform. 
6.3 Motion artefact rejection 
This section presents the work undertaken to develop a means by which 
continual appraisal of the arterial pulse waveform could be performed with the 
aim of automatically identifying and rejecting MA and other non-standard 
waveform components. The aim of this was to develop a gating mechanism, i. e., 
one which will state whether the Sp02 is being measured under normal or 
abnormal waveform conditions. 
6.3.1 Dataset acquisition 
The arterial pulse waveform dataset acquired from the patient sample group 
(Section 4.1.3) was insufficient for this task. Several hours worth of data was 
required in order to form the MA-identification mechanism, as will be seen in 
subsequent sections. We recall from Section 4.3.3 that the pulse oximeter 
sampled the waveform at a rate of 75Hz. For the purposes of system 
development, data was acquired independently from the normal data gathering 
procedure discussed in Section 4.3. Pulse waveforms were collected from 10 
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adult patients (mean age 46 years) during overnight studies. There was an equal 
distribution of male and female patients and all had no history of cardiovascular 
disease. The period of collection was 7 hours resulting in a waveform dataset of 
approximately 1.8Gb per patient. After collection, regions of MA and poor 
perfusion were identified by visual inspection by a physician and extracted. The 
result was two datasets, one containing samples of normal arterial pulse 
waveforms (58.36 hours), the other containing examples of MA and poor 
perfusion (11.64 hours). In order to develop a better understanding of the 
differences between the datasets, statistical waveform analyses were performed 
which are presented in the following section. 
6.3.2 Statistical models of the pulsatile waveform 
As will be shown in the following discussion, MA and episodes of poor 
perfusion (characterised by and henceforth referred to as abnormal waveforms) 
exhibit different statistical characteristics than normal arterial pulse waveforms. 
Given these heterogeneous characteristics, a measure of the differentiability 
between normal and abnormal waveforms could be established. The typical 
distribution of data points within the normal waveform and abnormal waveform 
datasets is shown in Figure 6.3. The data points were segmented into 100-bin 
histograms cross-sectioning the amplitude of the pulse waveforms. As can be 
seen from the histograms, the two datasets exhibited different data distributions. 
In a point of similarity, it can be seen that the majority of the data points 
occurred at around 20% - 30% of the overall waveform amplitudes. 
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Figure 6.3. (a) Normal, and (b) abnormal, arterial waveform amplitude 
distributions. 
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Whilst the abnormal waveform data distribution past this peak decayed at a 
seemingly exponential rate, the normal waveform dataset exhibited a large 
(relatively uniform) density of data towards the peak of the waveform amplitude. 
This is suggestive of the waveform frequently reaching its amplitude peak, and 
although the histogram cannot afford a measure of waveform periodicity, it is 
symptomatic of what one would expect of a periodic waveform. It can be seen 
from the two histograms that there are no sufficiently unique distributions within 
normal and abnormal waveforms that can facilitate discrimination. Figure 6.4 
gives a superposition of both distributions alongside fitted Gaussian curves for 
clarity. An N order Gaussian curve fit can be expressed in the following form: 
vz ýJn 
(p, (x) =1anexp - 
. k'- 
n=ý Cn 
where a,,, b and c, are the coefficients of the nth Gaussian. 
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distributions with Gaussian fitted curves. 
(6.6) 
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Two curve fits were established for the normal and abnormal datasets, and are 
given in Figure 6.4. From a visual inspection of Figure 6.3, a second order 
Gaussian fit was created for the normal dataset (SSE: 1.37x108) and a first order 
Gaussian fit for the abnormal dataset (SSE: 3.81 x 106). What is evident from 
Figure 6.4 is that there were no defining characteristics of abnormal waveforms 
from the distribution curves, which altogether mandated a different method of 
differentiating between normal and abnormal instances. 
63.3 Pulse waveform prediction with the Multi-Layer Perceptron 
Given that any means of non-parametric (e. g., ANN) classification of normal and 
abnormal arterial pulse waveforms would be impeded by seemingly homogenous 
waveform distributions, methods of waveform prediction were investigated. 
Waveform prediction with the MLP involved the ANN being trained with 
examples of the normal pulse waveform. The aim of this procedure was to 
subsequently engage the MLP in reconstructing the waveform from some trigger, 
followed by correlating the reconstructed waveform with the original signal. 
Given that heart rate and perfusion variability resulted in time and amplitude 
scaling of the arterial pulse waveform, simply correlating the measured 
waveform with some static periodic example would not suffice. The resultant 
high SSE would render such a system insensitive to MA and other waveform 
abnormalities. Figure 6.5 presents a block diagram of the proposed 
implementation. As can be seen from Figure 6.5 the observed signal x(t) was 
presented to a mechanism which triggered on each cardiac (and hence pulse 
waveform) cycle. From the trigger information z (t) the MLP constructed the 
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waveform y(t) which was cross correlated with the observed waveform x(t). 
The resulting cross correlation measure afforded a metric with which to assess 
the similarity of the observed waveform to the known standard. 
x(t) Threshold trigger z(t) MLP-based signal ý Y(t) t *mechanism 
reconstruction r- 
ýý- 'ý correlation 
Figure 6.5. Schematic representation of the MLP-based MA rejection 
mechanism. 
The trigger used throughout these experiments was a single-level threshold 
detector which generated a spike when the waveform x(t) exceeded some 
threshold with a positive gradient. The result was a spike train z(t) E {0,1} 
where the threshold was the waveform mean over aI second window (i. e., 75 
samples). Spike trains are of considerable interest to researchers as a means of 
efficiently coding information [12] since the work of Hodgkin et al., [13] who in 
1952 reported the biological process in the giant axon of Loligo (squid). The 
functional form of the threshold detector is z(t) =f (x (t)) where: 
I ifx(t+1)_m andx(t)<m f(x(t+1))= 
0 otherwise 
(6.7) 
where m is the mean of that 75-sample segment of the waveform. The 
continuously-valued waveforms from the normal and abnormal datasets were 
passed through the threshold detector generating associated spike trains. 
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For the MIT to be successfully trained with the normal arterial pulse waveform 
data and therefore be able to accurately flag subsequent abnormal instances, a 
training dataset was constructed from the available data. To successfully predict 
the pulse waveform, every training pass had to encompass information 
concerning the current and previous states of the waveform. The motivation for 
this is derived from the normal waveform being continuous and it is therefore the 
case that the instantaneous value of the waveform at time t partially depends 
upon the previous value at time t -1 . 
Original 
waveform 
Xx 
train Sample I lý"ºý Sample n Sample 2 ýf- -ºl 
Sample 3 "J 
Target n 
Target: I23 
Figure 6.6. Relationship between the continuous arterial pulse waveform, spike 
train samples and target values. 
Each training vector was composed of 100 elements corresponding to samples of 
the waveform spike train (1 25 seconds given a sampling frequency of 751Iz). It 
was required that the vector contained at least one spike therefore a window of 
time length greater than that of a cardiac cycle was used. The target value for 
this window was the corresponding 100"' element of the continuous waveform. 
To maintain the requirement that past as well as present states of the wavelorm 
were presented to the MLP in each sample, the window was time-shitted by I 
146 
Chapter 6: Pulse Oximetry Data Analysis 
sample. This is emphasised in Figure 6.6 which shows the relationship between 
the training samples and target values derived from the waveform. As can be 
seen from Figure 6.6, each training pattern provided a record of the past 1.25 
seconds of the arterial pulse waveform. The spike train provided no further 
information than the start of the systolic ejection of the cycle and in some cases 
the diastolic shut (we recall the potentially positive gradient between points V 
and D in Figure 6.2(a)). 
The training dataset of normal arterial pulse waveforms was created by taking 
5000 individual samples (of length 100 elements) from the data - which were 
generated using the window time-shifting method described above. The 
individual samples were evenly distributed amongst the 10 patients. An MLP 
was created possessing 100 neurones in the input layer (corresponding to the 100 
elements of the sample), and a single output neurone (corresponding to the 
continuous waveform). Linear neuronal activation functions were employed 
throughout. The alternative tangential sigmoid activation functions (discussed in 
Section 3.1.2) could introduce non-linear biasing effects which precludes their 
use here. To determine the number of MLP parameters that were effectively 
used during training, Bayesian Regularisation [14] was used in a precursory test. 
The first implementation used one neurone in the hidden layer resulting in 103 
effective parameters (101 neuronal weights and 2 neuronal biases). The 
regularisation technique reported that 102 of the parameters were being used 
during the learning process. This process was conducted again with a 100-2-1 
MLP and 101 of the available 205 parameters (202 neuronal weights and 3 
biases) were effectively used. 
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Given that the addition of the second hidden layer neurone had little impact on 
the computational complexity of the MLP, the 100-2-1 MLP architecture was 
retained. Furthermore, in the 100-1-1 configuration the MLP became a direct 
memory device in which the state of the target waveform was derived from the 
100 neuronal weights between the input and hidden layers. The addition of a 
second neurone did not impact upon the number of parameters being used 
because it was largely redundant; neuronal weights to and from this neurone 
were not required to represent the waveform. However the diastolic shut time 
could also trigger a spike, so it was possible that two input neurones could fire at 
any given time. The initial 100 input-hidden weights were not sufficient for 
encoding this eventuality and therefore a second neurone was added to 
accommodate these instances. 
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Figure 6.7. Reconstruction of a normal arterial pulse waveform by a spike- 
triggered 100-2-1 MLP. 
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During training it was observed that the overall SSE of the MLP stabilised at 200 
epochs. The SSE was 4.58x105 (MSE: 1.13x103) which from observation of the 
predicted waveform was attributable to waveform amplitude difference and not 
to periodicity. This is evident from Figure 6.7 which shows a novel 
(i. e., previously unseen) pulse waveform and its reconstructed counterpart. A 
measure of the agreement between the original and reconstructed waveforms was 
evaluated using the cross correlation [15]. For example, cross correlation of the 
two waveforms presented in Figure 6.7 yielded a coefficient of 0.99. The 
statistical significance (i. e., the probability that this correlation could occur by 
chance rather than by direct association) could not be established due to neither 
waveform exhibiting a normal distribution (Figure 6.3). The MLP was tested 
with the available dataset of MA-corrupted waveforms and an example is 
presented in Figure 6.8. 
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Figure 6.8. Reconstruction of an MA-influenced arterial pulse waveform by a 
spike-triggered 100-2-1 MLP. 
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Whilst the episode of MA was relatively short lived (1-2 seconds duration), the 
effect on the MLP was significant enough to generate a highly-erroneous 
reconstructed waveform. The correlation between these two waveforms was 
0.79. From the available dataset, 1000 examples of MA and 5000 examples of 
normal waveforms were randomly selected and tested by the MLP. The 
distribution of cross correlations was examined in order to determine the ability 
of the MLP to adequately filter normal waveforms from abnormal ones 
(Figure 6.9). 
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As is evident from Figure 6.9, the two distributions exhibited markedly different 
characteristics in their centre-point and spread. The normal waveform 
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Figure 6.9. Distributions of the correlation coefficients of normal and abnormal 
arterial pulse waveforms and their MLP-reconstructed counterparts. 
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distribution (fitted with a second order Gaussian, SSE: 2.8x 10'3) was mainly 
contained in the region above the 0.9 correlation coefficient mark whereas the 
abnormal waveform distribution (fitted with a second order Gaussian, 
SSE: 1.2x10"1) was mainly spread over the region between 0.5 and 0.95. 
Appropriate selection of the correlation coefficient cut-off a was required such 
that any novel waveform generating a coefficient above a would be deemed 
normal whilst any coefficient below a would be deemed abnormal. To aid this 
decision the associated Relative Operating Characteristic (ROC) curve [1S] was 
examined. The ROC curve is a plot of the sensitivity vs. 1-specificity of the 
classifier. The knee-point of the curve affords the best sensitivity trade-off 
available to the classifier for the given problem. 
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Figure 6.10. Sensitivity and specificity of the MA filtering mechanism. 
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Examination of the ROC curve indicated that a cross correlation coefficient cut- 
off of a=0.96 would provide the best available discrimination between normal 
and abnormal arterial pulse waveforms. Given this cut-off the sensitivity of the 
classifier became 98.0% with specificity 93.5%. Total predictive accuracy was 
found to be 98.9%. Figure 6.10 gives the plot of sensitivity and specificity. It 
can be seen from this figure that the a point is where the two plots intersect, and 
this is in agreement with a visual inspection of Figure 6.9. 
The MLP filtering mechanism presented in this section was capable of 
discriminating between normal and abnormal arterial pulse waveforms with an 
accuracy of 98.9%. The MLP required samples of 1.25 seconds duration in 
assessing whether the waveform was normal or not -a significant improvement 
on the time scales for existing techniques referred to in Section 6.2.2. These 
results are discussed in Section 6.3.5 alongside the results of another technique, 
given in the following section. 
6.3.4 Information extraction through stochastic resonance 
In the previous section we discussed a method of evaluating the correctness of 
the arterial pulse waveform by correlating it with a reconstructed version. Whilst 
the method yielded what appears to be an acceptable degree of predictive 
accuracy and sensitivity it nonetheless relied upon the MLP being trained with a 
example waveform from which the correlation was derived. The threshold 
detector given in (6.7) controlled the amount of information provided by the 
original waveform during spike train generation. Information concerning the 
state of the original waveform is not encoded into the spike train if it does not 
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cross the threshold with a positive gradient. The threshold detector can therefore 
be viewed as an information transmission channel [16,17]. 
We briefly discuss pulse waveform additive noise, how this affected the observed 
waveform information content, and how a classifier could be constructed in the 
context of the resulting phenomenon of Stochastic Resonance. Stochastic 
Resonance (SR) [18] is a phenomenon in which certain non-linear systems 
perform optimally with non-zero levels of noise q. The resonance effect is 
observed when there is a match between the system dynamics and noise 
statistics, in particular at a certain ratio of signal standard deviation (SD) o and 
additive noise SD Q,,. A single-level threshold detector similar to that presented 
in Figure 6.5 was used. The waveform with additive white noise was passed 
through the threshold detector and the resulting spike train was cross correlated 
with the original signal. The threshold detector expression in (6.7) was rewritten 
incorporating the noise term r7 (t) as: 
f (x(t+1))= 
fi ifx(t+l)+r7(t+1)ßa', and x(t)+i (t) <Q, (6 gß 
0 otherwise 
In each experiment, the normal and abnormal pulse waveform datasets were 
added with noise and thresholded using (6.8). The experiments were conducted 
repeatedly with increasing noise: waveform SD ratio. Disparities between the 
cross correlations of the two datasets were observed. The resonance curves for 
the abnormal and normal waveform datasets are shown in Figure 6.11. The 
maximum cross correlation coefficient for the abnormal waveform dataset was 
0.29 (SD: 1.0x10"2), and 0.45 (SD: 1.2x10"2) for the normal waveform dataset. 
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Figure 6.11. Cross correlations for a normal and abnormal arterial pulse 
waveform at different noise SD ratios (6, /6n) . 
Given the heterogeneous nature of the cross correlation coefficients obtained 
from the normal and abnormal waveform resonance curves, the construction of a 
classifier became trivial. A simple 1-1-1 MLP was used to map the cross 
correlations to binary targets ('I' indicating normal waveform and `0' otherwise) 
which was sufficient to correctly classify 100% of the normal and abnormal 
dataset patterns. 
6.3.5 Discussion 
The previous sections have introduced two possible means of identifying MA in 
arterial pulse waveforms through the continuous appraisal of the waveform 
structure. The gating mechanism fulfils a requirement that the pulse waveform 
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be free from non-physiological abnormalities when evaluating the accompanying 
Sp02 measurement. Both mechanisms (MLP reconstruction, and waveform 
resonance) allow a resolution of down to 2 seconds for accurate appraisal of the 
pulse waveform validity (98.0% and 100% respectively). The underlying 
statistical heterogeneity between normal and abnormal waveforms that is 
responsible for these performances has been demonstrated by the different 
resonance curves in Section 6.3.4. Now we will consider the arterial 
oxygenation measurements and their interpretation. 
6.4 Analysis of arterial oxygenation measurements 
As stated in Section 6.2.1, arterial oxygen saturation SpO2 is expressed as a 
percentage ratio of oxygenated haemoglobin to total haemoglobin in the blood 
stream. Measurements below 90% are indicative of cardio-respiratory (or 
circulatory) pathology, episodic MA, or some combination of these. Whilst 
Section 6.3 addressed the identification of MA and a means of validating pulse 
waveforms, this section focuses on the detection of clinical hypoxaemia 
(insufficient oxygen in the blood) [4,19] through assessment of the Sp02 
measurement. 
In order to define a range of acceptable oxygenation values, an experiment was 
conducted in which Sp02 measurements were acquired and classified by a 
consultant anaesthetist. The distributions of acceptable and unacceptably low 
Sp02 were then formalised for subsequent use in a classification system. The 
purpose of this exercise was to couple a classification mechanism with the MA- 
rejection system described in Section 6.3 to form a complete oxygen saturation 
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classifier for subsequent use in Chapter 7. We define the system as being 
complete due to the fact that it encompasses both classification and validation 
components. 
The Sp02 measurements were acquired from the sample group discussed in 
Section 4.1.3. Of the 194 patient SpO2 samples, 150 (mean age 51.78 years) 
were used of which 52% were from male patients, and 49% from female. 
Figure 6.12 shows the distribution of Sp02 measurements. 
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Figure 6.12. Distribution of Sp02 measurements acquired from patients. 
As can he seen from Figure 6.12, the acquired arterial oxygen saturation 
measurements were consistently over the 90% hypoxaemic threshold, with the 
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majority of samples being over 95%. When considering a patient's suitability for 
surgical anaesthesia, to state that a particular Sp02 measurement is either 
acceptable or unacceptable neglects the underlying causes that affect the 
measurement. ' For example, variables such as age, gender, haemodynamic 
properties and the presence (or history) of cardio-respiratory disease are 
contributing factors to a measured Sp02 value and these must be taken into 
consideration when directly assessing the arterial oxygen saturation. In 
determining the prevalence of these variables in an anaesthetist's decision, the 
acquired data was presented to a hospital anaesthetist for consideration. The 
aforementioned variables were presented alongside the acquired Sp02 
measurements and the anaesthetist was commissioned to group the patients into 
the three categories given in Section 1.4: 1) suitable for surgical general 
anaesthesia; 2) unsuitable for surgical anaesthesia; and 3) possibly suitable for 
surgical anaesthesia after referral for other tests. It is self evident that an 
anaesthetist would require more information than the Sp02 measurement when 
making this type of decision so an assumption that all other biometrics `indicated 
suitable' was applied, i. e. a decision was made exclusively on the merit of the 
Sp02 measurement. 
In order to determine the influence of age, gender and cardio-respiratory history 
on the decision-making process, the anaesthetist's classifications were grouped 
according to each variable and a statistical significance test was performed. The 
null hypothesis stated that the classification was made independent of these 
variables and was exclusively attributable to the Sp02 measurement. Paired 
contingency tables were computed for the influence of gender, age, and cardio- 
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respiratory history on the anaesthetist's decision and a McNemar's statistical test 
was performed for each variable. Table 6.1 presents the results of the statistical 
significance test for each of the aforementioned variables. 
Variable Applied P level Significance 
Age 
Gender 
Cardio-respiratory history 
x2 = 3.84, P=0.05 (5%) 
x2=3.84, P=0.05 (5%) 
x2 = 3.84, P=0.05 (5%) 
P=0.013 (i. e., P «0.05) 
P=0.00 1 (i. e., P«0.05) 
P=0.001 (i. e., P «0.05) 
Table 6.1. The statistical significance of the effects of age, gender and cardio- 
respiratory history upon the patient's suitability for surgical anaesthesia. 
Table 6.1 demonstrates that the level of statistical significance P«0.05, 
suggesting that the null hypothesis could be rejected, i. e., that the age, gender, 
and cardio-respiratory history variables impact upon the patient's suitability for 
surgical anaesthesia. These variables were used to create a classification scheme 
that would assign subsequent patients to the three anaesthesia groups. We 
required that the classification mechanism be capable of expressing its class 
assignments in such a way that a human expert examiner could interpret its 
decision-making strategy. ANNs are considered `black box' solutions insofar 
that classifications are derived from transfer functions and not from qualitative 
analysis of the input variables [20]. Various techniques have been developed to 
extract information (in the form of rules) from ANNs such as the MLP 
[21,22,23,24]; but here an alternative approach to classification called the Fuzzy 
Inference System (FIS) is used. In the following section, we introduce the 
concept of the FIS and further describe how it was employed in deriving a 
suitable classification mechanism. 
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6.4.1 The Fuzzy Inference System 
In this section we present a brief account of the FIS and how it was employed in 
the context of classifying Sp02 measurements. A more detailed exposition of the 
fuzzy paradigm is presented in Section 7.4. 
The FIS is derived from the calculus of fuzzy set theory introduced by Zadeh in 
1965 [25]. We consider that some continuously-valued variable x can be 
ascribed to a number of linguistic terms e. g., `very low', `low', 'slightly low', 
'medium', `slightly high', `high', and `very high' [26]. Given that x is on the 
universe of discourse 4) (i. e., xE (D ), x can belong to any of the linguistic terms 
with a degree of membership u,, where n is the linguistic term. For example, in 
the functional form un (x) describes the degree of membership of x to the nth 
(e. g., `medium') linguistic class, for any value of x on (1). Fuzzy rules can be 
derived from these membership functions 1u . 
Rule: 
Class C, 
Rule: 
Class Cz 
i 
-. º C: 
o 
Figure 6.13. An example two-input Sugeno FIS on domains X and Y with two 
fuzzy rules. 
A comprehensive treatment of fuzzy logic and fuzzy rules can be found in texts 
on soft computing, such as that by Jang et al., [26]. A FIS is an assemblage of 
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fuzzy rules which ascribes variables to classes (i. e., classify variables) through 
the logical flow of its rules. A desirable feature of the FIS is that the user may 
analyse the rule-base to determine how the system proceeds in classifying 
variables, which is an unintuitive task in ANNs. In the instance of classifying 
patients into suitability groups based on biometric variables such as age, gender, 
cardio-respiratory history and arterial oxygen saturation, the FIS becomes an 
attractive mechanism. 
A FIS was created with 4 input variables corresponding to age, gender, 
cardio-respiratory history and arterial oxygen saturation. The FIS provided 3 
output terms corresponding to `suitable for general anaesthesia', `possibly 
suitable for general anaesthesia (refer patient)', and `unsuitable for general 
anaesthesia'; binary 1-in-N encoded in accordance with Section 1.4. The FIS 
input variable range is given in Table 6.2. 
Variable Minimum value Maximum value 
Age 
Gender 
Cardio-respiratory history 
SpO2 value 
18 (year) 
0 (male) 
0 (no adverse history) 
1(%) 
110 (years) 
1 (female) 
1 (adverse history) 
99 ((V, ) 
Table 6.2. Variable ranges for each FIS input variable. 
The FIS itself does not provide any means of learning the optimal positioning of 
membership functions or fuzzy rules. The FIS was trained using the Adaptive 
Neuro-Fuzzy Inference System (ANFIS) [20,26] in which the variable 
membership functions, fuzzy rule-base and interconnecting weights were 
optimised. 
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Of the available 150 patient records, 125 were used to train the FIS whilst the 
remaining 25 were used to test the system with novel patterns. 59 samples of the 
available 150 were classified by the anaesthetist as `suitable for anaesthesia', 37 
as `suitable after referral', and the remainder as being `unsuitable for anaesthesia' 
(henceforth named suitable, refer, and unsuitable respectively). Test training 
identified that 30 training epochs allowed the FIS to be trained sufficiently 
without over fitting occurring. The FIS was trained via the ANFIS method on 
the available 125-sample dataset and the results obtained from a simulation with 
the 25-sample dataset. The FIS successfully classified all samples of the test 
dataset (100% accuracy). The relationships between the fuzzy membership 
functions for each variable are given in Figure 6.14. 
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Figure 6.14. Fuzzy relationship between the 4 FIS input variables. 
, OD 
Figure 6.14 demonstrates the relationship between input variable #1 (gender), 
variable #2 (age), variable #3 (history of adverse cardio-respiratory function), 
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and variable #4 (Sp02 measurement). As can be seen from the figure, a patient's 
history of cardio-respiratory disease presents the largest impact on patient 
suitability for anaesthesia. The FIS generated by the ANFIS training method 
contained a total of 81 rules which were used to classify patients into the three 
groups. These rules are too numerous to present here and are given in 
Appendix III. ANFIS generated an average of 6.75 rules per variable per class. 
Each rule in the rule-base has five parameters which define the impact of the four 
variables described above (the fifth parameter is an offset). Table 6.3 gives the 
mean and standard deviation of these parameters. 
Parameter Mean Standard deviation 
a (gender) -1.97 11.02 
P (age) 2.30 13.60 
x (cardio-respiratory) -0.08 13.55 
S (Sp02) -7.50 35.64 
e (offset) -0.46 14.30 
Table 6.3. Mean and standard deviations for the FIS consequent parameter-set. 
Each rule took information from the variables which were weighted against the 
parameters given in Table 6.3. The standard deviation of 8 was the largest 
(SD: 35.64), suggesting that the associated Sp02 variable had the largest impact 
on the decision-making strategy of the FIS. 
The ANFIS method of FIS training is compared with other techniques in 
Chapter 7 where it is demonstrated that evolutionary techniques to FIS training 
can potentially generate smaller, more compact rule-bases. 
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6.5 Conclusions 
This chapter has presented an analysis of arterial oxygen saturation in the context 
of validation and classification. In terms of validation, it has been shown that the 
arterial pulsatile waveform can be corrupted by physiological and extraneous 
environmental events, and importantly, that these events can be identified in the 
waveform. Detection of these artefacts allows rapid (< 1.25s) assessments to be 
performed on the validity of the arterial pulse waveform (98.0-100% accuracy), 
and an appropriate degree of confidence ascribed to the accompanying Sp02 
measurement. It has further been shown that the oxygenation measurement 
should be considered in the context of patient cardio-respiratory history when 
deciding upon their suitability for surgical anaesthesia. Whilst this may be 
considered intuitive it is highlighted by the fuzzy relationships between the 
variables: age, gender, cardio-respiratory disease history, and Sp02. 
In the context of Figure 6.1 it has been shown how the arterial pulse waveform 
data can be used to evaluate the validity of the associated Sp02 measurement and 
subsequently how a FIS can extract information from the acquired data. In 
conclusion, it can be stated that sufficiently rapid (i. e., <2 s) identification of 
MA-corrupted arterial pulse waveforms is possible using both ANN-based signal 
reconstruction methods (98.0% accuracy), and stochastic resonance techniques 
(100% accuracy). It can be further concluded that Sp02 measurements can be 
used in conjunction with rudimentary clinical histories in determining a patient's 
suitability for surgical anaesthesia. The following chapter extends this work to 
incorporate the cardio-respiratory data analysis systems (presented in Chapter 5) 
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with analysis of further biometric signals in the creation of an overall 
classification system for decision support. 
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CHAPTER 7 
Evolutionary Classifiers for Decision Support 
This chapter presents the decision support aid which was researched and 
developed to assist the anaesthetist/nurse in determining a patient's suitability for 
surgical anaesthesia. Discussed here are the methods by which information is 
extracted from the classifications performed in Chapters 5 and 6, and fused with 
other biometric signals in forming the decision support aid. Evolutionary 
approaches are discussed and applied to fuzzy classifiers and this chapter 
presents the design of the subsequent hybrid evolutionary fuzzy classifier for 
decision support. The chapter concludes by quantitatively assessing the patient 
diagnostic capabilities of this integrated decision support tool and demonstrating 
possible deployment modalities in the context of clinical decision-making. 
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7.1 Introduction 
In forming the Decision Support Aid (DSA) this chapter draws upon the work 
presented in Chapters 5 and 6 alongside other biometrics discussed in this 
chapter. As stated in Section 1.4 the purpose of this work was to develop a DSA 
for the anaesthetist (or less experienced physician). Forming part of this 
objective, the work presented in Chapters 5 and 6 address issues pertaining to 
abnormal physiological manifestations in the cardiac, respiratory and circulatory 
systems. In Section 1.4 it was stated that the decision-making strategy is broken 
down into, e. g., cardiac assessment, followed by respiratory assessment, etc. The 
systems developed in Chapters 5 and 6 performed these tasks and here they are 
combined to form the DSA, see Figure 7.1. They are augmented with biometric 
signals such as blood pressure, heart rate values and lung function responses. In 
the following sections the DSA is designed to realise the objectives stated in 
Chapter 1. 
7.2 Biometric signals within the decision support aid 
In Chapter 1 the biometrics considered in this work were introduced as being 
cardio-respiratory competence, blood pressure sphygmomanometry, pulse 
plethysmography, and lung spirometry. Motivation for their inclusion was 
subsequently given in Section 4.1. Whilst Chapters 5 and 6 presented the work 
undertaken to develop analysis mechanisms for cardio-respiratory auscultation 
and pulse oximetry measurements respectively, this chapter discusses the 
remaining biometrics: blood pressure (incorporating heart rate) and lung 
function; and the patients' clinical notes which detail, for example the patient's 
age, gender, history of cardio-respiratory disease, present medication, etc. 
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Considering that the purpose of a learning algorithm is to search input domain 
space for an optimal solution to the given problem, the domain space must be 
bounded [1]. Therefore each input variable x must be constrained between a 
minimum and maximum value (e. g., a and b) i. e., xER: a<_ x5 b. Prior to 
discussing the development of the DSA, consideration is now given to the form 
of the inputs and outputs, and any constraints imposed. 
7.3 System inputs, outputs and constraints 
In forming decisions with which to aid the anaesthetist, the DSA is loaded with 
information from the preceding-stage classifiers (i. e., cardio-respiratory 
auscultation and pulse oximetry classifiers) and the available biometric values. 
Figure 7.1 shows the relationship between the information sources, classifiers 
and the DSA. Given that the work presented in Chapters 5 and 6 addressed the 
data processing and information extraction aspects of cardio-respiratory 
pathology identification and pulse oximetry classification, we can now consider 
these systems to be information sources rather than data sources. 
Biometrics Data 
Information 
Sources 
............................................ 
Anaesthetist-lead 
training 
Figure 7.1. Relationship between information sources, classifiers and the DSA. 
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In Figure 7.1 the DSA is furnished with input from the cardiac and respiratory 
classifiers. The cardiac classifier provides 17 inputs - one input per pathology 
(or abnormality). Recalling Chapter 5, the outputs of the cardio-respiratory 
ANNs were 1-in-N encoded and normalised such that the Dempster-Shafer 
method could be applied to aggregate responses in forming more accurate 
classifications. The outputs from the DST-based system were similarly 
normalised thereby representing the classifications as probabilistic assertions as 
to the cardio-respiratory abnormality. Each DSA input from both the cardiac and 
respiratory classifiers is bound between 0 and 1 representing classification 
probabilities. A further DSA input is the patient's arterial oxygenation measured 
via pulse oximetry. The value presented to the DSA is a percentage and 
therefore bound between 1 and 100. The value 0 (zero) is retained for validity 
purposes, i. e., if the DSA encounters a zero from the pulse oximetry classifier, 
this is due to the oximetry value being rejected by the gating mechanism on the 
grounds of poor waveform validity. This gating mechanism was the 
MA-rejection system (MLP) developed in Chapter 6. The final DSA inputs are a 
plurality of biometric values comprising of BP, HR, lung function and clinical 
history. Systolic BP is bound between 40 and 220mmHg; diastolic BP between 
30 and 150mmHg; HR between 25 and 130bpm; lung function PEFR between 50 
and SOOL/min; and lung function FEV1 between 0.1 and 1OL. The values 
presented above do not constitute any physiological limits but are merely 
imposed to restrict any subsequent learning algorithm's search space. The values 
are chosen such that if any variable fell outside these ranges the DSA would 
impose the arbitrary classification of `referral'. With regards to clinical history, 
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the patient's age is bound between 18 and 110 years. The remaining variables 
are binary encoded and are presented in the summary Table 7.1. 
Metric Unit Minimum value Maximum value 
Cardiac sound classification N/A 0 1 
Respiratory sound classification N/A 0 1 
Blood Pressure (systolic) mmHg 40 220 
Blood Pressure (diastolic) mmHg 30 150 
Heart Rate bpm 25 130 
Peak Expiratory Flow Rate L/min 50 500 
Forced Expiratory Volume (1 second) L 0.1 10 
Sp02 % 1 100 
Patient age years 18 110 
Patient gender N/A 0 (female) l (male) 
Medication indicators 
Warfarin, Inhalers, HRT N/A 
Steroids, Aspirin, Diuretics N/A Binary encoded: Female Contraceptive Pill N/A 
Biohazard indicators 1: true / positive presence or history 
Hepatitis B, Hepatitis C N/A 0: false / negative presence or history 
MRSA, Active TB, HIV N/A 
Haemodynamic indicators 
Afro-Caribbean origin N/A 
Excessive alcohol intake N/A 
Infection N/A 
Blood disorders / anaemia N/A Binary encoded: 
Diabetic N/A 
Kidney / urinary problems N/A 1: true / positive presence or history 
Bleeding disorders N/A 0: false / negative presence or history 
Thyroid disease N/A 
Malignancy N/A 
Open wound N/A 
Cardiovascular indicators 
Smoker (> 40 per day) N/A Binary encoded: Cardiovascular disease NIA history 1: true / positive presence or history Varicose veins N/A 0: false / negative presence or history Diabetic N/A 
Respiratory indicators 
Smoker (> 40 per day) N/A 
Pneumonia / chronic N/A bronchitis Binary encoded: 
Asthma (well controlled) N/A 
Asthma (hospitalised) N/A 1: true / positive presence or history 
Shortness of breath at rest N/A 0: false / negative presence or history 
Respiratory disease history N/A 
Productive cough N/A 
Table 7.1. Values provided to the DSA during normal operation. 
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The encoding of the patient's clinical history and medication as presented in 
Table 7.1 merits particular attention. Relevant patient information can be 
grouped into five categories: haemodynamic, cardiac (incorporating circulatory), 
respiratory, biohazard and medication (see Section 4.4). Table 7.1 further 
expands each category into the relevant conditions which are noted in the 
patient's history. Each item (e. g., cardiovascular disease history) is a binary- 
encoded value with I and 0 representing the presence or absence of the item 
respectively. These values are masked such that the category value is set to 1 if 
any of its `child' values are 1, e. g, `Respiratory indicators IS smoker OR 
pneumonia OR... ' in Boolean logic form. Given the input variables, attention is 
now given to the structure of the DSA and how it aids decision support for the 
physician. 
7.4 Fuzzy classification techniques in decision support 
The purpose of the DSA was for it to be a classifier that would ascribe different 
levels of anaesthesia suitability to the patient. As such the DSA could either 
exist in the form of an ANN-type classifier; or as a fuzzy rule-based classifier 
(introduced in Section 6.4.1). Whilst ANNs can generalise solutions to domain 
classification problems, they cannot easily produce a linguistic interpretation of 
their decisions. The response of a conventional ANN is the weighted sum of 
successive linear and non-linear translations usually devoid of any inductive 
reasoning that could explain its decision-making. Because of this ANNs are 
infrequently employed in medical applications which require classifications 
based on this inductive reasoning. Fuzzy classifiers have taken this mantel as 
they possess the ability to linguistically demonstrate the chain of reasoning 
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which results in their classifications. Rule-based expert systems can also be used 
for this type of decision-making, however fuzzy systems are frequently used due 
to their ability to handle imprecision in their reasoning scheme [2]. For this 
compelling reason the DSA employed a form of fuzzy classification in its 
decision-making strategy. This section introduces aspects of fuzzy systems that 
will furnish the reader with sufficient information for the purposes of this 
chapter. For a more in depth treatment of the subject the reader is referred to 
[2,3]. Chapter 6 provided a brief account of FIS as a classification framework. 
In order for the DSA to classify input data into different categories the necessary 
fuzzy rules must firstly be developed. The manner in which these rules are 
developed is the subject of Section 7.5, whilst the structure of fuzzy rules is 
firstly discussed in Section 7.4.1. 
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Figure 7.2. Three example membership functions denoting the grade of 
membership of some value x to the fuzzy sets low, medium and high. 
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7.4.1 Fuzzy rules in classification 
In recalling Section 6.4.1 we consider some variable x to be continuously valued 
over the universe of discourse L (i. e., xe (D). Given an example in which x is 
bounded such that Ix E R: 1<_ x: 5 1001, three fuzzy sets A, B and C can be 
established describing whether x is low, medium or high respectively. The 
grades of membership u define x's membership to each of the aforementioned 
fuzzy sets. Figure 7.2 gives three example membership functions: 6uA 
(x), 
PB (x) and arc (x) which are represented by the graphs `is Low', `is Medium' 
and `is High' respectively. These membership functions can take the functional 
form of a Gaussian pg (depicted in Figure 7.2), triangular function u,,, trapezoidal 
function p and bell-shaped (or Cauchy) function Pb [2]. There are other 
functions but these are the ones which are most commonly used. In their 
algebraic form the functions are: 
ýtl(x; a, b, c, d)=max 
(min 
bx--a 
a, l, 
dd--cx ,0, 
(7.1) 
where a, b, c and d define the position on the x-axis of the four corners of the 
trapezoidal function; 
ýcrr (x; a, b, c) = max min 
x-atc-x, 0, 
b-a c-b 
(7.2) 
where a, b and c define the position on the x-axis of the three corners of the 
triangular function; 
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ßt8 (x; c, 0-) = 
2( OM ), (7.3) 
where c defines the centre-point of the Gaussian function and o defines the 
spread; 
2b 
, tb(x, a, b, c)= 1+ 
x-c 
a 
(7.4) 
where a defines the spread, b defines the gradient of the spread, and c defines the 
centre-point of the bell function. 
Returning to Figure 7.2 the response of the membership function u depends upon 
the value of x and is bound such that 0: 5 & (x) 51 where c can be any of the 
fuzzy sets A, B or C on 0. In this form the fuzzy membership function becomes 
a powerful tool in representing uncertainty and ambiguity in classification 
problems [2]. These membership functions can be used in fuzzy rules which 
follow the general form 
if x is A then y is B, (7.5) 
where x and y are some variables on respective universes of discourse X and Y, 
and A and B are linguistic values defined by fuzzy sets on the same universes [2]. 
The term `x is A' in (7.5) is commonly referred to as the antecedent whilst the 
term 'y is B' is called the consequent. Given a multiple-antecedent fuzzy rule, 
the associated consequent term can be computed from the degree of membership 
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each variable is ascribed to its fuzzy (e. g., the membership that x is ascribed to A 
in (7.5)). 
Fuzzy techniques based on the principles discussed above often surpass 
conventional techniques for system analysis due to their intrinsic ability to deal 
with scenarios in which vagueness and ambiguity are prevalent. Whilst being a 
method suited to forming classifications (e. g., medical diagnosis) fuzzy 
reasoning nonetheless requires a means of training for the construction of the 
underlying fuzzy rules (termed the rule-base). As was discussed in Section 6.4.1 
the assemblage of fuzzy rules and membership functions forming a classification 
mechanism is frequently referred to as a FIS. There are two main `flavours' of 
FIS: the Mamdani model, and Sugeno model [2]. The Sugeno model is 
computationally less complex than the Mamdani type, mainly due to its different 
defuzzification method (see Figure 6.13). Throughout the remainder of this 
chapter we will be using the Sugeno FIS model. Methods of training the FIS are 
considered in the following section. 
7.5 Training of Fuzzy Inference Systems 
This section introduces two principal means of training FIS implementations 
towards successfully classifying data according to some supervised learning 
mechanism. 
7.5.1 Adaptive Neuro Fuzzy Inference System 
A common approach to FIS training is via ANNs in which the creation of fuzzy 
rule-base antecedents and the weight attached to each rule is determined using a 
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combination of least-squares and error gradient descent learning algorithms. The 
method, known as Adaptive Neuro Fuzzy Inference System (ANFIS) [5] was 
briefly introduced in Section 6.4.1 as a means of identifying the influencing 
factors on the patient's arterial oxygenation measurements. Here the technique is 
evaluated as a means of training a FIS to classify data by adjusting the fuzzy 
rule-base parameters. For completeness, the architecture of an ANFIS is 
discussed and is foremost intended to illustrate the hybridisation of fuzzy rule- 
base with the ANN paradigm. Figure 2.1 shows some of the possible areas of 
intelligent system hybridisation. 
x 
I 
v 
Figure 7.3. Example two-input first-order ANFIS architecture with two rules [2]. 
Figure 7.3 gives an example ANFIS architecture comprising of two input 
variables utilised in two fuzzy classification rules: 
Rule 1: If x is AI and y is ! Jj then f, = plx + qty + rl, 
Rule 2: Ifx is A2 andy is 132 thenß =p2X+q2y+r2. 
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The purpose of the ANFIS hybridised training method is to adjust the parameters 
of fuzzy set membership functions and the output function parameter set 
{ p,, q,, r, } such that subsequent classifications of x and y can be correctly 
determined [2]. In Figure 7.3, the nodes in layer I apply the fuzzy membership 
functions , u,, 
(x), PA, (x), pý (y) and p (y) to variables x and y in 
determining the grade of membership of each variable to fuzzy sets in their 
respective universes. Layer 2 implements the rules given above by aggregating 
the responses oj., of the first layer (where of, is the ith node in layer j). From 
Figure 7.3 the response of node o2,, becomes: 
o2,; = w, = ,u, 
(x)"fua, (Y), _ =1,2, (7.6) 
where x is the T-norm operator, in this case derived from the union of two fuzzy 
sets and used as a logical AND operator for two membership functions [6]. The 
nodes in layer 3 normalise the outputs (referred to as rule firing strengths) of the 
second layer nodes using: 
03 t= wt = 
wf 
w, +w2 
(7.7) 
such that w, becomes the normalised firing strength of w,. Layer 4 nodes 
weight the normalised firing strength of the antecedents against the class-specific 
output function f, using: 
04,, = wf, = w, (PAX+9', Y+r), (7.8) 
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where j p, q,, r, } are the consequent parameter set. The fifth layer performs a 
summation of all the weighted-rule firing strengths in generating the overall FIS 
output via the expression: 
os,, =I ýwrf, - w; 
(7.9) 
The ANFIS hybridised training algorithm involves adjusting the FIS parameter 
sets during the forward-pass phase (i. e., when data is being presented to the FIS 
during training), and via error backpropagation. In the former, the premise 
parameters (i. e., the membership function parameters) remain fixed and the 
consequent parameter sets are adjusted using a least-squares algorithm. In the 
latter phase the consequent parameter sets remain fixed whilst the premise 
parameter sets are adjusted using an error gradient descent algorithm. 
The ANFIS method of FIS generation and learning has found numerous 
applications in the field of biomedical engineering [7,8,9]. A recurring theme 
throughout the literature is that of speed and computational complexity. As is 
discussed later in Section 7.6.9 the ANFIS method is a computationally complex 
one, and typically generates rules in the order of n" where n is the number of 
input variables. Therefore adaptive training via ANFIS is difficult to achieve in 
near real-time applications. The next section details two methods of FIS learning 
based on the evolutionary paradigm. We introduced some of medical 
applications of evolutionary techniques in Section 2.5. 
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7.5.2 Genetic Algorithm-based FIS learning 
Genetic Algorithms (GAs) can be defined as search procedures based on the 
mechanics of natural selection and genetics [10]. To better discuss GAs - and 
hence their application in this problem domain - we consider the following four 
points made by Koza [11]: 
1. There exists an environment possessing some entity which has the ability 
to reproduce; 
2. The environment contains a population of such self-reproducing entities; 
3. There is some variety between the self-reproducing entities; 
4. This variety affects the entity's ability to survive in the environment. 
Given a natural or artificial system adhering to these four points it becomes 
possible to observe an evolutionary process by which successive generations of 
the self-reproducing population change in response to their environment and 
peers (usually to the betterment of the population). Theorised by Darwin in 1859 
[12] the process of evolution remained until 1962 when Holland [13,14] 
demonstrated how it could be applied to artificial systems. One such modality is 
the GA which provides a framework for codifying the problem domain and 
evolving solutions via a mixture of `breeding' functions and random mutation 
operations. For a detailed exposition of the theory of GAs the reader is referred 
to [10,14,15]. For simplicity the GA is recounted in algorithmic form in 
Figure 7.4. In Figure 7.4, the `++' operator is programmatic shorthand for 
`increment by one'. Each entity is defined by a series of problem-specific 
parameters which fundamentally govern its fitness and it is these parameter sets 
that evolve over successive generations. 
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No 
P, 
Select one individual 
Copy entity into Insert new mutant 
into new population 
Figure 7.4. Flowchart of the conventional GA [I 11. 
In Figure 7.4 three probabilities P,, P., and P are defined representing the 
probabilities of reproduction, crossover (breeding) and mutation respectively: 
" During reproduction a single entity (sometimes referred to as chromosome or 
solution) is copied (unchanged) into the new population. 
Create initi.:, 
-ý, 
population 
Designate 
End 
Evaluate fitness for 
all M entities 
Yes 
izý 
No 
Select genetic 
operation 
probabilistically 
P, P, 
(Select two individuals Select one indiv 
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" During crossover two chromosomes are chosen and - in the simplest case - 
parameter information is taken from both in equal measure to form a `child' 
chromosome. The second child is created using the remaining parameter 
information. 
" During mutation a single chromosome is randomly modified (i. e., one or 
more chromosome parameters are randomly adjusted). 
The GA is typically allowed to run over a predefined number of generations. 
When executing a GA - which is inherently a recurrent process - one must 
specify a termination criterion by which the GA can establish whether the 
population of chromosomes can solve the given problem. Typically the fitness 
of each chromosome is used such that when the best chromosome fitness exceeds 
a predefined value, evolution terminates. In his book Goldberg [10] recounts a 
variety of applications of GA to control, optimisation and classification problems 
which all employ different termination and execution criteria. Here it is 
proposed that a GA variant (GAv) can be applied to the construction and 
evolution of a FIS by adjusting both the fuzzy rule-base and the membership 
function parameter sets. The variant aspect of the proposed solution is discussed 
later in Section 7.6.1. 
The theory of GAs as developed by Holland [13,14] and subsequent researchers 
was based primarily on the underlying principle that the GA operates on 
chromosome parameter sets of fixed size. Koza argues that this principle limits 
the effectiveness of GAs on numerous fronts [11]. Given that one generally 
lacks sufficient information concerning the optimisation problem, it is ill advised 
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to impose a fixed-size parameter set (or character string) on the GA as this can 
have the undesired effect of constraining the optimisation process. Koza noted 
that "The initial selection of string length limits in advance the number of 
internal states of the system and limits what the system can learn" [I I]. In 
response to the lack of dynamic variability of GAs the Genetic Programming 
(GP) paradigm has been lent considerable credence [I I]. 
7.5.3 Genetic Programming-based FIS learning 
The GP and GA paradigms share a common vein in that both of these approaches 
implement the evolutionary schema formalised by Holland. It is with the mode 
of implementation where these two techniques differ. The process of machine 
learning (e. g., the training of an ANN, or the learning of a FIS, etc. ) can be 
considered to be the attempt to discover a computer program that gives a desired 
output for particular inputs. Koza [11] claims that the solution to a given 
classification problem can be reformulated as the search for a highly fit computer 
program in the domain space of all possible computer programs. This is 
analogous to the GA approach which searches parameter set space for the fittest 
parameter set for a given problem. For GP, the chromosomes (or solutions) are 
referred to as programs. 
In the GP paradigm a genetic program consists of functions and terminals 
specific to the problem under consideration. Functions can by arithmetic 
operations, mathematical functions, logical operations, etc.; whilst terminals can 
be variables, parameters, internal system states, etc. These functions and 
terminals respectively form the function set F and terminal set T. 
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As an illustration let us now consider the GP approach in the context of the 
problem of FIS rule-base generation and training. For simplicity, consider a 
function set consisting of the fuzzy operator x and the membership functions 
PA, , p4 ,p and p8Z (used 
in Figure 7.3). Similarly the terminal set consists of 
variables x and y. The sets can be formulated as: 
. 
77 
= 1x1 fUA, 1P'f 
UBI 
1I B_ 
}1 
T={lx, y}. 
(7.10) 
If one were to express the antecedents of the two fuzzy rules given in 
Section 7.5.1 using a program tree in conjunction with (7.10) the representation 
would be similar to that given in Figure 7.5. As is demonstrated in Figure 7.5 the 
program tree decomposes the fuzzy rule antecedent terms into functional blocks 
that can be represented in a computer program. The GP paradigm employs the 
same genetic operators as the GA namely reproduction, crossover and mutation. 
In reproduction, program tree fragments are copied back into the program. 
Function set 
nodes 
Terminal set 
nodes 
x is A, and y is B1 x is A2 and y is B2 
Figure 7.5. Functional program tree of fuzzy rule antecedents in the GP 
framework. 
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Similarly the crossover operation swaps two program tree fragments between 
two parent programs thereby generating two offspring programs. Finally 
mutation involves the random adjustment of either a function node, terminal 
node or both. 
The GP approach is relatively new in relation to GA and other evolutionary 
strategies, and as such there are few cited examples of its application in the 
medical literature. In their paper Tsakonas et. al., [16] apply the GP technique to 
the evolution of fuzzy classifiers in two medical domains: the diagnosis of the 
subtype of aphasia (impairment of the power to use or pronounce words), and the 
classification of pap-smear examinations. The authors applied a correlation 
measure as the fitness of each program which provided an accurate account of 
program performance [17]. The correlation measure C was defined as: 
C- 
(tpxtn)-(fnx fp) 
(7.11) 
(tn+ fn)x(tn+ fp)x(tp+ fn)x(tp+ fp) 
where tp, tn, fp and fn are true positive, true negative, false positive and false 
negative classifications respectively. A further observation that Tsakonas et. al., 
made was program tree complexity. They employed a simplicity measure that 
would effectively reward simple programs whilst penalising complex ones. They 
give the simplicity measure D as: 
M-RN-(1-R) 
(7.12) 
M-1 
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where M is the maximum allowable tree size (expressed in nodes) and N is the 
tree size of the program under consideration. They further define 
R= 100 - H), '100 and H =1.005 100 -100/T) where T is the size of the 
training set. The simplicity measure is implemented via multiplication with the 
fitness measure. Given that the fitness measure is a normalised form of the 
correlation function C, the overall individual program fitness F can be expressed 
as [16]: 
F=1 (7.13) 
such that F --ý [0,1] . This technique of evaluating the 
fitness of each program 
whilst incorporating the complexity of the program tree was implemented in the 
DSA, which is discussed in the following section. The process flow of a genetic 
program is similar to that of the conventional GA given in Figure 7.4. The GP 
process flow is shown in Figure 7.6. 
7.6 On the development of the DSA 
Two implementations of the DSA were formulated: one implementing the GAv 
approach to FIS evolution; and one utilising the GP paradigm. These two 
approaches were benchmarked against the ANFIS method of FIS training. 
Section 7.6.1 and Section 7.6.2 detail the development of the GAv-based DSA 
whilst Section 7.6.3 and Section 7.6.4 gives an account of the GP-based 
approach. 
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Figure 7.6. Flowchart of the conventional GP [ 11 ]. 
7.6.1 The Genetic Algorithm variant-based DSA 
The GAv method was applied to the FIS in evolving a classifier that would 
provide decision support to the anaesthetist. There was a departure from the 
conventional GA approach insofar that this implementation could handle 
chromosomes of varying lengths thereby precluding Koza's statement of 
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dynamic variability [11]. Given the nature by which the FIS was trained the 
system was referred to as an evolutionary Fuzzy Mixture Model (eFMM) [18] 
which was the kernel of the DSA, and is described thus. 
The eFMM is notionally derived from the Gaussian Mixture Model (GMM) 
introduced in Section 3.3.2. In many real-world scenarios, data does not 
generally follow set distributions e. g., Gaussian, etc. For example, the arterial 
oxygen saturation readings presented in Section 6.4 follow a skewed-normal 
distribution. When analysed with models employing fuzzy membership 
functions such as those in (7.1 - 7.4) the analysing mechanism is committed to 
increasing rule-base complexity to account for these distributions, sometimes to 
the detriment of classification accuracy and sensitivity. The eFMM attempts to 
ameliorate this by providing a framework for the mixing of membership 
functions. Given the set of membership functions V={ prr, Pg' Pb' p, } one can 
identify a set of common function parameters: the function's centre point c and 
spread value c Other membership function parameters (such as b in (7.4)) can 
be derived from some arbitrarily-defined function of a. The fuzzy membership 
functions are mixed by simple addition of the weighted functions of yr such that 
p (x) = WtrUtr (x) +WgIUg `x) + Wblub 
(x) + Wtut (x), 
(%. 14) 
where wf., Wg, Wb and w1 are weight terms which sum to unity. The weights 
themselves are defined by a series of triangular membership functions which are 
governed by a mixture coefficient m (0: 5 mS 100). The membership function 
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p (x) will be a linear mixture of at most two functions in yr. Between the range 
0: 5 mS 33 the membership function will be a mixture of triangular and Gaussian 
components (at m= 33 the function is purely Gaussian). Similarly between the 
range 33: 5 m! 5 66 the membership is a mixture of Gaussian and bell-shaped 
components (at m= 66 the function is purely bell-shaped), and so forth. The 
fuzzy rules are aggregated using the AND x, OR + and NOT -, fuzzy operators. 
Whilst the membership function parameter set was real-encoded, the fuzzy 
operator parameter set was integer-valued. 
Mix m- 
Centre c- 
Spread a- 
Input variables Rule #I Rule #2 Rule #3 
.. ... . ... .. . .. .. ... . .. ... . ... .. . .. .. ... . .. ... . ... .. . .. .. ... . Rule complexity ` 
. 
AND IF (x, is high) 
Figure 7.7. Structure of the eFMM chromosome. 
The consequent terms employed by the eFMM were those introduced in 
Section 1.4 and subsequently used in Chapter 6, namely `suitable for general 
anaesthesia', `possibly suitable for general anaesthesia (refer patient)', and 
'unsuitable for general anaesthesia'. Two constraints were imposed on the 
system: 
1. mutation involved changing a membership function parameter AND a 
consequent term parameter; and 
2. the maximum rule complexity was limited by some arbitrarily value 
(discussed below). 
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The structure of the chromosome is given in Figure 7.7. Recalling Table 7.1, 
there were 44 input variables available to the eFMM: 17 cardiovascular 
classifications, 14 respiratory classifications, 6 biometrics, 2 patient details, and 5 
indicators. It is important to note at this juncture that the eFMM was not obliged 
to select all of these variables during its evolutionary learning. 
Of the available dataset (discussed in Chapter 4), 150 patient samples were made 
available to the eFMM for learning whilst 44 samples were retained for testing 
purposes. The system was trained for 100 generations on a dataset which had 
been previously classified by a practicing hospital anaesthetist. The GAv 
population size was 500 and the maximum allowable rule complexity was 44 
antecedents per rule i. e., permitting one antecedent term per variable. 
Furthermore, the termination criterion was that at least one chromosome had an 
MSE S 0.1, which was chosen arbitrarily to assess whether the population could 
evolve to an optimal solution. The following section details the results obtained 
from these two tests. 
7.6.2 Results obtained from the GAvbased DSA 
System evolution was terminated after 15 generations because a visual inspection 
of the MSE showed that the error gradient was approximately zero. Termination 
criteria did not include `minimum error gradient'. Figure 7.8 shows the MSE of 
the best and worst performing chromosomes throughout the generations. As can 
be seen from Figure 7.8 the FIS converged to a solution after 5 generations, with 
the fittest chromosome MSE being 0.26. 
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Figure 7.8. Error curves for the best and worst performing eFMM chromosomes 
over the generations. 
The worst performing chromosome MSE appeared to stabilise at approximately 
1.75. The final population was sorted according to fitness, and as can he seen 
from Figure 7.9, the majority of the population exhibited approximately the same 
MSF of 0.26. 
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Figure 7.9. Change in error between the final ct' MM chromosomes. 
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The rules obtained from the best performing chromosome of the final population 
are given as: 
Rule # 1: (Suitable for surgical anaesthesia) 
IF (X(7) IS high) AND (X(12) IS high) AND (X(12) IS low) OR (X(4) IS NOT high) AND 
(X(34) IS NOT high) OR (X(2) IS low) AND (X(13) IS NOT high) OR (X(5) IS low) AND (X(8) IS high) 
OR (X(11) IS NOT high) AND (X(14) IS low) AND (X(4) IS NOT low) AND (X(13) IS high) AND 
(X(10) IS high) AND (X(8) IS low) THEN (Y IS class-1) 
Rute #2: (Referral) 
IF (X(10) IS low) AND (X(11) IS high) AND (X(3) IS high) OR (X(9) IS NOT low) AND 
(X(3) IS NOT high) AND (X(9) IS NOT medium) AND (X(5) IS low) AND (X(11) IS NOT medium) AND 
(X(11) IS high) OR (X(2) IS NOT medium) AND (X(5) IS low) AND (X(12) IS NOT low) OR 
(X(4) IS high) THEN (Y IS class 2) 
Rule #3: (Unsuitable for surgical anaesthesia) 
IF (X(7) IS high) AND (X(8) IS NOT high) AND (X(2) IS low) AND (X(30) IS high) AND 
(X(2) IS low) OR (X(10) IS NOT low) AND (X(13) IS low) AND (X(9) IS NOT high) AND (X(3) IS high) 
AND (X(4) IS NOT low) AND (X(5) IS low) AND (X(10) IS low) AND (X(2) IS NOT low) AND 
(X(13) IS NOT low) THEN (Y IS class 3) 
These rules can be logically reduced by removing contradicting terms which 
cannot coexist. Variable descriptions are shown in Table 7.2. The reduced 
rulebase can be expressed as: 
Rule # 1: (Suitable for surgical anaesthesia) 
IF (X(4) IS NOT high) THEN (Y IS class 1) 
Rule #2: (Referral) 
IF (X(11) IS high) AND (X(5) IS low) AND (X(3) IS NOT high) AND (X(9) IS high) OR (X(14) IS low) 
AND (X(11) IS high) AND (X(3) IS high) OR (X(5) IS low) AND (X(12) IS NOT low) AND 
(X(2) IS NOT medium) OR (X(4) IS high) THEN (Y IS class 2) 
Rule #3: (Unsuitable for surgical anaesthesia) 
IF(X(2) IS low) AND (X(7) IS high) AND (X(8) IS NOT high) THEN (Y IS class 3) 
Variable Variable description 
x(1) Gender 
x(2) Age 
x(3) Systolic blood pressure 
x(4) Diastolic blood pressure 
x(5) Heart rate 
x(6) Sp02 
x(7) Peak expiratory flow rate 
x(8) Forced Expiratory volume (1 second) 
x(9) Medication indicator 
x(10) Biohazard indicator 
x(11) Haemodynamic indicator 
x(12) Cardiovascular indicator 
x(13) Respiratory indicator 
x(14)-x(30) Heart sound classification (1-17) 
x(31)-x(44) Lung sound classification (1.14) 
Table 7.2. Variable descriptions for the evolved rulebase. 
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The rule `pruning' was conducted manually after evolution. Upon inspection the 
above rules appear implausible; for example suitability for anaesthesia cannot 
exclusively be based on diastolic BP. Furthermore one would expect the rules to 
reference variables x(14) -x(44) more frequently. It was possible to implement a 
means of penalising chromosomes that were `too simple', i. e., rule #1 above, but 
this could also have a detrimental affect by constraining the evolutionary system 
(recall that we also stipulated a maximum rule complexity). Given the training 
dataset of 150 samples, the GAv eFMM correctly classified 87.56% with a 
sensitivity of 81.33% and specificity of 90.67%. The eFMM was tested with the 
44 remaining samples and correctly classified 90.91% with a sensitivity of 
86.36% and specificity 93.18%. A discussion of these results alongside the 
results obtained from other eFMM implementations is given in Section 7.6.9. 
We now discuss the GP-based DSA. 
7.6.3 The Genetic Programming-based DSA 
This section provides an account of the GP-based DSA development. This 
approach was implemented in the Java programming language, as an object- 
based language was deemed the most appropriate for coding. As will be seen in 
subsequent diagrams, the optimal structure of the eFMM is object-based. As was 
discussed in Section 4.3.2, Java is a suitable language for these types of 
programming problems. The Java programming language is more portable i. e., 
platform-independent than C++ thereby allowing easier deployment of the DSA 
and parallelisation in distributed computing environments (see Section 8.3). 
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The kernel of the DSA was the eFMM, as given in Section 7.6.1. The structure 
of the eFMM and the program environment is described in Unified Modelling 
Language (UML) form [19] in Figure 7.10 and Figure 7.11 respectively. The 
eFMM was implemented in two distinct fashions: object-based and thread-based, 
and the rationale behind both implementation strategies is discussed in 
Section 7.6.4 and Section 7.6.5 respectively. 
7.6.4 The thread-based GP-DSA 
With reference to the UML diagram in Figure 7.10, the Thread! anager class is 
responsible for creating and maintaining the universe of genetic programs 
involved in the solution to the FIS training problem. The terms thread, solution 
and program are used somewhat interchangeably, suffice to say that a solution is 
a thread-based genetic program. ThreadManager creates an initial population of 
solution objects (which extend the Thread class). Making solution an 
extension of Thread gives one the ability to execute solutions concurrently 
instead of sequentially. 
Each solution object is created by ThreadManager firstly writing new source 
code (in accordance with the GP paradigm), compiling the code, executing, and 
then auditing. Each solution is therefore different in its behaviour towards the 
classification of data, as implemented by its unique rule-base and membership 
function parameter set (as defined by the Parameterset object). Furthermore 
the ReferenceLedger object is responsible for maintaining the audit of active 
GP thread-based solutions. ReferenceLedger audits and periodically polls the 
solutions in the search for the best and worst performing programs. Periodic 
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polling of each program's performance is governed by the GlobalTimer thread. 
Another function that GlobalTimer performs is the periodic spooling of data 
from ThreadManager to each solution being audited by ReferenceLedger. 
Figure 7.10. UML diagram of the thread-based GP approach to FIS training. 
In the Java programming framework threads are computationally intensive 
constructs, so it was desirable that a configurable means of clocking the GP 
solution universe was in place. In the interests of computational overheads, each 
thread terminated at a different time. Given that each thread would need to 
observe all of the available training data in order to determine its fitness, under 
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normal circumstances every thread would terminate at the same time after being 
presented with the last data point. A proportion of threads would breed or 
reproduce thereby placing additional pressure on the simulation platform. 
Allowing threads to execute for longer coupled with the introduction of 
randomised life expectancies would spread out the computational load thereby 
improving system efficiency. The Java programming code for this system is 
presented in Appendix IV. 
7.6.5 The object-based GP-DSA 
The alternative approach investigated was the object-based method which 
realised each solution as a sequentially-accessed object rather than a thread. This 
presented two distinct advantages over the aforementioned implementation: 
1) the overall system architecture complexity could be reduced (see Figure 7.11); 
and 2) the computational overheads could be minimised. Due to this 
implementation being executed sequentially the requirement for listeners (such 
as G1oba1TimerListener and ChromosomeThreadListener) is negated. 
Furthermore the complexities of synchronous access to objects (e. g., the 
reference ledger) ceases to be a design consideration. 
A preliminary trial with both approaches identified that the object-based design 
methodology surpassed its thread-based counterpart in terms of the maximum 
allowable population size. 
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Figure 7.11. UML diagram of the object-based GP approach to FIS training. 
The thread-based method could not support more than 25 parallel threads before 
system memory limitations (- 350Mb) mandated that the program terminate. In 
contrast to this, the object-based approach supported 2500 concurrent genetic 
programs before realising the same memory limitations. In addition the object- 
based approach afforded significant improvements in system speed thereby 
motivating its use as the preferred training method for the eFMM kernel. The 
program code for this implementation is given in 
Appendix IV. Given the design overview of the GP-based DSA, the results 
obtained from simulations on the object-based approach are presented in the 
following section. 
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7.6.6 Results obtained from the GP-based DSA 
The GP-based DSA incorporating the eFMM kernel was executed with an initial 
population size of 50 programs. This was performed as a preliminary test to 
assess the performance of the system. The poorest performing 20% of the 
population was arbitrarily terminated between generations, thereby freeing space 
for new programs. Furthermore a probabilistic measure was applied to program 
crossover such that the highest fitting programs had the highest probability of 
breeding, in accordance with the genetic paradigm formalised by Holland 
[13,14]. The probability of mutation and reproduction were both 10%. 
Figure 7.12 shows the error curves for each population of 20 generations. 
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Figure 7.12. Error curves for the best and worst performing eFMM programs 
over 20 generations. 
Figure 7.12 shows that as the population changed from generation to generation, 
the average program MSE became smaller. After ascertaining that the GP-based 
eFMM did converge and that population MSE became smaller over the 
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generations, the experiment was conducted again with a larger population size 
(1000 programs) and over 100 generations. The early stopping criterion was that 
at least one program MSE <_ 0.25. Figure 7.13 shows the population MSE 
(sorted according to fitness) for the 100`h generation. The fittest program 
classified the training dataset (i. e., successfully predicted the surgical anaesthesia 
suitability group) with an accuracy of 89.86%, sensitivity of 88.37% and 
specificity of 92.11%. When presented with the test dataset, the fittest program 
correctly classified 91.79% (88.21 % sensitivity, 95.18% specificity). 
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Figure 7.13. Error curves for the best and worst performing eFMM programs 
over 100 generations. 
The optimal fuzzy rule-base, as derived by the fittest program on the final 
generation can be formulated as: 
Rule #1: (Suitable for surgical anaesthesia) 
IF (X(6) IS high) AND (X(9) IS NOT high) AND (X(30) IS medium) AND (X(4) IS low) OR 
(X(4) IS NOT high) AND (X(41) IS NOT high) OR (X(38) IS low) AND (X(5) IS NOT high) OR 
(X(8) IS low) AND (X(5) IS low) OR (X(41) IS NOT high) AND (X(3) IS low) AND (X(13) IS low) AND 
(X(7) IS NOT medium) AND (X(7) IS high) AND (X(IO) IS low) AND (X(17) NOT high) AND 
(X(l) IS NOT medium) OR (X(7) IS medium) AND (X(9) IS low) THEN (Y IS class I) 
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Rule #2: (Referral) 
IF (X(40) IS low) AND (X(5) IS high) AND (X(6) IS high) OR (X(5) IS NOT high) AND 
(X(8) IS NOT high) AND (X(17) IS NOT medium) AND (X(24) IS low) OR (X(22) IS NOT medium) AND 
(X(4) IS high) OR (X(4) IS NOT medium) AND (X(1) IS NOT high) OR (X(13) IS low) OR (X(5) IS high) 
OR (X(9) IS high) AND (X(3) IS medium) AND (X(10) IS low) OR (X(19) IS NOT low) AND 
(X(4) IS low) THEN (Y IS class 2) 
Rule #3: (Unsuitable for surgical anaesthesia) 
IF (X(5) IS low) AND (X(13) IS high) AND (X(8) IS low) AND (X(I1) IS high) AND (X(6) IS low) OR 
(X(4) IS NOT medium) AND (X(17) IS high) AND (X(12) IS NOT low) AND (X(3) IS high) AND 
(X(7) IS NOT low) AND (X(6) IS low) OR (X(28) IS high) OR (X(37) IS high) AND (X(2) IS high) AND 
(X(1) IS medium) THEN (Y IS class 3) 
These results were pruned manually. These results alongside the results of a 
benchmark case are discussed in Section 7.6.9. Section 7.6.8 discusses the 
relative performance obtained from the Evolutionary Fuzzy Neural Network 
[20,21]. The following section discusses the application of ANFIS to FIS 
generation and training. 
7.6.7 Application of ANFIS 
In benchmarking the GAv and GP systems, one would typically do so with 
reference to an established technique such as ANFIS. The ANFIS method of 
constructing and training a Sugeno FIS could not be undertaken in the context of 
this work due to the computational complexity of the technique. There were 44 
input variables to the DSA which ultimately would have resulted in the ANFIS 
prescribing 4445 decision rules; clearly an unacceptable number of rule 
permutations. It is plausible to suggest that a FIS with this number of rules, for a 
task such as this, is an inefficient implementation and as such a method of 
dynamic construction and pruning of the FIS connectionist architecture is 
desirable. In the following section we discuss the application of the Evolving 
Fuzzy Neural Network in the context of this problem. 
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7.6.8 Comparison with the Evolutionary Fuzzy Neural Network 
The Evolving Fuzzy Neural Network (EFuNN), introduced by Kasabov in 2001 
[20], is a hybridised intelligent systems paradigm. The system is a fuzzy ANN 
which allows for the construction of fuzzy rules from the network weights, and 
hence knowledge extraction. Furthermore the system implements a strategy of 
dynamically growing and pruning the connectionist (i. e., ANN) architecture. For 
a detailed treatment of the EFuNN architecture, the reader is referred to [20,21 ]. 
The EFuNN system was trained on the 150 sample training dataset, and 
subsequently tested on the 44 sample test dataset. During training, the EFuNN 
system generated 64 rule nodes. The training algorithm did not prune or 
aggregate any rule nodes during the training phase. The final training RMSE 
was 0.48. The system correctly predicted the surgical anaesthesia suitability 
class with an accuracy of 96.44% (94.67% sensitivity and 97.33% specificity). 
When tested with the remaining 44 samples the system attained a predictive 
accuracy of 90.91% (86.36% sensitivity and 93.18% specificity). The resulting 
EFuNN architecture alongside the attained predictive accuracies is given in the 
following section. 
7.6.9 Discussion 
When comparing the performances of the GAv and GP approaches, two criteria 
must be considered: system accuracy and architectural size. The former relates 
to the ability of the system to correctly predict the `surgical anaesthesia 
suitability' group, in accordance with the anaesthetist's decision. The second 
pertains to the `efficiency' of the decision i. e., how many antecedent rule-base 
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terms the system required in order to make the decision. As was evident from 
the rule-base evolved by the GAv eFMM, there were insufficient terms by which 
the system could make an accurate appraisal; yet the system attained an accuracy 
of 87.56%. This is suggestive of the GAv eFMM using the `suitable for 
anaesthesia' category as a default classification: a potentially dangerous mode of 
operation. In comparison, the GP-based approach resulted in a more complex 
rule-base which accounted for more input variables. This would suggest that the 
system offered `competition' between the rules, rather than the default-state case 
of the GAv-based system. Importantly however, it can be suggested that the 
problem is solvable in that the EFuNN technique succeeded in evolving a 
connectionist system in solution to the problem. A summary of the results 
obtained using the different approaches is given in Table 7.3. The main findings 
of this work are presented in the following section. 
DSA Approach Classification Accuracy 
Genetic Algorithm variant 90.91% 
Genetic Programming 91.79% 
Evolving Fuzzy Neural Network 90.91% 
Table 7.3. Summary of main results obtained from the GAv, GP and EFuNN 
approaches. 
7.7 Conclusions 
The work presented in the chapter has attempted to address the issue of 
categorising patients into the three `suitability for surgical anaesthesia' groups as 
given in Section 1.4. Two main approaches were investigated: a GAv-based 
approach, and a GP-based approach. It can be demonstrated that the process of 
knowledge discovery (i. e., the encapsulation of the anaesthetist's knowledge into 
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a fuzzy rule-based system) is possible, which is highlighted by the predictive 
accuracies obtained from both implementations. The GAv approach attained 
90.91% accuracy on the unseen, test dataset, whilst the GP approach attained 
91.79%. In terms of the complexity of the evolved systems, the GP 
implementation afforded a compact and robust rule-base from which to derive an 
understanding of the anaesthetist's decision-making strategy. These results, in 
combination with the work presented in Chapters 5 and 6, can be aggregated to 
form a DSA, as will be discussed in the next chapter. 
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CHAPTER 8 
Conclusions and Further Work 
This chapter summarises the main findings of this research and presents the 
conclusions which are formed. The chapter discusses further work that could be 
undertaken using this research and to deliver more generic clinical decision 
support tools; thus contributing to what may one day become the perfect 
healthcare assistant: the virtual doctor. This can provide the healthcare 
professional with all the information, etc. which they need so the professional 
can make the correct decision more effectively using more of the latest 
information as it becomes available over the health information network, 
worldwide web, etc. Section 8.1 summarises the main findings of this research, 
whilst Section 8.2 presents the main conclusions. Section 8.3 discusses further 
work and future potential avenues of research and development. 
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8.1 Summary of main findings 
The main findings of this research are presented as follows: 
" Data collection. In Chapter 4 it was proposed by the author that the 
collected data types constituted a sufficiently informative body of evidence 
on which to base a clinical decision as to the patient's suitability for 
anaesthesia. Given the ability of the DSA to learn the anaesthetist's decision- 
making strategy, it was found that the proposition was merited in that 
sufficient information could be conveyed during DSA learning. 
9 Cardiovascular data processing. In Chapter 5 it was demonstrated that the 
frequency spectra of an auscultated heart sound contained sufficient 
information on which to diagnose a cardiovascular abnormality. It was 
shown that the MLP could diagnose the abnormality with an accuracy of 
99.20%; the RBFN with an accuracy of 99.88%; and the CPNN with an 
accuracy of 89.17%. 
" Respiratory data processing. In Chapter 5 it was demonstrated that the 
Levinson-Durbin autoregression algorithm could reduce the dimensionality 
of the lung sounds frequency spectra whilst retaining enough information to 
enable the sounds to be diagnosed by the ANNs. It was shown that the MLP 
could diagnose the lung sounds with an accuracy of 67.11 %; the RBFN with 
an accuracy of 95.79%; and the CPNN with an accuracy of 97.80%. 
" Arterial pulse waveform analysis. In Chapter 6 it was demonstrated that a 
MLP could adequately reconstruct the arterial pulse waveform and hence 
enable an automated means of detecting MA and other forms of `noise' with 
98.0% accuracy. It was shown that the normal pulse waveform exhibited a 
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unique resonance peak that could be similarly used in identifying MA- 
corrupted waveforms with 100% accuracy (on the test dataset). 
" GP evolution of the DSA kernel. In Chapter 7 it was shown that the GP 
paradigm could be applied to the design of a decision support rule-base tool. 
It was further shown that the process of evolutionary DSA learning formed 
knowledge from the information content of the DSA inputs. It was 
subsequently demonstrated that the GP approach was superior to the GA- 
variant approach in this context in terms of computational complexity. 
The points above summarise the main findings of this research, presented in 
Chapters 4,5,6 and 7. The following section draws upon these findings in 
forming the main conclusions to this thesis. 
8.2 Conclusions 
The objective of this work was to attempt to capture and model the expert 
knowledge of the anaesthetist, and hence develop a decision support aid that 
would assist the physician in determining a patient's suitability for surgical 
anaesthesia. This thesis has tried to address this objective by decomposing the 
anaesthetist's perceived decision-making strategy into a plurality of 
(sub)problems. The three main problems were: 
1. How does the physician diagnose cardio-respiratory disease processes from 
the associated heart and lung sounds? 
2. How can the physician determine a normal arterial pulse waveform from a 
corrupted waveform, and hence validate the Sp02 measurement? 
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3. How can the anaesthetist combine the above diagnoses with additional 
patient information in determining their suitability for surgical anaesthesia? 
From the summaries presented in Section 8.1, it can be concluded that an 
automated means of cardio-respiratory disease process classification is possible 
using ANNs (individually and collectively). In particular, the frequency spectra 
of the heart and lung sounds provided sufficient information with which to form 
these classifications, and the parametric signal estimation coefficients could 
provide appropriate data for the ANNs to learn from. It can be concluded that 
Widrow's geometric mean approach to MLP topology estimation [1] provided a 
near-optimal MLP architecture with over 50% of the ANN effective parameters 
being used during learning. 
In the context of arterial pulse waveform identification, it is concluded that the 
neural spike-train method of data encoding allows for sufficient information to 
be assimilated by the MLP during learning. The MLP is shown to be able to 
predict the pulse waveform with a clinically acceptable degree of accuracy. 
Furthermore, it can be concluded that whilst stochastic resonance can provide a 
sufficiently informative classification of the arterial pulse waveform, the 
method's computational complexity may preclude its use in (near) real-time 
applications. 
The final conclusions relate to the function of the DSA; to its design; and to its 
performance in the context of the thesis objectives. In the context of this work, 
the main function of the DSA was to encapsulate the knowledge of the 
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anaesthetist, and do so in such a way that an understanding of the decision- 
making strategy could be imparted in the form of a rule-base. It is concluded that 
the evolutionary approach to rule-base generation is attractive, due to it being 
computationally efficient. This approach can confer the additional advantage of 
not generating overly-complex rules, thereby facilitating an easier understanding 
of the decisions it makes. 
A caveat to the provision of clinical decision support (such as the DSA) is given 
by Dreiseitl et al., [2]. The important question Dreiseitl et al., posed was 
whether a physician would accept the diagnosis of an automated expert system or 
change their diagnosis if contradicted by the system. In their study they assessed 
the diagnostic opinion of 52 dermatologists on 25 skin legion images. They 
found that when contradicted by the expert system 24% of the dermatologists 
were willing to change their decision. Dreiseitl et al., [2] also make two 
observations from their study that may potentially be applicable to this work: 
" the number of times a decision was reversed correlates negatively with 
the experience level of the physician using the system; and 
" physicians are more willing to accept a decision support system 
recommendation when they are not confident of their diagnosis. 
In conclusion, it is possible to encapsulate the knowledge of the anaesthetist in an 
expert decision support system, in determining whether a patient is suitable for 
surgical anaesthesia, and that this tool can - in theory - be adopted by the 
medical community. The contribution of this thesis is in the demonstration that 
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intelligent systems, such as ANNs, fuzzy systems and evolutionary techniques, 
can be applied to the healthcare domain in eliciting knowledge of the anaesthetist 
in the context of pre-operative anaesthesia assessment. 
8.3 Further work 
The work presented in this thesis can be extended on numerous fronts, the most 
potentially advantageous being generic clinical diagnosis. A generic model for 
clinical diagnosis can be formalised to be a combined process of pattern 
recognition and inductive reasoning. Pattern recognition is performed by the 
physician identifying patient symptoms with past experience; and inductive 
reasoning is derived from an understanding of the relationships between clinical 
biometrics, etc. An artificial implementation of this process could potentially 
exist in the form shown in Figure 8.1. 
D aonosuc 
Diagnos 
Machine 
Diagnostic 
Machine #4 
Figure 8.1. A network of clinical diagnostic machines. 
Diagnosis 
In Figure 8.1 it is proposed that there exists a network of 'diagnostic machines', 
i. e., a plurality of DSAs. From Figure 8.1, the diagnostic machine follows a 
structured approach of data processing (information elicitation) followed by 
211 
Chapter 8: Conclusions and Further Work 
some expert knowledge-base (KB) system. Each diagnostic machine can be 
created and updated in response to new data using for example a GP-based 
approach. 
For systems to exist like that presented in Figure 8.1, a large data repository 
containing biometric data and clinical diagnoses needs to be in place. With the 
emergence of electronic health records (EHRs), such a diagnostic system 
becomes possible. The Health Level 7 (HL7) international standard provides a 
technological framework for clinical information exchange between healthcare 
providers [3,4,5]. In particular HL7 standardises name-value paired messages in 
its framework (e. g., `name=haematocrit, value=44.1 %' [5]) and defines trigger 
events and responses [4]. This framework would work well with the proposed 
network of clinical diagnostic machines as these systems would be trained on the 
large datasets available through EHRs and implemented through the triggering 
mechanisms of HL7. 
A result of the proposals detailed in this section could be a large-scale distributed 
clinical diagnosis network, which is continually trained and updated on EHR 
datasets, and enacted when new patient data becomes available via 11L7 
messaging. Furthermore it can be envisaged that such a system can form part of 
a larger clinical monitoring and pro-active medical decision support system that 
can operate transparently. By dynamically creating, growing and pruning these 
clinical diagnostic machines in conjunction with continuous patient monitoring, 
greater understanding of medical abnormalities and their early detection may be 
possible. 
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APPENDIX I 
Derivation of the error BP algorithm 
This appendix describes the derivation of the error BP algorithm, as given by 
Rumelhart et al., [1]. This derivation is cited in Section 3.1.4, and demonstrates 
that the algorithm minimises the MLP training error by following the largest 
negative error gradient. The derivation is presented as follows. 
We start by defining the MLP output values as opj (where p is the MLP input 
pattern and j is the neurone under consideration). The difference between 
desired output values tpj and actual output values opj can be defined as 
Spy = tpj - opj . In order for the error BP algorithm to follow the largest negative 
error gradient, it should be shown that: 
aEp 
_= voJIPi oC Opwf,, (A1.1) 
IDWJ, 
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where ip; is the ith element of input pattern p and Apwj, is the change to be made 
to the weight from the ith to the jth neurone. Using the chain rule and 
considering output neurones only, the first derivative of the overall error with 
respect to the neuronal weight can be expressed in terms of the derivative of the 
overall error with respect to the neuronal output multiplied by the derivative of 
the neuronal output with respect to the weights: 
aEp 
= 
DE, ao,; 
aw; 
i 
aOpj aw;, (A1.2) 
From (A1.2) and considering that the neuronal output is a linear combination of 
its inputs and weights such that: 
Opi =ýwj, ipi, (A1.3) 
it can be shown that the two derivatives expressed in (Al. 2) can be reduced to - 
4,, j and ipf like so: 
aE 
_ 
P 
aOPl 
ao"_l 
. Pi Vjl (A1.4) 
Combining the two expressions given in (Al . 4) the resultant expression can be 
seen to be identical to that given in (A1.1) 
aEp 
^ gpjipi. (A1.5) 
ji 
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The same can be seen to apply to MLP network configurations containing hidden 
layers and is discussed in [1]. Given a two layer network consisting of input and 
output layers, the calculation of Spy is a trivial exercise. However, when 
considering an MLP consisting of hidden layers of neurones (such as that 
depicted in Figure 3.2), calculation of each neurone's contribution to the overall 
error becomes a more complex task [2]. Indeed, calculation of the hidden layer 
neuronal errors and the subsequent back propagation of these errors in the 
weight update procedure is how the algorithm is given its name. Derivation of 
the hidden layer errors and the output layer errors is now given. Generalising the 
notation to accomodate input and hidden neurones gives: 
net,, (A1.6) 
where o; = i; if the neurone is in the hidden layer, A semi-linear activation 
function f can be defined as being partially linear within a certain range and 
when applied to (3.3) and (A1.6) yields: 
opj = fj net ). (A1.7) 
Recalling that Apw;, oc 4,, ip, and subsituting opi for netp; in (Al. 2), the following 
expression can be obtained: 
3Ep 
_ 
aEp anetp, 
Ow,, - änetpj öwj, 
aEp a 
önet 
pj öwj7 
2: 
l 
w'k opk 
äEp 
önet., o°,. (A1.8) 
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Recalling (A1.4), it can be shown that: 
aE 
_ a118tPj ^ -SP 
and therefore by substitution (Al. 8) can be reduced to: 
DEp 8Ep 8netp1 
äwß; cýnet 
pj 
&j; 
_ -8pJop,. 
(A1.9) 
(A1.10) 
The objective becomes to compute the value of Spj for all neurones. Therefore 
given (A1.9), the following can be determined: 
aE aE a0. SP, __ PP PI (A1.11) 
anet,, aOP, artet., 
The second factor can be related to (A1.7) and it can be seen that: 
aoPJ 
änetP, = 
fj'(netp, ). (A1.12) 
Evaluation of the first factor of (A1.11) depends upon whether the neurone under 
consideration is an output layer neurone. If so, the expression given in (A1.4) 
may be applied such that the output neurone error can be expressed as: 
84 =(tpj-opi) fj(net,, j 
). (A1.13) 
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If the first factor of (A1.11) is not an output neurone (i. e., it is a hidden neurone), 
then the factor can to be expanded using the chain rule such that: 
äE. önetk 
= 
3Ep a 
k 
Önetpk [9Oß k 
anetpk ÖOpj 
wk`ýpis 
i 
aEp 
anetPk wk'' 
-1: Spk Wki 
k 
(A1.14) 
By substituting back into (Al. 11), the expression for calculating the value 4j 
becomes: 
SPA = fj(net,, 
)Egkwh, 
k 
(A1.15) 
which is a recursive expression. The expression given in (A1.15) can be solved 
iteratively during the weight updating process. Using (A1.13) and (A1.15) the 
neuronal weights of the MLP can be updated during the learning process, when 
input patterns are being presented to the network alongside the desired targets. 
Recalling (A1.1), the weight update expression can be given by: 
Apwiº - r1 13viovº (AI. 16) 
where the constant scalar i is the learning rate [1]. The larger this constant, the 
larger the changes in the weights. Termination of this algorithm occurs when the 
error gradient, calculated between iterations, falls below a certain threshold. 
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APPENDIX II 
Patient Information Sheet 
The following page gives the patient information sheet that was used to record 
the patient's clinical history. The information sheet is based on the design 
recommended by The Association of Anaesthetists of Great Britain and Ireland 
[1]. The sheet records information, and is split into the five categories: 
medication indicators, biohazard" indicators, haemodynamic indicators, 
cardiovascular disease indicators, and respiratory disease indicators (see 
Section 4.4). The patient information sheet is presented overleaf. 
References 
[1] Pre-operative assessment: the role of the anaesthetist, The Association of 
Anaesthetists of Great Britain and Ireland, London, 2001. 
220 
Appendix II., Patient information sheet 
PATIENT INFORMATION FORM 
PID 
-. ___... _... ý. _..... _____.... _. _..... ý_... _. __. 
DOB 
__.. _ _............ __........... . ý.. _.... ý .................... 
Gender: M/F 
Afro-Caribbean origin Blood disorders / anaemia 
Varicose veins Have crowns / false teeth 
Excessive alcohol intake IBD 
Infection Smoker > 40 per day 
Rheumatoid arthritis Bleeding disorder 
Diabetic Thyroid disease 
Pneumonia / Chronic bronchitis 
Asthma (well controlled) 
SOB at rest 
Pregnancy 
Asthma (req. hospital admission) 
Has liver disease 
Stroke / CVA 
Kidney / urinary problems 
Epilepsy 
Cardiovascular disease 
Malignancy 
Productive cough 
Wound 
Respiratory disease 
Diuretics Contraceptive pill 
Warfarin Inhalers 
HRT Aspirin 
Steroids 
MRSA Infection HIV 
Hepatitis B Hepatitis C 
Active TB 
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APPENDIX III 
Sp02 Fuzzy Inference System Rule-Base 
This appendix gives the FIS rule-base and membership function parameters after 
training with the ANFIS technique. The FIS was generated in Section 6.4.1, and 
contained 81 rules in its rule-base. Each rule followed the form: 
If (x1 is A,, ) and (x2 is Bq) and (x, is C, ) and (x4 is D, ) Then y=C, (A3.1) 
for all combinations of p, q, r and s which correspond to high, medium and low 
(i. e., 34 81 rules), where x are the input variables. (A3.1) can be reformulated: 
)`(xI)x*"aq (xz)XPc, (x3)x*Un, (x4), 
f a, x, +. ß, x2+x, x3+8; x4+si, 0<i581, (A3.2) 
C 
The values a,, A, x,, ä, and c, for all rules are given in Table A3.1. 
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Consequent Consequent parameters for rule i 
Rule a, (Gender) (Age) , (History) 9SO c, (Offset) 
1 -9.805x10'' -10.72 0.00927 -0.3561 -0.388 
2 -0.001016 2.176 0.003064 -16.59 -18.03 
3 0.002381 0.01703 0.03277 -2.771 3.651 
4 -0.0001622 3.423 0.1393 0.1118 0.116 
5 -0.001188 0.07244 0.04603 -0.8499 -1.01 
6 -0.0005959 -0.07223 0.4924 0.01073 0.7043 
7 -0.002689 69.55 2.383 2.277 2.382 
8 -0.01939 -0.9372 0.7879 2.03 0.7177 
9 -0.01263 -1.258 8.427 2.962 8.441 
10 -0.001376 0.1589 0.04785 3.06 2,659 
11 0.002216 0.1633 -0.0134 22.76 -30.28 
12 0.00211 0.00293 0.05943 -0.1392 1.223 
13 -0.01447 -0.1824 0.7188 0.8697 0.8717 
14 0.0003271 0.00613 -0.2013 2.149 -1.974 
15 -0.005852 -0.004401 0.8928 -1.339 0.9609 
16 -0.2473 -3.294 12.3 11.88 12.31 
17 0.003398 -0.05837 -3.445 14.11 -3.563 
18 -0.1027 -0.07856 15.28 -22.87 15.28 
19 -0.001009 0.09002 0.05675 -0.5454 -1.434 
20 4.35x 10-5 0.239 0.2205 -37.82 19.27 
21 -0.006448 0.02006 0.1078 3.04 -3.003 
22 -0.01519 -0.009026 0.8525 0.9347 0.7652 
23 -0.0006701 0.01171 3.312 -8.818 4.428 
24 0.00565 0.01228 1.62 -3.836 1.437 
25 -0.26 -0.2453 14.59 16.61 14.59 
26 -0.01156 -0.03836 56.68 -113.6 56.76 
27 0.1035 0.1909 27.72 -68.95 27.71 
28 -0.001475 -0.6356 0.0003853 -0.02318 -0,02416 
29 -0.01529 0.1318 -0.0009508 -0.9878 -1.07 
30 0.03583 0.002047 0.00118 -0.1823 0.2491 
31 -0.002441 0.5397 0.005788 -0.01012 0.00435 
32 -0.01787 0.007951 -0.01428 -0.07566 -0.07688 
33 -0.008967 -0.005864 0.01772 0.06501 0.03225 
34 -0.04046 9.91 0.09906 -0.1507 0.09896 
35 -0.2917 0.004457 -0.2445 -0.3097 -0.2486 
36 -0.19 -0.1028 0.3033 1.3 0.3043 
37 -0.0207 0.01313 -0.01162 0.1192 0.1349 
38 0.03335 0.009801 -0.0005858 1.313 -1.737 
39 0.03175 0.0005921 -0.002511 -0.03051 0.1031 
40 -0.2177 0.008493 -0.1745 -0.7521 -0.1659 
41 0.004921 0.0005427 . 0.008801 0.1124 -0.1105 42 -0.08806 -3.429x 10"5 -0.03772 0.2018 -0.03153 43 -3.721 0.1328 -2.987 -13.04 -2.986 44 0.05113 -0.000501 -0.1506 0.6141 -0.1574 45 -1.545 -0.001183 -0.6455 3.498 -0.6451 46 -0.01518 0.0004206 -0.01184 -0.05687 -0.09895 47 0.0006545 0.01493 0.01222 -2.216 1.127 48 -0.09702 0.008345 0.01234 -0.008907 -0.2722 49 -0.2285 0.01078 -0.1778 -0.3205 -0.1829 50 -0.01008 0.001003 0.1835 -0.4979 0.2488 51 0.08501 0.001899 0.1854 -0.5643 0.1687 52 -3.912 0.1849 -3.043 -5.449 -3.044 53 -0.1739 0.002276 3.141 -6.333 3.146 54 1.558 0.02427 3.173 -9.687 3.172 
Continued... 
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Consequent Conseq uent arameters for rule i 
Rule a, (Gender) , (Age) r (History) aSO sr (Offset) 
55 -0.0252 -0.1964 -0.002652 -0.04176 -0.02671 
56 -0.2612 0.08688 -0.01936 -0.3667 -0.3314 
57 0.612 0.0181 -0.0125 -0.3588 0.6262 
58 -0.0417 5.836 -0.03984 -0.2852 -0.04125 
59 -0.3053 0.064 -0.2909 -0.4485 -0.3092 
60 -0.1532 -0.02842 -0.1878 1.104 -0.1504 
61 -0.6912 100.5 -0.6818 -4.858 -0.6819 
62 -4.983 1.013 -4.979 -7.338 -4.98 
63 -3.245 -0.5064 -3.215 19.33 -3.212 
64 -0.3536 0.06646 -0.247 -1.013 -0.3432 
65 0.5696 0.00499 0.003336 -0.2072 0.4518 
66 0.5424 0.007228 -0.1024 -0.3841 0.5471 
67 -3.72 0.3278 -3.71 -13.77 -3.716 
68 0.08406 0.003184 0.05012 -0.2195 0.07639 
69 -1.504 0.003808 -1.538 4.798 -1.5 
70 -63.55 5.566 -63.5 -235.5 -63.5 
71 0.8733 0.0497 0.8577 -3.563 0.8595 
72 -26.39 0.05818 -26.33 82.83 -26.33 
73 -0.2594 -0.0827 -0.2596 -0.4306 -0.2649 
74 0.01118 0.01727 -0.01069 -0.2338 0.08614 
75 -1.657 0.1231 0.1039 -3.19 -1.669 
76 -3.904 0.1939 -3.901 -6.429 -3.901 
77 -0.1722 0.005509 -0.1607 0.2695 -0.155 
78 1.452 0.02031 1.562 -5.846 1.458 
79 -66.82 3.415 -66.76 -110 -66.76 
80 -2.97 0.07734 -2.75 4.864 -2.75 
81 26.61 0.2255 26.73 -97.25 26.72 
Table A3.1. Consequent parameters for the Sp02 FIS rule-base. 
Analysis of the values presented in Table A3.1 is given in Section 6.4.1. The 
input variable membership functions (3 membership functions per variable) are 
given in Figure A3.1. 
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Figure A3.1. Membership functions for the four FIS input variables 
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APPENDIX IV 
Evolutionary FMM Source Code 
The source code for the three eFMM implementations may be found on the 
compact disc accompanying this thesis (back page). There are three directories 
on the disc: eFMM matlab, GP 
_thread 
j ava, and GP_ob j ect_j ava. The Java 
implementations will require compiling, and for optimal results, the author 
recommends the free Java J2SE compiler (part of the standard software 
development kit) available for download from http: //java. sun. com. 
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